The role of biofeedback in improving anal continence after anterior resection by Pilkington, Sophie A.
University of Southampton Research Repository
ePrints Soton
Copyright © and Moral Rights for this thesis are retained by the author and/or other 
copyright owners. A copy can be downloaded for personal non-commercial 
research or study, without prior permission or charge. This thesis cannot be 
reproduced or quoted extensively from without first obtaining permission in writing 
from the copyright holder/s. The content must not be changed in any way or sold 
commercially in any format or medium without the formal permission of the 
copyright holders.
  
 When referring to this work, full bibliographic details including the author, title, 
awarding institution and date of the thesis must be given e.g.
AUTHOR (year of submission) "Full thesis title", University of Southampton, name 
of the University School or Department, PhD Thesis, pagination
http://eprints.soton.ac.ukSA Pilkington    References 
  1   
 
The Role of Biofeedback 
in Improving Anal 
Continence after 
Anterior Resection 
 
Thesis for the Degree of Doctor of Medicine 
 
August 2010 
 
University of Southampton 
School of Medicine 
Division of Cancer Sciences 
 
Sophie A. Pilkington, FRCS SA Pilkington    Abstract 
  1   
CANCER SCIENCES 
SCHOOL OF MEDICINE 
DM 
THE ROLE OF BIOFEEDBACK IN IMPROVING ANAL CONTINENCE AFTER ANTERIOR 
RESECTION 
By Sophie Anne Pilkington 
 
Incorporation of routine biofeedback into the management of patients with rectal 
cancer who are undergoing anterior resection offers potential for improved anal 
continence compared with standard management. A multicentre randomised controlled 
trial was performed to investigate this and 121 participants undergoing major rectal 
resection were randomly assigned to receive biofeedback training. In the control group 
participants received standard management. Randomisation was stratified for 
preoperative radiotherapy exposure. The primary end point was Cleveland Clinic 
Incontinence (CCI) score at 1 year. Analysis was by intention to treat (ITT). Secondary 
end points were serial symptom-score, quality of life questionnaires and anorectal 
physiology measured during the first postoperative year. 
 
Follow-up to one year was completed by 89 participants. A mean CCI score of 4 was 
recorded at 1 year in both groups. Before anterior resection, 15 (17%) participants 
reported severe anal incontinence. At 3 months after anterior resection, 27% of 
participants reported severe anal incontinence, which caused a negative impact on 
their quality of life. Function improved in some participants but 15% complained of 
severe anal incontinence at one year. 
 
Anal continence after anterior resection is a poorly defined problem. Although no 
advantage was found by the addition of routine biofeedback to standard management, 
this study establishes a working definition for “Anterior Resection Syndrome” and 
evaluates methods for measuring the structural and functional abnormalities 
associated with it. Symptom-score and quality of life questionnaires, anorectal 
physiology and proctography are frequently used to evaluate pelvic floor patients but 
are also relevant to assess anterior resection patients. 
 
An additional study was carried out to compare Barium (BaP) and MR proctography.  
BaP reproduced rectal emptying and demonstrated structural abnormalities to a 
greater extent than MR proctography and would be the best test for assessing 
structural abnormalities after anterior resection.  
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Rectal cancer (See Figure 1.1) is the fifth most common cancer in both sexes in 
England and Wales (Quinn, Babb, Brock, Kirby, & Jones, 2009). The five-year relative 
survival for adults (15-99 years) diagnosed with rectal cancer between 2001 and 2006 
and followed up to 2007 was 51% for men and 55% for women (Walters et al., 2009). 
Rectal cancer is more frequent in men than women and the annual numbers of patients 
diagnosed during 2001 to 2006 were 6,340 men and 4,070 women (total: 10,410) 
(Walters, et al., 2009). Recent advances in surgical technique, chemotherapeutic 
options and radiotherapy have resulted in an improvement in survival and reduced 
permanent stoma rates (Kirwan, O'Riordain, & Waldron, 1989). Over the last 2 decades 
there has been an increase in five-year relative survival of 22% in rectal cancer (Trends 
in Cancer Survival in Scotland 1980-2004) (ISD National Service Scotland, 2009). It is 
predominantly a disease of the elderly. In 2001, the Office for National Statistics 
recorded that 71% of patients presenting with rectal cancer were aged 60 years or 
older in England and Wales and 53% were aged 70 years or older (Office for National 
Statistics, 2009). 
 
Cancer of the colon is more common than rectal cancer (Figure 1.2) with 16,880 
patients diagnosed annually. Colorectal cancer is the second commonest cause of 
death from cancer in the UK (Figure 1.3). Cancers of the colon and rectum are often 
considered together as colorectal cancer as they present with common symptoms 
either as an emergency or chronically (See Table 1.1) (M. R. Thompson et al., 2003).  
 SA Pilkington    Introduction 
  21   
 
 SA Pilkington    Introduction 
  22   
14%
7%
3% 4%
3%
5%
27%
37%
 SA Pilkington    Introduction 
  23   
 
0 10,000 20,000 30,000 40,000
Other cancers
Bone and connective tissue
Uterus 
Oral
Mesothelioma
Malignant melanoma
Multiple myeloma
Liver
Brain with central nervous system
Kidney
All leukaemias
Ovary
Non-Hodgkin lymphoma
Bladder
Stomach
Pancreas
Oesophagus
Prostate
Breast
Colorectal
Lung
Number of deaths
Males
FemalesSA Pilkington    Introduction 
  24   
 
  Rectal bleeding with a change in bowel habit to looser stools or increased 
frequency of defaecation persisting for 6 weeks (all ages) 
  Change in bowel habit as above without rectal bleeding and persisting for 6 
weeks (>60 years) 
  Persistent rectal bleeding without anal symptoms (soreness, discomfort, 
itching, lumps, prolapse or pain) (>60 years) 
  Palpable right-sided mass (not pelvic) (all ages) 
  Palpable rectal mass (not pelvic) (all ages) 
  Unexplained iron deficiency anaemia (all ages) 
 
  Rectal bleeding with anal symptoms and no persistent change in bowel habit 
(all ages) 
  Rectal bleeding with an obvious external cause, e.g. anal fissure (all ages) 
  Change in bowel habit without rectal bleeding (<60 years) 
  Transient changes in bowel habit, particularly to harder or decreased frequency 
of defaecation (all ages) 
  Abdominal pain as a single symptom without signs and symptoms of intestinal 
obstruction (all ages) 
 
Patients with higher risk symptoms should have the large bowel visualised with either 
colonoscopy, CT colonography (Kuwayama, Iimuro, Kitazumi, & Luk, 2002) or barium 
enema with sigmoidoscopy to search for suspected colorectal cancer. The gold 
standard for diagnosis is the presence of adenocarcinoma on histology from 
endoscopic biopsy. Once the diagnosis is established, preoperative imaging with a CT 
scan of the chest, abdomen and pelvis is used to predict staging of the cancer. In the 
case of rectal cancer, an MRI scan is also performed to predict involvement of the 
circumferential resection margin (CRM) (Brown & Daniels, 2005) and the T and N SA Pilkington    Introduction 
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staging of the tumour. This is important for the selection of patients for preoperative 
radiotherapy (Sebag-Montefiore et al., 2009). There may be a role for rectal ultrasound 
in selecting patients for short course radiotherapy (Garcia-Aguilar et al., 2002; Mackay, 
Pager, Joseph, Stewart, & Solomon, 2003; Pilkington, Winter, Harris, & Nugent, 2009). 
 
 
 
A precise clinical definition of the boundaries and length of the rectum is not 
universally recognised. This is at least in part because it is extremely difficult to 
measure the length of a curved distensible tube that is located deep within the bony 
pelvis and does not have start and end points that are easily identifiable clinically.  
 
The sigmoid colon has a mesentery and the rectum does not. Therefore the 
rectosigmoid junction is located where the sigmoid mesentery ends. Anatomically this 
is located over the third part of the sacrum. The three taeniae coli broaden out over the 
sigmoid colon and then fuse together over the rectum to form a complete outer layer 
of longitudinal muscle with no appendices epiploicae or diverticulae. Despite its name 
(“rectus” comes from the Latin meaning “straight as if ruled”) the rectum is curved, 
following the concavity of the lower sacrum, coccyx and pelvic floor (Sinnatamby, 
1999). It has three lateral curves with the middle portion passing to the left. The lower 
part of the rectum is supported on the levator ani muscle before passing through the 
pelvic floor between the puborectalis sling posteriorly and the perineal body anteriorly 
to become the anal canal. In the upper third of the rectum, peritoneum covers the 
anterior and lateral surfaces. In the middle third, peritoneum covers only the anterior 
surface and the lower third is below the level of the peritoneal reflection. In men, the 
peritoneum sweeps over the upper part of the bladder to form the rectovesical pouch 
and in women it is reflected over the upper vagina to form the rectouterine pouch (of 
Douglas). The rectum is about 12cm long. When measured from the anal verge with a 
rigid sigmoidoscope the rectosigmoid junction is located at approximately 15cm 
(Lowry et al., 2001). Unfortunately the anal verge is not a fixed point and, particularly 
in large patients, it can be difficult to identify accurately. In addition, this measurement 
includes the anal canal which is of variable length. The surgeon needs to gauge 
whether an anastomosis can be safely performed with sphincter preservation. The 
height of the tumour above the uppermost part of the sphincter is critical in making 
this assessment. Some surgeons recommend measuring tumour height from the 
dentate (or pectinate) line (Phillips, 1992). The dentate line marks the embryological 
change from anal skin (ectoderm) to rectal mucosa (endoderm) and can be felt as a 
difference in “slipperiness”. 
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The UK Coordinating Committee on Cancer Research defines a rectal cancer as a 
tumour within 15cm of the anal verge on rigid sigmoidoscopy (United Kingdom 
Coordinating Committee on Cancer Research (UKCCCR), 1989) and this definition will 
be used for the current research project.  Additional useful clinical information about 
the cancer include whether the tumour is fixed or not, height of the lowermost part of 
the tumour and position in a coronal plane (anterior, posterior, left, right or 
circumferential). The height of the cancer is often summarised according to which third 
of the rectum it is located in (upper, mid or lower). 
 
 
 
The lifetime risk of colorectal cancer in the general UK population is about 5%. 
Colorectal cancer develops as the result of a complex interaction between an 
individual‟s genotype and their environment. In less than 5%, the contribution of 
inheritance is significant and these individuals have a high risk of developing colorectal 
cancer. In a further 30% genotype may influence the development of colorectal cancer 
but in a less predictable fashion.  
 
It is useful to subdivide the population into three broad categories (low medium and 
high) according to risk of developing colorectal cancer based on their family history. 
See Table 1.2 
 
Most people fall into the low-risk group.  Those people in the low-risk group, who are 
also aged between 60 and 69 years, are increasingly being screened by the NHS Bowel 
Cancer Screening Programme (BCSP). The BCSP uses faecal occult blood testing to 
select patients for colonoscopy (Hewitson, Glasziou, Irwig, Towler, & Watson, 2007). 
 
People in the moderate-risk group have a three to six-fold relative risk and should be 
offered colonoscopy at 35 to 40 years and again at 55 years (Dunlop, 2002).  
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  No personal history of bowel cancer; no confirmed family history of bowel 
cancer 
  No first-degree relative (parent, sibling or offspring) with bowel cancer 
  One first degree relative with bowel cancer diagnosed at age 45 or older 
  One first-degree relative with bowel cancer diagnosed before the age of 45 
years (without high-risk features described below) 
  Two first-degree relatives with bowel cancer diagnosed at any age (without 
the high-risk features outlined below) 
  Member of a family with known FAP or other polyposis syndrome 
  Member of a family with known HNPCC 
  Pedigree suggestive of autosomal dominantly inherited colorectal cancer 
 
In the high-risk group there is a 1 in 2 chance of inheriting a high risk of developing 
bowel cancer. These patients should be referred to a clinical genetics team. Hereditary 
non-polyposis colorectal cancer (HNPCC) and familial adenomatous polyposis (FAP) are 
the main conditions in the high risk group and are autosomal dominant. HNPCC is the 
commonest and accounts for about 2% of colorectal cancers. It is characterised by an 
early onset of colorectal tumours with the average of diagnosis being 45 years. 
Tumours tend to be in the proximal colon and are also frequently multiple, both 
synchronous and metachronous. Typical histological features include mucinous, poorly 
differentiated tumours with „signet-ring‟ appearance and microsatellite instability (MSI) 
detected with immunohistochemistry (Frayling, 1999). In 1984, HNPCC was divided 
into Lynch syndrome I which includes those with colorectal cancer diagnosed at a 
young age and Lynch syndrome II which describes those with both colorectal and 
extracolonic cancers (Thorson, Knezetic, & Lynch, 1999). The frequency of developing 
a large bowel cancer in HNPCC is 80%. Associated cancers include gastric (15%), 
urothelium (5%) and in women endometrium (40%) and ovary (12%). HNPCC is due to 
germline mutations in mismatch repair (MMR) genes. MMR genes are responsible for 
repairing errors in base-pair matching during replication of DNA. They are tumour 
suppressor genes. Defective MMR results in multiple mutations leading to tumour 
formation. Genetic testing is expensive. Selection of individuals for genetic testing is 
based on assessment of pedigree according to the Amsterdam criteria which were 
proposed in 1990 and modified in 1999 (Vasen, Watson, Mecklin, & Lynch, 1999). SA Pilkington    Introduction 
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Although families who fulfil these criteria are very likely to have HNPCC, not all 
affected families will have a positive pedigree. 
 
In HNPCC, regular colonoscopic surveillance is recommended every 2 years from the 
age of 25 years or 5 years younger than youngest affected relative if earlier. 
Alternatively prophylactic colectomy may be performed. Once a colorectal tumour has 
been identified, subtotal colectomy with ileorectal anastomosis or restorative 
proctocolectomy is recommended. 
 
FAP is less common than HNPCC but the risk of colorectal cancer is nearly 100%. It is 
characterised by hundreds of adenomatous polyps in the colon and rectum. Duodenal 
adenomatous polyps are common and there are multiple extraintestinal manifestations 
including the development of desmoid tumours. The mutation responsible for FAP is in 
the adenomatous polyposis colic (APC) gene on chromosome 5q. The mutation varies 
between families but can be located in approximately 80% of affected individuals. Once 
the diagnosis is made, prophylactic surgery is offered before a cancer develops. 
 
 
 
The aim of treatment for rectal cancer is to provide cancer cure whilst preserving 
quality of life and bowel, bladder and sexual function as much as possible. Therapeutic 
options for achieving this include surgery, radiotherapy and chemotherapy. When there 
is no likelihood of cure due to the extent of local disease, presence of distant 
metastases or patient co-morbidity, aggressive treatment with these modalities is not 
appropriate. 
 
An individualised management regime for each patient with a diagnosis of rectal 
cancer is planned at dedicated colorectal cancer multidisciplinary team meetings 
(MDT). Consultants with a special interest in colorectal cancer contribute to the 
meeting and this includes representatives from colorectal surgery, oncology (medical 
and clinical), pathology and radiology. Other core members of the MDT are colorectal 
nurse practitioners, stoma therapists, oncology nurses, MDT co-ordinator and 
psychiatric support. 
 
Once the diagnosis of rectal cancer is established with a biopsy showing 
adenocarcinoma, a search is made for metastatic disease. This includes a thorough 
history and physical examination as well as a CT scan of the chest, abdomen and 
pelvis. The extent of local disease is assessed with a pelvic MRI scan. In particular, 
involvement of the CRM is assessed. Where there is CRM involvement, long course SA Pilkington    Introduction 
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chemoradiotherapy may be offered to the patient prior to surgical resection with the 
aim of reducing local recurrence. If the CRM is not involved, patients either have 
surgery alone or if the tumour is thought to be T3 on MRI, patients may be selected for 
short course radiotherapy prior to resection. 
 
Patients with a mid or upper rectal cancer who have no metastatic disease and a 
resectable tumour are suitable for an anterior resection, providing they do not have 
major co-morbidity which precludes general anaesthesia. In cancers of the lower 
rectum, a careful evaluation of the height of the tumour above the sphincter complex 
is necessary to determine whether sphincter-preservation is possible without 
compromising excision of the tumour. Where the anal sphincter is involved or is too 
close to the tumour for complete excision, an abdominoperineal resection (APR) is 
performed with the creation of a permanent stoma and excision of the anal canal in 
continuity with the rectum. Higher local recurrence rates have been found after APR 
(Hewitson, et al., 2007) and it is important to perform total mesorectal excision (TME) 
without “waisting” of the specimen. 
 
The situation is more complicated in the presence of metastatic disease. However, 
where complete resection of all metastases is possible without compromising vital 
structures, rectal resection is still recommended. The 5-year cancer specific survival 
rate after liver resection for colorectal metastases is 36% (Rees, Tekkis, Welsh, 
O'Rourke, & John, 2008). Patients with the best prognostic indicators after hepatic 
surgery have a 5-year cancer specific survival of 64%. 
 
  1.4.1
The aim of an anterior resection is to remove part or all of the rectum with its 
surrounding lymphovascular structures while preserving a functioning anal sphincter 
(Heald, Husband, & Ryall, 1982; MacFarlane, Ryall, & Heald, 1993). Intestinal continuity 
is maintained with anastomosis of the sigmoid colon to the remaining rectum or 
superior anal canal. A circular double stapling device is most commonly used to create 
the anastomosis and this is introduced via the anus. The development of such circular 
stapling devices has enabled surgeons to perform a lower pelvic anastomosis more 
easily and has consequently reduced the rate of permanent stomas (Kirwan, et al., 
1989). Alternatively a hand-sewn anastomosis may be created. In very low anterior 
resections this can be performed transanally. A temporary loop ileostomy is employed 
in selected cases to divert the faecal stream and allow the anastomosis to heal. This is 
particularly important after radiotherapy and low rectal anastomosis. There is 
conflicting evidence to suggest that a stoma may reduce leak and re-operation rates 
(Tan, Tang, Shi, & Eu, 2009; Wong & Eu, 2005). The integrity of the anastomosis is SA Pilkington    Introduction 
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assessed after 2 months with a gastrografin enema. Providing no leak is seen, a 
second operation to reverse the ileostomy can be performed. Although a much smaller 
operation, closure of ileostomy is not trouble-free and morbidity rates of up to 23% 
and mortality rates of 2.5% have been reported (Gastinger et al., 2005; Machado et al., 
2002; Saha et al., 2009). 
 
The importance of performing TME, which includes removal of the entire 
lymphovascular package surrounding the rectum, was popularised by Professor Heald 
from Basingstoke in the 1980‟s and is now well-recognised (Heald, et al., 1982; 
MacFarlane, et al., 1993). A reduction in both 5-year cancer specific survival and local 
recurrence rates has been demonstrated after the introduction of this method (A. 
Martling et al., 2005; A. L. Martling et al., 2000). Sharp dissection with diathermy is 
used to remove the complete mesorectum under direct vision. In contrast, blunt 
dissection with a finger or hand passed blindly into the depths of the pelvis, results in 
fragmentation of the mesorectum with tissue left behind that may contain cancer. 
 
Complications of anterior resection include general complications of major surgery 
such as thrombo-embolism, cardiac arrhythmias, myocardial infarction, respiratory 
compromise and wound problems such as infection, dehiscence, herniation and cancer 
implantation. More specific complications include anastomotic leakage (6%), 
bowel/bladder/sexual dysfunction and local cancer recurrence. The risk of death 
following anterior resection varies according to patient co-morbidity and anaesthetic 
risk, but on average the 30-day mortality rate is 2 - 3% (Branagan & Finnis, 2005). 
 
Although  intestinal continuity is preserved by an anterior resection, up to 50% of 
patients may experience „anterior resection syndrome‟ with faecal leakage, urgency 
and frequency (Karanjia, Schache, & Heald, 1992). Such symptoms are distressing to 
the patient and adversely affect their quality of life (Mellgren et al., 1999). Changes 
detected with anorectal ultrasound and physiological studies of the anal sphincter 
before and after anterior resection have been shown to correlate with changes in anal 
continence reported by the patient (Farouk, Drew, Duthie, Lee, & Monson, 1996; 
Farouk, Duthie, Lee, & Monson, 1998; Lee & Park, 1998). Patients with pathology up to 
30cm from the anal verge also undergo anterior resection and experience similar 
functional problems. In one small study of 39 patients undergoing stapled low anterior 
resection, 18% had long-term evidence of internal anal sphincter disruption and this 
was associated with a poorer functional outcome (Farouk, et al., 1998). Serial 
manometry has demonstrated a moderate reduction in maximal anal resting pressure 
and loss of the rectoanal inhibitory reflex. A study of 32 patients demonstrated the 
RAIR before surgery in 30/32 cases but in only 8/32 cases at 3 months after surgery. SA Pilkington    Introduction 
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There was some recovery of the reflex with 4 patients regaining RAIR. The RAIR was 
not essential for full continence (Lee & Park, 1998). 
 
Health-related quality of life assesses the personal burden of illness. This is not directly 
related to stage of disease but by how the disease is perceived by the patient. It is 
important that patients assess their own quality of life rather than health-care 
professionals trying to guess or assume what it might be. Over the last 20 years, 
measurement of quality of life has gained importance, as health-care professionals 
have recognised the value of using treatment to improve function and how the patient 
feels, in addition to simply curing the underlying condition.  
 
Faecal incontinence is one of the most debilitating complications of surgery for rectal 
cancer. The most commonly used endpoint of surgical treatment for rectal cancer is 
survival. Much emphasis is also placed on avoiding a stoma, achieving a complete 
surgical excision and reducing cancer recurrence rates (Scott et al., 1995). However, 
the functional outcome of the neorectum is also a significant factor for patients 
(Karanjia, et al., 1992). 
 
  1.4.2
Radiotherapy is useful for reducing local recurrence in an adjuvant role (short course 
preoperative radiotherapy with high doses usually 25Gy in five daily fractions) and for 
reducing tumour bulk to enable complete resection where CRM involvement is 
predicted (long course preoperative chemoradiotherapy with lower doses usually 45Gy 
over 5 weeks with fractions of 2Gy). Radiotherapy is associated with toxicity related to 
treatment volume, total dose, fraction size and irradiation field. Complications include 
altered bowel, sexual and bladder function. Surgery remains the key to cure for 
patients with rectal cancer but it also results in a significant insult to anorectal 
function. Advances in surgical technique and radiotherapy have occurred at the same 
time and this has obscured their relative risks and benefits.  
 
The benefit of radiotherapy in terms of reduced local recurrence is well documented in 
several large trials (Colorectal Cancer Collaborative Group, 2001; Holm, Rutqvist, 
Johansson, & Cedermark, 1995; Kapiteijn et al., 2001; Sebag-Montefiore, et al., 2009). 
Preoperative function was not included in all these studies (Holm, et al., 1995; 
Kapiteijn, et al., 2001) and uniformity of surgery was not always rigorously 
demonstrated (Holm, et al., 1995). In addition, radiotherapy fields have been improved 
so that the anal sphincter is no longer included in the irradiation (Cedermark, 
Johansson, Rutqvist, & Wilking, 1995; A. Martling, Holm, Johansson, Rutqvist, & 
Cedermark, 2001). Despite large numbers of randomised trials (Colorectal Cancer SA Pilkington    Introduction 
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Collaborative Group, 2001; Peeters et al., 2005), there is still debate over the role of 
short course radiotherapy in rectal cancer patients who have surgery with TME 
dissection. The CR07 trial randomised 1350 patients to either short course 
preoperative radiotherapy or salvage long course postoperative radiotherapy for 
patients with involved resection margin. A lower local recurrence rate was 
demonstrated for all pathological stages in the short course group (Sebag-Montefiore, 
et al., 2009), but this was small for cancers with histology staging T2 or less. Although 
CR07 was carried out in the era of TME, there was no formal assessment of surgical 
technique. The excised specimens were assessed for completeness and patients who 
had a superior dissection (according to specimen features) and radiotherapy had a 
local recurrence rate of only 1% (Quirke et al., 2009). Individual surgeons often entered 
only a few patients into the trial and these patients may not be representative of the 
whole population of rectal cancer patients. The CR07 Trial did include assessment of 
quality of life using EORTC QLQ-CR38 instrument but completion rates were not high 
(Stephens et al., 2009). At baseline 87% completed the questionnaire and this fell to 
61% (proportion of those alive) at one year. The assessment of overall bowel function 
did not differ between the two treatment arms. However the participants who received 
routine short course preoperative radiotherapy reported a worse score for 
“unintentional release of stools” at 2 years but this was not significant (p=0.12). 
 
Many unanswered questions remain about short course radiotherapy. In particular, 
whether patients can be selected for short course preoperative radiotherapy with an 
added reduction in local recurrence which occurs in addition to TME dissection and 
what the cost of this is in terms of reduced anorectal function. The MERCURY study 
(Brown, 2006) establishes pelvic MRI as an accurate method for assessing CRM and 
thereby selecting patients for long course chemoradiotherapy. The group of patients 
who are most likely to benefit from short course radiotherapy are those with T3 
disease, however MRI is not so accurate for T staging (Bolgeri et al., 2009; Branagan, 
Chave, Fuller, McGee, & Finnis, 2004). There may be a role for rectal ultrasound for 
identifying patients for short course radiotherapy (Pilkington, Winter, et al., 2009; 
Starck, Bohe, Fork, Lindstrom, & Sjoberg, 1995).  
 
The long-term effect of radiotherapy on anorectal function has not been extensively 
studied. Surgery probably has the biggest effect on function, but there is evidence to 
suggest that radiotherapy has an added detrimental effect (Bordeianou et al., 2008; 
Jang et al., 2010; Peeters, et al., 2005; Pollack, Holm, Cedermark, Holmstrom, & 
Mellgren, 2006). Pollack et al assessed 64 patients randomised within the Stockholm 
Radiotherapy Trials 1 & 2 to low anterior resection only or short course preoperative 
radiotherapy (Pollack, et al., 2006). Mean follow-up time was 14 years (range 9 to 23). SA Pilkington    Introduction 
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Faecal incontinence was defined as involuntary leakage of liquid or solid faeces with a 
minimum frequency of “once a week or less”. This gives rather a broad definition, but 
no further information is provided. Irradiated patients had significantly more faecal 
incontinence (see Table 1.3). In this study the researcher assessing the patients was 
not blinded to radiotherapy treatment group and this may have introduced bias. Only 
12% (64 / 528) of the original study group were included and therefore it is important 
to know whether anorectal function was similar in the two treatment arms before any 
radiotherapy was given. Unfortunately, no preoperative assessment was carried out. In 
addition the radiotherapy regime was changed so that the irradiated field did not 
include the sphincters for the Stockholm Radiotherapy Trial 2. The relative contribution 
of patients from the two trials is not given and again this could cause bias. Most 
patients in the study had an anastomosis at 10cm and did not have TME. In contrast 
the Dutch TME trial, had a rigorous method for ensuring good TME surgery and the 
anal sphincters were not irradiated in patients undergoing anterior resection (Peeters, 
et al., 2005). Questionnaire assessment of these patients was carried out with a 
median follow-up time of 5 years. Similar results to the Stockholm study were found, 
with increased rates of faecal incontinence in patients who had received radiotherapy 
(see Table 1.3) and 39% (597 / 1530) of the original study group were included. There 
was a surprisingly high rate of tumour margin involvement (23%) which suggests that 
despite attempts to standardise the TME procedure performed, a significant number of 
patients were undergoing suboptimal rectal dissection. There are no studies 
comparing anal incontinence rates in an age-matched control group without a history 
of pelvic disease or treatment.  
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*In both studies “faecal incontinence” is defined as: involuntary leakage of liquid or 
solid faeces with a minimum frequency of “once a week or less” 
 
Mean follow-up = 14 years
64  57%  26%  0.01 
Mean follow-up = 5 years
597  62%  38%  <0.001 
 
 
  1.4.3
Adjuvant chemotherapy is used in rectal cancer with the aim of improving the outcome 
of patients with lymph node involvement (stage III disease). The majority of patients 
will not benefit, because they will be cured by surgery alone or will ultimately develop 
recurrent disease despite additional treatment. Identifying those patients who will 
benefit is important to reduce the numbers of patients exposed to the inconvenience 
and toxicity of chemotherapy without any added advantage. Despite lots of research, it 
remains difficult to identify these patients with certainty. 
 
In rectal cancer with lymph node involvement, chemotherapy is based on 5-fluorouracil 
(5-FU) and folinic acid (FA) given as a weekly bolus (Quasar Collaborative Group, 2000).  
Most studies have been carried out on patients with colon cancer so the relevance to 
patients with rectal cancer remains unknown. However the overall improvement in 
absolute survival is in the region of 5 to 10%. There may be increased toxicity in elderly 
patients and some trials have excluded these patients.  
 
Patients with lymph node involvement typically start their chemotherapy as soon as 
possible after primary surgery and usually this is within 6 to 8 weeks. Those who also 
have a defunctioning stoma will have a delayed stoma reversal procedure to allow 
completion of chemotherapy. 
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5-FU toxicity occurs in about 10% of patients and includes diarrhoea, vomiting, nausea, 
fatigue, plantar-palmar erythema, epistaxis and sore eyes. Severe toxicity necessitating 
emergency admission to hospital occasionally causes death. 
 
Neoadjuvant chemotherapy has already been mentioned in the section on 
radiotherapy. It is useful in fit patients with unresectable rectal cancer to attempt to 
downsize the disease before surgery and increase the chance of complete resection 
and sphincter-preservation. A combination of 5-FU and FA is given with a longer course 
of low dose radiation. 
 
Recent advances in chemotherapeutic options for rectal cancer include the arrival of 
monoclonal antibodies directed at blocking tumour growth and spread. The EXPERT-C 
trial has recently finished recruiting patients from UK, Spain and Sweden. This 
randomised trial is studying oxaliplatin, capecitabine and radiation therapy to compare 
how well they work with and without a monoclonal antibody called cetuximab in 
treating patients who are undergoing surgery for high-risk rectal cancer. Eligible 
patients for this study have rectal cancer that is predicted to be at high risk of local 
recurrence according to MRI scanning. They undergo long course chemoradiotherapy 
with oxaliplatin and capecitabine and are randomised to receive cetuximab, prior to 
TME surgery. The primary outcome is pathological complete response at TME and 
secondary outcomes include follow up to 5 years with quality of life questionnaires and 
survival rates.  
 
 
 
The ability to maintain both anal continence and normal rectal evacuation depends on 
many inter-related factors, of which we are surprisingly unaware until something goes 
wrong. The resulting loss of balance between these two opposing processes causes 
either anal incontinence or a rectal evacuatory disorder or sometimes both.  Factors 
responsible for this equilibrium can be divided into intestinal, pelvic and sphincteric. 
Structural, functional and neurological aspects of these three factors need to be 
considered in normal defaecation. 
 
  1.5.1
An intact and innervated pelvic floor, rectum and anal canal are necessary for normal 
bowel function (see Figures 1.4 and 1.5). Stool is transferred to the rectum by high-
amplitude propagated contractions. These may be stimulated by a meal or after waking 
from sleep. Stool delivered to the rectum can be stored until a convenient time for 
defaecation. Rectal capacity is determined by rectal volume, tone, compliance and SA Pilkington    Introduction 
  36   
sensation. Rectal hyposensitivity and hypersensitivity have been defined as a maximum 
tolerated rectal volume (MTV) of greater than 400ml and less than 90ml respectively 
(Chan, Scott, Williams, & Lunniss, 2005). In rectal hyposensitivity the patient has little 
or no urge to defaecate even when the rectum is full. Conversely, patients with 
hypersensitivity get the urge to evacuate when there is only a small amount of stool in 
the rectum. The consistency and volume of stool is variable depending on diet, 
hydration and gastrointestinal length. The Bristol Stool Form Scale is useful for 
recording stool form reproducibly (Heaton, Ghosh, & Braddon, 1991; Heaton et al., 
1992; O'Donnell, Virjee, & Heaton, 1990).  
 
During defaecation, anal relaxation occurs accompanied by raised intrarectal pressure. 
There is relaxation of the pelvic floor especially puborectalis, to allow expulsion of 
rectal contents. Proctography is used clinically to assess abnormalities of rectal 
emptying. Changes in anorectal angle have been described in association with 
evacuation but the limits of normality have not been clearly defined (Shorvon, McHugh, 
Diamant, Somers, & Stevenson, 1989).  
 
Sympathetic, parasympathetic and somatic nerve fibres supply the pelvic floor, rectum 
and anal canal and enable effective co-ordinated rectal evacuation. Sympathetic fibres 
are derived from the lowermost thoracic ganglion in the paravertebral sympathetic 
chain. They join branches from the aortic plexus to form the superior hypogastric 
plexus, which then divides into right and left hypogastric nerves. The hypogastric 
nerves unite with preganglionic parasympathetic fibres from the ventral rami of S2, S3 
and S4 to form the inferior hypogastric plexus. This is located posterior to the bladder 
and ultimately innervates the rectum. Somatic motor innervation of the external anal 
sphincter and sensory input from the lower anal canal is carried via the pudendal 
nerve. Right and left pudendal nerve motor innervation to the external anal sphincter 
has an overlapping distribution. Stimulation of either nerve will cause circumferential 
contraction of the external anal sphincter. Distension of the rectum causes a sensation 
of rectal fullness which is interpreted by the individual as the need to pass stool or 
flatus. The anal canal is exquisitely sensitive to light touch, pain and temperature. In 
addition it is able to discriminate between gas, liquid and solid stool. The anal 
transition zone (ATZ) (Thompson-Fawcett, Warren, & Mortensen, 1998) is a highly 
innervated area which is thought to be crucial for assessing rectal contents. Relaxation 
of the internal anal sphincter allows sampling of rectal contents by the ATZ. Anal 
relaxation is stimulated by distension of the rectum and this reflex is called the 
rectoanal inhibitory reflex (RAIR). It is mediated by intrinsic nerves and is absent in 
Hirschsprung‟s disease. In contrast when the extrinsic (sympathetic and SA Pilkington    Introduction 
  37   
parasympathetic) nerves are damaged as in cauda equina lesions or after spinal cord 
transaction, the reflex is preserved. 
 
Anorectal function is difficult to measure accurately, both clinically and for research 
purposes. There is a wide range of normality and often a poor correlation between 
measurements and the impact of patient symptoms on their lives. A careful, sensitive 
history and examination are vital to understanding the patient‟s symptoms. The use of 
validated and widely used symptom score and quality of life questionnaires is 
important for defining and accurately documenting the patient‟s symptoms. In addition 
to these subjective measures, objective measures such as anorectal physiology, 
endoanal ultrasound and proctography can be used. 
 
One of the difficulties in trying to study anal incontinence is that there is no precise, 
useful definition of it. There is a plethora of studies focusing on this condition and its 
associated problems but the case mix tends to be heterogeneous and the assessment 
of incontinence haphazard without the use of validated questionnaire instruments. 
Anal incontinence usually refers to the uncontrolled leakage of solid, liquid or gas from 
the anal canal, whereas faecal incontinence refers only to the leakage of solid or liquid 
faecal material. Flatus incontinence can be difficult to assess but is important for many 
individuals. The term “anal incontinence” is misleading because it suggests that the 
anal canal itself is the main site for maintenance of continence. Although integrity of 
this structure is important for normal continence, the rectal reservoir function, stool 
consistency, etc. are also of importance and may be even more important than the anal 
canal (Chan, Lunniss, Wang, Williams, & Scott, 2005). The anal canal is the last resort 
for preventing or allowing the passage of intestinal contents and as such significant 
emphasis has been placed on assessing its structure and function. However there is an 
increasing awareness that this is only one component in a very complex multi-factorial 
process (Bharucha et al., 2005). Anal incontinence is defined by the International 
Continence Society as “the involuntary loss of flatus or faeces which becomes a social 
or hygienic problem”. SA Pilkington    Introduction 
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(Reproduced with permission from Harcourt Publishers Ltd) 
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 (Reproduced with permission from Harcourt Publishers Ltd) 
 
 
 
 
 
 
  1.5.2
Many questionnaires have been described for assessing anorectal function. There is 
little uniformity in their use as each clinician or researcher tends to have their own 
favourites. The questionnaires can be broadly split into symptom severity indices or 
quality of life instruments. Frequently used symptom severity scoring systems are 
summarised in Table 1.5.1. Generic quality of life instruments are summarised in Table 
1.5.2 and condition-specific questionnaires are summarised in Table 1.5.3.  
 
The Cleveland Clinic incontinence score (CCI) is an anal incontinence severity score. It 
is easy to use and gives the patient a score of 0 to 20, where zero equates to perfect 
continence and twenty equates to complete anal incontinence. It was first proposed by 
Wexner et al (Jorge & Wexner, 1993) and is widely used as a tool to measure the 
severity of anal incontinence (Deutekom et al., 2005; Portier, Bonhomme, Platonoff, & 
Lazorthes, 2005). It is already in use in the anorectal physiology laboratory in 
Southampton General Hospital. Rothbarth investigated the impact of CCI on patient 
quality of life after anterior sphincter repair (Rothbarth et al., 2001). He studied 35 SA Pilkington    Introduction 
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patients and found that when the CCI score was between 9 and 20, there was a 
significant impact on quality of life. When compared with reference ranges, the quality 
of life scores differed significantly to those of normal individuals and equalled those of 
individuals confined to the home. If CCI score is 9 or greater, the individual is 
considered to have severe anal incontinence which is likely to significantly impact on 
their quality of life. 
 
There are other formal definitions of incontinence. For example, the Rome 
Multinational Working Team have revised two previous definitions of functional faecal 
incontinence to produce the Rome III definition (Bharucha, Wald, Enck, & Rao, 2006) 
which is: the uncontrolled passage of faecal material recurring for >= 3 months in an 
individual with a developmental age of at least 4 years that is associated with:  
  abnormal functioning of normally innervated and structurally intact muscles, 
and/or 
  no or minor abnormalities of sphincter structure and/or innervations 
insufficient to explain faecal incontinence, and/or  
  normal or disordered bowel habits (i.e., faecal retention or diarrhoea), and/or 
  psychological causes 
This definition is slightly broader than previous ones and does include patients with 
minor structural abnormalities. However Rome III still excludes patients who have an 
organic cause (such as diabetic neuropathy or dementia) for faecal incontinence and 
those who have flatus incontinence. Using the Rome definition a low prevalence rate of 
6.9% (95% CI: 5.4 to 8.4) (W. G. Thompson, Irvine, Pare, Ferrazzi, & Rance, 2002) anal 
incontinence is found. Estimated prevalence of faecal incontinence is between 11 and 
15% in other studies where sources of bias have been minimised although only one of 
these studies used a validated questionnaire (Johanson & Lafferty, 1996; Kalantar, 
Howell, & Talley, 2002; Lam, Kennedy, Chen, Lubowski, & Talley, 1999; Macmillan, 
Merrie, Marshall, & Parry, 2004; Marr et al., 2005). No studies have been published on 
the prevalence of anal incontinence as assessed with the CCI Score in a UK community-
dwelling population such as the inhabitants of Southampton City. 
 
Many quality of life questionnaires have been published, but there is little consensus 
about the optimal instrument to use. Generic assessment tools, such as SF-36, are 
often not specific enough to detect changes in quality of life in a specific patient 
population. Condition specific quality of life instruments such as the Faecal 
Incontinence Quality of Life Scale (FIQL) (Rockwood et al., 2000), EORTC QLQ-C30 and 
CR29 module (Aaronson et al., 1993; Whistance et al., 2009) and Manchester Health SA Pilkington    Introduction 
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Questionnaire (Bug, Kiff, & Hosker, 2001) are more likely to be sensitive to the effects 
of a given health problem, such as faecal incontinence. These examples have been 
validated and tested for reliability.  
 
The European Organisation for Research and Treatment of Cancer (EORTC) was 
founded in 1962 with the aim of conducting, developing, coordinating and stimulating 
research in Europe. It is an international non-profit organisation. Through the EORTC 
multidisciplinary groups of clinicians and basic scientists are able to execute large, 
prospective, randomised, multicentre, cancer clinical trials.  The EORTC created a 
Quality of Life Group which focuses on developing, validating and updating quality of 
life instruments for evaluating patients participating in cancer clinical trials. An 
integrated modular approach was developed with rigorous psychometric testing. The 
output from the Quality of Life Group includes a core questionnaire (EORTC QLQ-C30) 
(Aaronson, et al., 1993) and multiple supplementary questionnaires. The core 
questionnaire has 30-items and is designed to be cancer specific, multidimensional in 
structure, appropriate for self-administration and applicable across a wide range of 
cultural settings. It is a third generation questionnaire and is currently on its third 
version (Bjordal et al., 2000). The same response categories are used throughout the 
questionnaire except for questions 29 and 30 which assess global health status/quality 
of life. The responses are: “not at all”, “a little”, “quite a bit” and “very much”. The 
questions are either grouped together to provide multi-item scales or interpreted 
individually as single-item measures. The average of the items in a scale is 
standardised by linear transformation so that the calculated scores for each scale 
range from 0 to 100. A high score for a functional scale represents a high or healthy 
level of functioning whereas a high score for a symptom scale /single item represents 
a high level of symptoms or problems. There are five functional scales, three symptom 
scales, a global health status/QOL scale and six single items. 
 
Supplementary questionnaire modules can be used with the core questionnaire to 
allow more detailed assessment and evaluation of quality of life in specific patient 
populations. The colorectal cancer module (QLQ-CR38) (Sprangers, te Velde, & 
Aaronson, 1999) has been recently updated and validated internationally (QLQ-CR29) 
(Whistance, et al., 2009). The new questionnaire is shortened and allows direct 
comparison of patients with and without stomas (Gujral et al., 2007).  It consists of 
multi-item scales and single items which are grouped into five functional scales and 
eighteen symptom scales. The responses and scoring systems are the same as for the 
QLQ C30 questionnaire. 
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The relative performance of health-related QOL instruments after colorectal surgery 
has been compared. A study from York compared EORTC QLQ-C30 & CR38, FACT-C, 
SF12 and EQ5D (Wilson, Alexander, & Kind, 2006). An impressive questionnaire return 
rate of 95.7% was achieved to give a study group of 201. Condition-specific 
instruments and those in which the patient subjectively rated their overall health-
related quality of life were best suited to assessing these patients. Missing data was a 
problem for the FACT-C summary scale which had 14 times more missing data than 
the EORTC QLQ global health status/QOL score. SA Pilkington    Introduction 
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Pescatori  
(Pescatori, Anastasio, 
Bottini, & Mentasti, 1992)  
Described by Pescatori (1992), modification of Miller‟s 
score (Miller, Bartolo, Locke-Edmunds, & Mortensen, 
1988)  
Type x frequency matrix 
3 types of leakage: flatus/mucus, liquid stool and solid 
stool 
3 frequencies: Occasional, weekly and daily 
Total score: 
Bristol Stool Form Scale  
(Heaton, et al., 1991; 
Heaton, et al., 1992; 
O'Donnell, et al., 1990)  
Heaton (1992) 
7 stool forms described with words and pictures 
Valid and reproducible 
Cleveland Clinic 
Incontinence Severity Score 
(CCI) (Jorge & Wexner, 
1993)  
Described by Wexner (1993) 
Type x frequency matrix 
5 types: solid, liquid, gas, need to wear pad, lifestyle 
alteration 
5 frequencies: scored 0 to 4 
Frequencies: never (0), rarely (less than  once a month, 
sometimes (monthly), often (weekly), always (daily) 
 Total score:  0 to 20 where 0 equates to perfect anal 
continence and 20 is daily episodes of solid, liquid and 
gas incontinence requiring a pad and affecting the 
patients‟ lifestyle  
Widely used but not rigorously validated. Practical. Easy 
to use and interpret 
Vaizey  
(Vaizey, Carapeti, Cahill, & 
Kamm, 1999)  
Described by Vaizey (1999) 
Type x frequency matrix plus 3 additional items:  
4 types: gas, fluid, solid, alteration in lifestyle 
5 frequencies: scored 0 to 4 
3 additional items:, need to wear a pad/plug, use of 
constipating medication, lack of ability to defer 
defaecation for 15mins  
Total score: 0 to 24(complete incontinence) 
Well validated but not widely used 
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(Continued) 
 
Fecal Incontinence Severity 
Index (FISI)  
(Rockwood, 2004)  
Described by Rockwood (2004) 
Type x frequency matrix  (see appendix)with patient and 
surgeon severity ratings 
4 types: gas, mucus, liquid stool, solid stool 
5 frequencies: scored 4 to 0 
Frequencies:  1 to 3 times a month, once a week, 2 or 
more times a week, once a day, 2 or more times a day 
Total score: 0 to 61(patient ratings) or 57(surgeon 
ratings) 
Well validated but complicated to use 
MSKCC  
(Temple et al., 2005) 
 
Described by Temple (2005) 
Instrument to evaluate bowel function after sphincter-
preserving surgery 
Frequency matrix with 18 questions 
3 subscales: frequency, dietary, urgency/soilage 
4 individual items 
Frequencies: Always, most of the time, sometimes, rarely, 
never 
Validated in anterior resection patients in America SA Pilkington    Introduction 
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SF-36 
(Ware & Sherbourne, 1992)  
36 questions 
8 health domains: physical activities, role limitations due 
to physical health, emotional state, bodily pain, 
perception of general health state, vitality, social activity 
and mental health 
Well validated and very widely used 
EQ-5D  
(Dolan, 1997; The EuroQol 
Group, 1990)  
5 questions 
5 domains: mobility, self-care, usual activities, 
pain/discomfort, anxiety/depression 
3 severity levels: no problems, some or moderate 
problems, extreme problems 
Transform responses to 5 domains into summary utility 
value with range: -0.594 (worst imaginable health state) 
to 1 (optimal health state) 
Visual analogue scale: Health state today 
Well validated but simplistic 
Used for health economics 
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EORTC QLQ-C30  
(version 3) 
(Aaronson, et al., 1993; 
Bjordal, et al., 2000)  
Published in 1993 and updated in 2000 
Assesses quality of life of cancer patients, especially 
those undergoing chemotherapy trials  
Validated and widely used in clinical trials 
Core questionnaire of 30 questions 
  Multi-item scales and single item measures 
  5 functional scales, 3 symptom scales, a global 
health status/QoL scale and 6 single items 
  Scores range from 0 to 100 after linear 
transformation 
  High score on functional scale: high/healthy level 
of functioning 
  High score on global health status/QoL: high QoL 
  High score on symptom scale: high level of 
symptoms/problems 
EORTC Colorectal Cancer 
Module QLQ-CR29 
(Whistance, et al., 2009)  
 
Updated 2009  
Supplementary questionnaire module 29 questions 
Accompanies core questionnaire QLQ –C30 
Targeted for patients with colorectal cancer 
  5 functional scales and 18 symptom scales 
  Same scoring process as QLQ-C30 
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(Continued) 
 
Fecal incontinence quality 
of life scale (FIQL)  
(Rockwood, et al., 2000)  
Described by Rockwood 
29 items that evaluate psychometric properties of a 
health-related quality of life scale with issues specifically 
related to faecal incontinence 
4 subscales: lifestyle, coping/behaviour, depression/self 
perception, embarrassment 
Validated in men and women 
Widely used 
Adopted by the American Society of Colorectal Surgeons 
Functional Assessment of 
Cancer Therapy – 
Colorectal (FACT-C) (Yoo, 
Kim, Eremenco, & Han, 
2005)  
27 items from the general core questions 
Disease specific subscale containing 9 colorectal cancer-
specific subscales 
Tested in cancer survivors and found to be reliable, valid 
and responsive 
Manchester Health 
Questionnaire (Bug, et al., 
2001)  
Condition specific health-related QOL questionnaire 
32 questions 
8 domains: general health perceptions, incontinence 
impact, role limitations, physical limitations, social 
limitations, personal relationships, emotions, 
sleep/energy, severity measures 
Validated in women only 
 
 
  1.5.3
Anorectal manometry, rectal distension volumes and anal mucosa sensitivity form the 
basis of anorectal physiology. Several different catheter systems are in use and 
measurements differ according to the type of catheter. Units tend to use their own 
reference ranges according to their equipment type and experience. Catheters are 
available in water-perfused or solid state forms. The whole length of the anal canal is 
assessed by withdrawing the catheter with either a continuous automated withdrawal 
device allowing vector manometry, or a hand-held system with measured withdrawal at 
1cm intervals (station pull through method) (Freys et al., 1998).  
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Although anorectal manometry is widely used to assess anal sphincter function in 
pelvic floor patients, there have not been many studies on normal individuals. Normal 
reference ranges and reproducibility are not well established. Freys et al 
(Freys, et al., 1998) studied ten male volunteers and performed standardised anorectal 
physiology three times on each individual on two days separated by four weeks. They 
found good reproducibility in resting pressure and sphincter length but other 
parameters showed large inter-individual variability. No comment is made about who 
performed the manometry. It is important to know whether all tests were performed by 
the same individual and how experienced/trained that individual was. Differences in 
the commands used during manometry assessment and the individual technique could 
have a profound effect on the results. The authors suggest that the reason for the 
large variability was that MSP is a voluntary act and therefore dependent on participant 
cooperation which may be variable. Although the study group was selected for 
uniformity and a strictly standardised method was used, analysis demonstrated a high 
degree of intra individual variability leading the authors to conclude that although 
sphincter length and mean resting pressure were reproducible, the other parameters 
including MSP were not and should therefore be interpreted with caution. The study 
group of young men is not typical for individuals who are undergoing anorectal 
physiology and this may in part explain why there was a low level of reproducibility. 
Squeeze pressures may be too effort-dependent to be truly reliable. Anorectal 
physiology is most frequently tested in women with anal incontinence and who may be 
elderly and may also have obstetric anal sphincter injuries. A more recent study 
included anorectal manometry on 146 healthy individuals (72 women) with a median 
age of 64 years in both men and women. Although there was no gender difference in 
mean resting pressure of the anal canal, the maximum squeeze pressure was much 
lower in women (151mmHg) than in men (201mmHg), (p=0.007). Important age 
associated differences were found with both mean resting and maximum squeeze 
pressures decreasing with age (Gundling et al., 2010). An elegant study conducted by 
Williams et al (Williams et al., 2000) recorded anal canal pressures and 3-dimensional 
endoanal ultrasound on 10 male and 10 female asymptomatic subjects. No difference 
was found in maximal resting pressure between men and women but men had 
significantly higher maximal incremental squeeze pressures than women. The study 
also demonstrated that the maximal anal canal squeeze pressure is found where 
puborectalis overlaps the external anal sphincter. A study on 351 women who were 
evaluated for faecal incontinence found that a worse incontinence score (FISI) 
(Rockwood, 2004) was used) correlated with lower resting pressures (Bordeianou, et 
al., 2008). 
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  1.5.4
After anterior resection a considerable number of patients have disordered defaecation 
as a result of their surgery. Imaging of these patients during simulated rectal 
evacuation may distinguish between structural and functional causes. However, all 
measures whether using radiological techniques or an expulsion test, only simulate 
rectal evacuation. The natural process of defaecation is more complicated and involves 
coordination of colonic propulsion waves with abdominal and diaphragmatic effort in 
addition to the final event of rectal emptying. A Japanese study carried out on 62 
patients who had undergone rectal resection, found that barium proctography was 
useful in evaluating defaecatory disorders (Morihiro, Koda, Seike, Miyauchi, & Miyazaki, 
2008). They studied 62 patients who had undergone anterior resection and found that 
participants who were able to evacuate over 55% of the rectal contrast had a 
significantly lower CCI score, less soiling and less urgency. 
 
Evacuation proctography is a clinical test for assessing the anatomical changes that 
occur during defaecation. For a Barium proctogram, the rectum is filled with barium 
paste. The vagina and small bowel are opacified with contrast medium. The patient is 
asked to evacuate the rectum during fluoroscopic imaging. Images are taken in the 
sagittal plane during rest, straining and defaecation. Until recently this was the gold 
standard test (Karasick, Karasick, & Karasick, 1993; Mellgren et al., 1994), but 
advances in Magnetic Resonance Imaging have enabled the acquisition of dynamic MR 
images during evacuation (Rentsch et al., 2001). Ultrasound gel is placed in the rectum 
and the patient is asked to evacuate during sequential MR imaging.   
 
There is ongoing debate about which is the most appropriate test to use (Pilkington, 
James, Monga, Dewbury, & Nugent, 2009). Significant differences exist between these 
two tests: 
 
1.  Barium proctography is associated with radiation exposure to the pelvic 
organs. The mean effective dose equivalent has been estimated at between 
3.6 and 6.5mSv, which is approximately 360 chest radiographs (Goei & 
Kemerink, 1990). No radiation is involved with MR proctography. Although 
some hospitals are using dynamic MR proctography as a substitute for 
barium proctography because no radiation is involved (Pilkington, James, et 
al., 2009), it is still not clear whether the results of these two investigations 
are comparable. 
 
2.  During Barium proctography the individual is seated on a radiolucent 
commode in a physiological position for defaecation. However, during MR SA Pilkington    Introduction 
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proctography the subject is supine. Studies that report poor performance of  
supine MR proctography when compared to barium proctography, 
frequently fail to include MRI scans acquired during defaecation, whereas 
this is always part of the barium study protocol (Bertschinger et al., 2002; 
Vanbeckevoort et al., 1999). When dynamic MRI scans do involve simulated 
defaecation, rectal intussusception can be detected (Rentsch, et al., 2001). 
In addition, although MRI scanning in the supine position may not simulate 
exactly the same mechanisms taking place in the squatting or seated 
position usually adopted for defaecation, it may provide useful information 
about the structures that will be encountered when the patient is supine on 
the operating table. This is likely to be particularly important when planning 
stapled transanal rectal resection (STARR) operations for rectal 
intussusception where there is a risk of forming an enterorectal fistula if the 
stapling device is fired through an adjacent enterocele. 
 
The development of open configuration MRI scanners has allowed MRI 
scanning to be carried out with the patient in an upright position during 
defaecation (Mortele & Fairhurst, 2007). A suspension of gadolinium is 
placed in the rectum and T-1 weighted images are taken during 
defaecation. One study has compared these two MRI techniques using 
patients who presented with stress urinary incontinence and/or symptoms 
of pelvic prolapse (Bertschinger, et al., 2002). Although they report that all 
rectal intussusception was missed on supine MRI, only 3 patients in the 
study group of 38 patients had rectal intussusception and there was no 
information as to whether these patients were symptomatic or not. In 
addition, although MRI during straining was carried out in the closed coil 
scanner, images were not acquired during defaecation due to restrictions 
imposed by the institution guidelines. 
 
3.  The Barium paste is thicker than the ultrasound gel used during MR 
proctography and this may affect the ease of evacuation.  
 
There is considerable variation in the appearances on proctography in “normal” 
subjects. Trying to define the boundaries of “normal” appearances is difficult and 
symptoms often do not correlate closely with proctogram findings. In 1989, Shorvon et 
al (Shorvon, et al., 1989) studied 47 healthy student volunteers who denied faecal 
incontinence or difficulty with defaecation and had no history of anorectal surgery. 
There were 23 women in the study and they were all nulliparous. In this asymptomatic 
group of men and women, Shorvon found a wide range in values for anorectal angle as SA Pilkington    Introduction 
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well as a high frequency of structural abnormalities such as rectal intussusception. In 
most studies participants are recruited from pelvic floor patients undergoing 
proctography as part of their routine investigation and therefore they are likely to have 
symptoms. 
 
For the purposes of quantitative research it is possible to measure the change in 
position of the pelvic organs during defaecation with respect to their neighbouring 
bony and soft tissue structures even though the normal ranges for these values are not 
known and are not likely to be useful clinically. The pubococcygeal line (PCL) connects 
the inferior aspect of the symphysis pubis with the last coccygeal joint (Mortele & 
Fairhurst, 2007) and is an important landmark for assessing pelvic floor movement. At 
rest in a normal patient the base of the bladder, the upper third of the vagina and  the 
peritoneal cavity (including small bowel and sigmoid colon) are usually situated 
superior to the PCL (Healy et al., 1997). The anorectal junction (ARJ) is the point at 
which a line along the posterior border of the rectum transects a line along the central 
axis of the anal canal. This point is usually situated within 3cm of the PCL and perineal 
descent can be measured by movement of the ARJ with reference to the PCL.  
 
Several methods for measuring rectoceles on imaging have been described. A 
reference line may be drawn along the anterior wall of the anal canal and extended 
(Healy, et al., 1997), or the maximum distension of the rectocele beyond the predicted 
margin of the anterior rectal wall is measured (Mellgren et al., 1995; Mellgren, et al., 
1994). Mellgren et al classified rectocele size into three groups according to the 
maximum distension. In addition to grading the size of the rectocele, the presence of 
post-defaecatory trapping can be demonstrated. Invagination of the rectal wall, known 
as rectal intussusception, frequently co-exists with a rectocele. Rectal intussusception 
may be anterior, posterior or circumferential. The intussusception may be contained 
within the rectal ampulla or it may extend into the anal canal or beyond, where it is 
known as a rectal prolapse. The Oxford Radiological Grading of Rectal Intussusception 
is a useful and reproducible system for describing rectal intussusception (Collinson, 
Cunningham, D'Costa, & Lindsey, 2009) (Table 1.5.4). 
 
It is important to remember that during proctography the process of defaecation is 
merely simulated and may not be a true reflection of what happens to the patient in 
the privacy of their bathroom seated on their own toilet. Patient embarrassment may 
inhibit what is normally a very private process and the findings on proctography must 
be interpreted with caution. 
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I     (high rectal)  Descends no lower than proximal limit of the rectocele 
II    (low rectal)  Descends into the level of the rectocele, but not onto 
sphincter/anal canal 
III   (high anal)  Descends onto sphincter/anal canal 
IV   (low anal)  Descends into sphincter/anal canal 
V    (overt rectal 
prolapse) 
Protrudes from anus  
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  1.5.5
Altered bowel function, faecal leakage and incomplete evacuation are recognised 
problems after anterior resection and cause a major problem for many survivors of 
rectal cancer. Rectal cancer is a common disease in the UK and recent advances have 
led to improved overall survival, making the functional outcome even more important 
for patients.  
 
Poor functional results have been reported in 50 to 60% of patients undergoing 
resectional surgery (Emmertsen & Laurberg, 2008). The main focus of rectal cancer 
research has been directed at improving survival, reducing local recurrence rates 
(Sebag-Montefiore, et al., 2009) and maximising sphincter  preserving surgery (Marr, et 
al., 2005; Morris et al., 2008). However the functional result following anterior 
resection can have a significant impact on the patients‟ physical, mental and social 
capabilities in both the short and long-term. Identifying patients at high risk of a poor 
functional outcome would allow appropriate preoperative counselling and early 
management.  
 
The term “anterior resection syndrome” (Karanjia, et al., 1992) has been used to 
describe patients who experience persistent problems with anal incontinence, urgency 
and frequency of defaecation (fragmented defaecation) after anterior resection. The 
aetiology of these symptoms is not clear but is likely to be multifactorial. Causes may 
include height and configuration of the rectal anastomosis, post surgical scarring, 
reduced rectal capacity and compliance, denervation, altered stool consistency and in 
some cases anal sphincter disruption. 
 
Health-related quality of life after anterior resection is not routinely measured despite 
recent advances in treatment and quality of life assessment. Reasons for this may 
include the confusing number of QOL assessment instruments available and difficulties 
with interpreting the data collected by these tools. Wilson et al carried out health-
related QOL assessment at 6 weeks after surgery in the follow up of 201 consecutive 
patients after potentially curative surgery for colorectal cancer (Wilson, et al., 2006). 
Poorer health-related QOL was associated with the presence of a stoma and symptoms 
of constipation and diarrhoea. Younger participants (<65 years old) were also found to 
have a poorer health-related QOL. It is important to detect poor health-related quality 
of life after anterior resection so that the contributing factors can be recognised and 
appropriate treatment initiated. 
 
A study from Stockholm assessed anal manometry using vector volumes in 71 patients 
who had been randomised to receive a low anterior resection with either a colonic J-SA Pilkington    Introduction 
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pouch anastomosis or a side to end anastomosis. They found that postoperative anal 
sphincter pressure volumes were halved after anterior resection compared with the 
preoperative values (Machado, Nygren, Goldman, & Ljungqvist, 2005). This did not 
recover during 2 years follow up and was not related to anastomotic configuration.  
 
Functional impairment and recovery after anterior resection has been assessed with 
serial anorectal physiology to try to identify contributing factors. A Korean study 
evaluated 32 patients with preoperative and 1, 3, 6 and 12month postoperative 
anorectal physiology (Lee & Park, 1998). Mean resting pressure and rectal capacity 
were reduced. Residual rectal length after surgery was calculated by subtracting the 
length of the high-pressure zone measured on manometry at 3 months, from the 
height of the anastomosis measured with rigid sigmoidoscopy. Stool frequency, 
urgency and incontinence score were worse if the residual rectum length was less than 
4cm.  
 
Although proctography is widely used in pelvic floor patients to assess structure and 
function (Savoye-Collet, Koning, & Dacher, 2008), it has not been used extensively 
after anterior resection. There is some evidence to suggest that it is useful in this 
context (Morihiro, et al., 2008).   
 
Large prospective studies that combine serial evaluation of condition-specific symptom 
severity and health-related quality of life questionnaires with anorectal manometry, 
ultrasound and proctography before and after anterior resection are lacking from the 
published literature but would be important for defining “anterior resection syndrome” 
so that it can be targeted for appropriate management. 
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Historically biofeedback was born from psychological learning theories such as 
“operant conditioning” or “task reinforcement” in the 1950‟s and 60‟s. Initially this 
behavioural approach was applied to all areas of medicine but cardiovascular medicine 
and subsequently gastroenterology received most attention. Despite research efforts, 
no evidence was found to substantiate this approach in most aspects of medicine. Over 
the last 30 years, a behavioural approach has been found to be useful in disorders of 
defaecation (Enck, van der Voort, & Klosterhalfen, 2009).  
 
Biofeedback refers to the process of amplifying a bodily function so that the individual 
is more aware and consequently may be able to improve function with training (Enck, 
et al., 2009). Biofeedback is a specific form of behavioural modification and is thought 
to involve cortical reconditioning. In the treatment of faecal incontinence, manometry 
or electromyographic (EMG) recording from the anal canal is used to provide a visual 
display of anal sphincter muscle activity. With the help of a specialist nurse, the 
individual is able to recognise from the visual display when they are achieving an 
adequate anal squeeze. Most biofeedback programmes include a series of exercises 
similar to pelvic floor exercises to improve muscle strength and co-ordination (Norton 
& Chelvanayagam, 2001). Many similar biofeedback techniques are in use but there is 
little uniformity between treatment centres. The method in use at Southampton 
General Hospital involves 30-minute sessions. During the biofeedback sessions the 
patient is advised about methods of efficient defaecation. A visual display based on 
anal pressures is used to give feedback to the patient as they attempt to squeeze the 
anal sphincter. Using this to demonstrate when the patient is achieving an adequate 
squeeze pressure, the patient is taught a series of exercises to practise to improve 
sphincter function.  
 
In addition to the specific techniques taught in the biofeedback sessions, the nurse-
patient relationship is also thought to be beneficial. Faecal incontinence is an 
embarrassing condition which is often difficult to verbalise (if you don‟t ask, they won‟t 
tell) (Whitehead, 2005; Whitehead et al., 2009). Providing the patient with a forum for 
discussing this problem may be therapeutic in itself and the importance of such “non-
specific factors” in psychotherapy treatments is well recognised (Chelvanayagam & 
Stern, 2007; Koch, Selim, & Kralik, 2002). Individuals with faecal incontinence often 
feel alone, stigmatised and hopeless about any improvement in their condition. 
Providing them with the vocabulary to explain and explore what they are experiencing 
within a safe and confidential environment is beneficial. Trying to determine how much 
the effect of biofeedback is due to the physical side of the treatment and how much is SA Pilkington    Introduction 
  56   
due to the nurse-patient relationship is difficult to unravel. Indeed attempts to separate 
these two components are artificial as they are interdependent upon each other. A 
recent study by Norton et al (Norton, Chelvanayagam, Wilson-Barnett, Redfern, & 
Kamm, 2003), attempted to evaluate the isolated roles of advice, advice and verbal 
instructions, hospital based biofeedback and both hospital and home based 
biofeedback. Although over 50% of patients reported clinical improvement, there was 
no difference between the four groups. In this particular study no benefit was seen 
with biofeedback. However this study was carried out by nurses who run the 
biofeedback service. It is not possible to predict whether the same improvement could 
be achieved in a unit that does not provide biofeedback. 
 
Telephone follow-up after initial sessions with biofeedback have been demonstrated to 
be effective instead of repeated face-to-face sessions (Byrne et al., 2005). Compliance 
with BFB programmes is one of the main determinants of outcome and patients who 
are most likely to complete biofeedback are usually more severely affected, female and 
older than those who discontinue treatment (Byrne, Solomon, Young, Rex, & Merlino, 
2007). Other factors indicative of likely success are a high level of motivation, intact 
cognition and absence of depression. 
 
Biofeedback has been shown to be beneficial in the treatment of faecal incontinence 
with an overall efficacy of up to 80% (Norton & Kamm, 1999). However, there is a lack 
of high quality randomised controlled trials that address the role of biofeedback in 
treating faecal incontinence (Norton, Hosker, & Brazzelli, 2000). Studies that have been 
carried out use a wide variety of outcome measures making direct comparisons 
difficult. There are few long term follow-up studies and a wide variety of different 
methods, equipment and training programmes are in use.  
 
The routine use of biofeedback to prevent faecal incontinence after surgery for rectal 
cancer has not been studied in detail. Only one study has looked at the role of 
biofeedback in patients who are symptomatic after rectal surgery with excessive stool 
frequency or incontinence following anterior resection or total colectomy (Ho, Chiang, 
Tan, & Low, 1996). The number of patients in this study was small but biofeedback 
was found to be safe and effective. Ten out of 13 patients treated had at least 90% 
reduction in their incontinence episodes.  
 
Poor bowel function after anterior resection is thought to relate to many factors 
including reduced reservoir capacity of the rectum because the proximal colon is 
anastomosed to the rectal stump. Poor rectal compliance results in less efficient 
storage of stools. Loss of colonic length may cause reduced fluid absorption capacity SA Pilkington    Introduction 
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so that the stools are looser. These factors would make anal continence more difficult 
to maintain. In addition there may be loss of rectal sensation and poor coordination 
with the anal sphincter. There is some evidence to suggest that the stapling process 
injures the anal sphincter in some cases (Farouk, et al., 1998). The surgery itself may 
distort the supporting structures of the anal canal and reduce innervation. Biofeedback 
may improve the functional outcome after anterior resection by improving anal 
sphincter coordination, rectal and anal canal sensation, strengthening the muscles of 
the pelvic floor and anal sphincter and improving rectal capacity. The mechanism by 
which biofeedback works, is not well described. Previous studies have not found a 
correlation between incontinence symptoms and anorectal physiology measurements 
done before and after biofeedback (Loening, 1990). 
 
Despite the lack of high quality randomised trials (Pares, Norton, & Chelvanayagam, 
2008), biofeedback programs have emerged as a popular and successful treatment for 
faecal incontinence with reported success rates of between 50 and 92% (Norton, et al., 
2003; Solomon, Pager, Rex, Roberts, & Manning, 2003) and a clinical improvement 
lasting at least 2 years. The method is safe, painless, well tolerated and does not 
preclude further treatment if it is unsuccessful. It is a promising technique for avoiding 
the debilitating complication of anterior resection syndrome. 
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 Rectal function and quality of life are not affected by anterior resection 
 Routine biofeedback training started before surgery does not improve anal 
continence after anterior resection 
 MR proctography is no better than Barium proctography for assessing pelvic floor 
problems SA Pilkington    Aims 
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 To determine anal continence before anterior resection 
 To assess anal continence after anterior resection 
 To determine whether biofeedback improves outcome after anterior resection 
 Define anterior resection syndrome 
 Determine predictive factors for poor outcome after anterior resection 
 Validate methods for assessing functional outcome: Barium proctography versus 
dynamic MR proctography 
 
The overall aim of this thesis is to assess the impact of major rectal resection on rectal 
function and quality of life and to determine whether routine biofeedback improves the 
outcome of surgery.  SA Pilkington    Methods 
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4.1  Randomised controlled trial of biofeedback for anal incontinence after 
anterior resection 
4.2  Barium proctography versus dynamic magnetic resonance proctography  
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  4.1.1
 
This is a single blind prospective randomised controlled trial to assess the role of 
biofeedback in improving anal continence after anterior resection. Participants were 
randomised to either no biofeedback (control group) or biofeedback (BFB group) in a 
ratio of 1:1. Randomisation was stratified for exposure to radiotherapy. See Appendix 
VII for Protocol.  
 
This study was reviewed by the Southampton and South West Hampshire Ethics 
Committee. No objections were raised on ethical grounds. All participants gave 
informed written consent. Detailed information about the trial was given in both 
written and oral form. See Appendix I for patient information sheet. Ethical approval 
was granted to recruit participants from Southampton General Hospital, Royal 
Hampshire County Hospital and Salisbury District Hospital. 
 
Initial recruitment was from Southampton General Hospital. Recruitment was extended 
from 12 to 21 months to allow for adequate accrual. Potential participants at Salisbury 
District Hospital were not willing to travel to Southampton General Hospital for the 
research tests and recruitment from this site was abandoned after inviting 12 eligible 
patients who all declined. Patients at Winchester Hospital were more willing to travel 
the shorter distance to Southampton and 3 were successfully recruited. Patients who 
lived on Jersey but were having their surgery in Southampton were also invited to 
participate and 11 accepted. 
 
All adverse events that occurred during the investigation (i.e. after the participant had 
given informed consent) were documented in the Case Report Form. Postoperative 
complications such as chest infection, wound infection, cardiorespiratory problems, 
thromboembolism and anastomotic leak resulting in further surgery or death were 
recorded in the case report form. SUHT Research related SAE/SUSAR initial reporting 
form was completed for all deaths and for adverse events. The researcher made an 
assessment of severity and causality. The participants were encouraged to phone 
directly the principal investigator (SP) or their GP if they experienced a problem. 
The participant could choose to withdraw from the study at any time and for any 
reason. Completion of the study was at one-year post surgery. A participant lost to 
follow up was defined as a participant who was recruited to the study but did not turn 
up for follow-up visits. They were sent a letter with another appointment and were SA Pilkington    Methods 
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contacted by telephone to ascertain the reason for their non-attendance (e.g. patient 
withdrawal of consent). 
 
  4.1.2
Patients undergoing anterior resection for pathology within 30cm of the anal verge 
who fulfilled the inclusion and exclusion criteria shown in Table 4.1.1 were eligible for 
recruitment to this study.  
 
 
Booked for anterior resection for 
pathology within 30cm of the anal verge 
Patients considered by their surgeon as 
being unlikely to comply with the protocol  
Aged 18 years or older  Mentally incompetent  
Patient knows diagnosis and treatment 
plan  
Pregnant and nursing mothers 
Written informed consent   
 
Southampton General Hospital provides services for the 1.3 million people living in 
Southampton and South Hampshire. All patients with colorectal cancer in the 
Southampton and South Hampshire region are discussed at the weekly Southampton 
MDT meeting. Patients with potentially curable disease are offered a combination of 
surgery, chemotherapy and/or radiotherapy. In general the policy in Southampton is to 
give preoperative short course radiotherapy for rectal cancers and preoperative long 
course chemoradiotherapy for rectal cancers where the CRM is threatened or breached. 
Radiotherapy is thought to be detrimental to bowel function and therefore 
randomisation was stratified for preoperative radiotherapy exposure. Potential 
research participants were identified at the MDT meeting by the researcher (SP). They 
were approached by the colorectal nurse specialists who offered them a verbal 
explanation of the project and a standard Participant Information Sheet (See Appendix 
I). Patients were given at least 2 days to decide whether they were willing to 
participate.  Participants were recruited to the study and asked to sign a consent form 
to document fully informed consent. A similar process took place in Winchester 
although it was not possible for the researcher (SP) to attend all the MDT meetings so 
the colorectal nurse specialists were responsible for identifying potential participants. 
A letter was sent to the patient‟s GP to inform the GP about the recruitment of the 
patient to the trial (See Appendix III). A full register of patients screened and recruited 
to the study was kept.  
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Data collection took place in the Pelvic Floor Unit at Southampton General Hospital. 
Postal questionnaires were sent out to the participants at 6 and 9 months for 
completion at home.  
 
  4.1.3
The Pelvic Floor Unit in Southampton offers biofeedback training to patients with pelvic 
floor disorders including anal incontinence and rectal evacuatory disorders. The 
sessions are carried out by a specifically trained GI motility nurse specialist (SG).  
 
Participants who were randomised to the BFB group were given their first BFB training 
session preoperatively. Each session lasted 10 to 30 minutes and took place 
immediately after baseline data collection. The second session was 3 months after 
restoration of intestinal continuity (either after closure of defunctioning ileostomy or 
after anterior resection if no stoma was used). Subsequent sessions were carried out by 
telephone. 
 
During the biofeedback sessions, advice was given about methods of efficient 
defaecation including positioning on the toilet. Participants were taught a series of 
exercises to practise to improve sphincter function based on the exercises devised by 
Christine Norton(Norton et al., 2001). The nurse specialist (SG) used an anorectal 
probe with visual feedback display to demonstrate to the participant when they were 
achieving an adequate squeeze pressure. The participant was encouraged to repeat the 
exercises 5 times each day. The exercises began before surgery and participants with a 
stoma were advised to continue with the exercises while defunctioned.  
 
The control group had minimal contact with the BFB nurse. After collecting the baseline 
data the researcher left the room so as to remain blind to the treatment allocation. The 
nurse then opened the envelope to determine which arm of the trial the participant was 
entering. If the participant was in the control group (no biofeedback) they were free to 
leave and were given no additional information. SA Pilkington    Methods 
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  4.1.4
No changes were made to the trial outcomes after the trial commenced. The primary 
outcome was final CCI reported at 1 year. Table 4.1.2 shows the timetable for data 
collection. 
 
  Baseline  3 months  6 months  9 months  12 months 
Questionnaires           
Anorectal 
Physiology 
   
     
 
Secondary outcome measures included changes over the first postoperative year in 
CCI, EORTC QLQ-C30 & CR29, FIQL, MSKCC and anorectal physiology. 
 
Four questionnaires were administered for self-completion (See Appendix V & VI). 
 Cleveland Clinic Incontinence Score (Jorge & Wexner, 1993)  
 European Organization for research and treatment of cancer and the new 
colorectal cancer module (EORTC QLQ-C30 and CR29) (Miller, et al., 1988; 
Whistance, et al., 2009)  
 Fecal incontinence quality of life questionnaire (Rockwood, et al., 2000)  
 Memorial Sloan Kettering Bowel Function Instrument (Temple, et al., 2005)  
Severe faecal incontinence was defined as CCI of 9 or greater because previous studies 
have demonstrated that at this level quality of life is reduced (Rothbarth, et al., 2001). 
Participants who failed to return their questionnaire within 1 month were contacted by 
telephone and invited to go through the questionnaire. A small group of participants 
requested telephone follow-up instead of postal questionnaires. 
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A standard technique was used for all patients. Baseline anorectal physiology was 
performed by the author (SP) in all except 5 cases, which were performed by the GI 
motility nurse specialist (SG). The author was trained by SG prior to starting participant 
recruitment to ensure that a standard, reproducible method was used. A stationary pull 
through technique with a 4-channel Medtronic catheter was used to measure resting 
and squeeze pressures within the anal canal at 1cm intervals from 6cm to 1cm above 
the anal verge. Recordings at each station from 6 to 1cm were an average of the 
pressure recorded by the four channels in the catheter tip. The manometer was 
calibrated before each patient. A computerised system (Polygam Lower GI, Synectics 
Medical, Stockholm, Sweden) was used for data acquisition. 
 
The rectoanal inhibitory reflex was assessed using rapid inflation of 50ml of air into 
the balloon. No relaxation response after 3 attempts was recorded as an absent reflex. 
Maximal tolerable rectal volume was assessed by inflating a rectal balloon on the 
Medtronic catheter with water at body temperature. The patient was asked to report 
“first sensation”, “first urge” and maximum rectal volume when they felt they could 
hold on no longer. A balloon expulsion test was carried out with 50ml of water at body 
temperature. The patient was asked to bear down and try to push out the balloon. Anal 
canal pressures were measured to evaluate paradoxical contraction or relaxation of the 
internal anal sphincter as evidenced by a fall in resting pressure. 
 
Anorectal sensitivity was measured using an Anuform electrical stimulation probe. 
Three assessments were made at 3 different levels (1, 2 and 3cm from the anal verge). 
The patient was asked to report a change in sensation as the current was increased 
from 0 to a maximum of 25mA. The test was complete when the patient reported a 
change in sensation and the current at that level was recorded. 
 
  4.1.5
Using a standard deviation (Portier, et al., 2005) of 10, an analysable sample size of 45 
patients in each arm could detect a 30% (Solomon, et al., 2003) difference in Cleveland 
Clinic incontinence scores. In a recent study of 239 patients treated with biofeedback 
for faecal incontinence, 11% failed to start treatment and a further 6% failed to 
complete treatment (Norton & Kamm, 1999). Assuming that a similar dropout rate of 
about 20% is encountered, 110 patients would need to be recruited to ensure that a 
final sample size of 45 per treatment arm was achieved. 
 
Recruitment began on 27 November 2006. Trial progress was reviewed at 18 months 
(25 June 2008). Analysis of the first 10 patients completing follow-up suggested that if SA Pilkington    Methods 
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45 similar patients in each arm completed, with a common standard deviation of 4 and 
80% power, then a difference of 2.4 in CCI score could be detected.  
 
The dropout rate at 18 months was approximately 30%. The sample size was therefore 
increased to 120 to account for the higher dropout rate. With a dropout rate of 30%, 
this would give an analysable sample of 84. Assuming a common SD of 5 and 80% 
power, difference of 3 could be detected. This would be clinically significant. 
 
  4.1.6
In this multicentre randomised controlled trial, 121 participants undergoing anterior 
resection for colorectal cancer were randomly assigned to control or BFB groups. 
Randomisation was stratified for radiotherapy treatment. The decision to give 
radiotherapy or not was made at the MDT meeting. Only preoperative radiotherapy was 
used but both short course radiotherapy and long course chemoradiotherapy were 
included.  
 
The method used to generate the random allocation sequence was computer-
generated permuted blocks. The random allocation sequence was concealed in 
sequentially numbered sealed envelopes. The envelope was not opened until after the 
baseline data had been collected. 
The random allocation sequence was generated by the trial statistician (Scott Harris) 
who also performed the allocation concealment in envelopes. The researcher (SP) 
enrolled participants and carried out the data collection. Participants were assigned to 
control or biofeedback groups by the GI motility nurse specialist (SG) who also 
performed the intervention. 
 
  4.1.7
The researcher (SP) assessed the outcome measures and was blinded to the 
assignment of intervention. After assessment of baseline outcomes, the researcher left 
the Pelvic Floor Unit and the GI motility nurse (SG) opened the envelope to assign the 
intervention. When the participant was seen in the Pelvic Floor Unit at 3 months, the 
outcome measures were assessed by the researcher first. After this the researcher left 
the Pelvic Floor Unit and the participant saw the GI motility nurse for BFB intervention. 
Participants in the control group left after the researcher but did not have any 
discussion with the GI motility nurse. SA Pilkington    Methods 
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  4.1.8
The primary outcome measure is sphincter function as measured by the Cleveland 
Clinic incontinence score at one year compared to baseline function. The one-year 
Cleveland Clinic incontinence score was examined in a linear regression model 
adjusted for the baseline level. A comparison of treatment groups was conducted with 
its 95% confidence intervals. This primary comparison was conducted on an intention 
to treat (ITT) basis. The secondary analyses were carried out using similar regression 
models. The percentages of severe incontinence before and after surgery were 
compared using McNemar‟s test. Paired samples T-test and Wilcoxon signed ranks test 
was used to compare parametric and non-parametric data respectively. 
 
Advice was sought from Dr Steven George (Epidemiologist) and Mr Scott Harris 
(Medical Statistician) regarding statistical analysis. 
 
  4.1.9
This project was funded by a  
 BUPA Research Fellow Grant 
  Joint Dunhill Medical Trust and Royal College of Surgeons Research into Aging 
Grant 
Participants were given a free car-parking ticket to attend the Pelvic Floor Unit for 
assessment. Participants from Jersey were given £100 as a contribution towards their 
travel expenses for each additional trip for research assessment. 
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  4.2.1
This cohort study compared BaP and MR proctography on 42 consecutive consenting 
patients (See Appendix XIII for protocol). The proctograms were reported by two 
consultant radiologists (DT and CT) who specialise in pelvic floor disorders. At the time 
of reporting, the radiologist was blinded to the results of the other investigation.  
 
It was not anticipated that additional conditions such as cancer would be found during 
magnetic resonance imaging because volumetric data through the pelvis was not 
collected. Instead just one slice in a dynamic sequence was performed. 
 
Source data will be stored in the radiology departments at Poole and Dorchester 
Hospitals for 5 years. The Data Protection Act 1998 was adhered to. A screening and 
recruitment log was maintained.  
 
  4.2.2
All patients in the study group had been referred for BaP as part of their NHS 
management. Patients who fulfilled the inclusion/exclusion criteria (see Table 4.2.1) 
were invited to take part in the research and offered an additional appointment at 
Dorchester Hospital for MR proctography. Participants were also asked to complete a 
questionnaire (Table 4.2.2). 
 
These patients had been seen at the colorectal or gynaecology clinics at Poole or 
Dorchester Hospitals as part of the pelvic floor service. This was an appropriate group 
of patients to study because they had been referred for proctography already as part of 
their NHS management.  
 
The patient invitation letter and information sheet were posted to the patient so that it 
was received a minimum of 2 days before the proctogram. At the appointment in the 
radiology department in Poole Hospital, the study was explained to the potential 
participant by a senior radiographer (Jane Brenner) and consultant radiologist (Dr 
Tarver). Every participant signed a consent form (see appendix IX) to document 
informed consent. An appointment for an MR proctogram was arranged at Dorchester 
Hospital for participants. 
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Participants who did not attend the MR proctogram after informed consent were 
contacted by telephone to determine whether they had withdrawn from the study or 
not. One further appointment for an MR proctogram in Dorchester was arranged if the 
patient had not withdrawn consent. 
 
Referred for proctography as part of routine 
NHS management  
Patient gives informed consent 
Patient is aged greater than  18 years old 
Patient incompetent to give informed 
consent 
Claustrophobia or unable to tolerate MRI 
Contraindications to MRI such as 
pacemaker, high BMI 
Patient unable to lie flat 
 
 
Q1  Do you feel that you opened you bowels as usual during the test today?  YES / 
NO 
Q2  Would you have this test repeated if it was necessary for your treatment? YES / 
NO 
Q3  Which test did you prefer and why? 
 
 
  4.2.3
The primary objective was to demonstrate whether BaP or MR proctography would be 
best for investigating rectal function after anterior resection. The presence of 
measureable differences between pelvic floor structures visualised on BaP and MR 
proctography was assessed. The length of rectocele demonstrated on erect BaP and 
supine MR proctography was compared.  
 
The secondary objectives were: 
 
 A comparison of proctogram measurements including anorectal descent and 
change in anorectal angle SA Pilkington    Results and Discussion 
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 Comparison of presence of complete rectal emptying, anismus, mucosal 
prolapse, rectal intussusception, uterovaginal prolapse, cystocele, enterocele, 
rectocele and rectocele emptying between the two proctograms 
 Determine tolerability and patient preference for the two procedures 
 Determine whether differences between the two investigations have any clinical 
significance 
 
  4.2.4
During BaP, the rectum was filled with contrast (Barium paste) and the vagina and small 
bowel were opacified with contrast medium. The participant was seated on a 
radiolucent commode behind a screen. Fluoroscopic images were taken in the sagittal 
plane during rest, contraction and rectal evacuation. The commode is fixed to the floor 
and the fluoroscopic equipment is centred on the commode at a standard distance 
from the commode for all imaging to ensure reproducibility of radiological 
magnification. A correction factor of 0.7 is used in the radiology department at Poole 
based on measurements taken with a radio-opaque ruler placed on the commode. 
 
The technique for MR proctography was similar to BaP in that the participant had 
contrast (ultrasound gel) placed in the rectum. However no contrast was placed in the 
vagina or small bowel. The MRI scanner had a 1Tesla magnet (Phillips Intera). The 
participant was positioned supine during scanning with a support for the feet so that 
the knees and hips were flexed. The MR sequence was recorded over a 40-second time 
period while the participant attempted rectal evacuation whilst lying in the scanning 
machine. Twenty T2-weighted single midsagittal sections each 5mm thick were taken 
at 2-second intervals to build-up a dynamic sequence as the participant was bearing 
down and evacuating the rectum.  
 
A standardised case report form was used to collect data from the proctograms (See 
appendix XI). A record was made of the presence or absence of rectocele, complete 
rectocele emptying, rectal intussusception, complete rectal emptying, anismus, 
mucosal prolapse, enterocele, uterovaginal prolapse, cystocele. Rectal intussusception 
was classified according to the Oxford Radiological Grading of Rectal Intussusception 
(Collinson, et al., 2009) as summarised in Table 1.5.4. Rectocele size was measured as 
the maximum length from an extended anterior wall of the anal canal. To provide an 
estimation of pelvic floor descent, the distance (ARJ) from the anorectal junction to the 
pubococcygeal line was measured during rest, squeeze and evacuation. The anorectal 
angle (ARA) was measured at the intersection between a line along the posterior wall of 
the rectum and a line along the central axis of the anal canal. All length measurements 
on BaP were multiplied by a correction factor of 0.7 to allow for radiographic SA Pilkington    Results and Discussion 
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magnification. Intra-observer variability and inter-observer variability in rectocele 
length measurement was assessed by comparing repeated measurements on the last 
20 proctograms. 
 
  4.2.5
This was an exploratory study and there was inadequate previous data to base a 
sample size calculation on. An analysable sample of 60 patients was proposed based 
on feasibility in the given time frame of one year. Assuming a dropout rate after 
recruitment of 20% we planned to recruit 75 patients. Between 16/07/2006 and 
17/07/2007 a total of 115 barium proctograms were carried out in Poole Hospital. So 
if the recruitment rate was 70%, we expected to recruit the proposed sample size of 75 
patients in 11-12 months. 
With a sample size of 60 and standard 80% power, allowing for a maximum difference 
in rectocele size of 0.5 cm, we could pick up a standard deviation of 1.5, at most. This 
is a clinically relevant difference to detect.  
 
  4.2.6
All participants who attended both proctograms were included in the analysis. Cohen‟s 
Kappa was used to assess agreement between BaP and MR proctography. A paired T-
test was used to look at difference with a 95% confidence interval and 0.5cm 
equivalence. Bland and Altman plots were used to assess agreement between the 
measurements made on BaP and MR proctography. 
 
  4.2.7
The study was conducted in compliance with the Research Governance Framework for 
Health and Social Care and Good Clinical Practice (GCP). A favourable ethical opinion 
was given for this study by the Dorset Research Ethics Committee meeting on 20
th 
December 2007 and a subsequent amendment to the study was also approved on 10
th 
April 2008.  
  4.2.8
A Research Bursary was awarded by the Bowel Disease Research Foundation to support 
the running costs of this project.  
Patients were reimbursed with £12 as a contribution towards their travel expenses. 
Free car-parking at Dorchester Hospital was provided for the additional proctogram.  SA Pilkington    Results and Discussion 
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5.1  Rectal function and quality of life before anterior resection 
5.2  Loss of anal continence at 3 months after anterior resection 
5.3  Severity of anal incontinence during first year 
5.4  Changes in bowel function during the first year after anterior resection 
5.5  Estimating anastomotic height from tumour height and resection margin 
5.6  Barium versus MR proctography 
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A persistent change in bowel habit to looser stools or increased frequency of 
defaecation are recognised symptoms associated with an increased risk of colorectal 
cancer in patients older than 60 years (UK Department of Health Criteria: Table 1.1). 
This chapter explores why some patients may complain of anal incontinence as a 
manifestation of their change in bowel habit. 
 
Study procedures were carried out as described in Section 4.1. Data on 121 
consecutive consenting participants undergoing anterior resection for pathology within 
30cm of the anal verge were collected as part of a randomised trial. One participant 
withdrew from the study shortly after randomisation and therefore is not included. 
Data on 120 participants is investigated. A summary of the raw data is given in 
Appendix XIV. 
 
  5.1.1
Figure 5.1.01 shows the CCI score in a group of 120 patients awaiting anterior 
resection for suspected cancer. Fifty-four (45%) reported perfect anal continence (CCI = 
0) and 22 (18%) had severe anal incontinence as recorded by a CCI score of 9 or 
greater (Rothbarth, et al., 2001).  
 
Tables 5.1.01 and 5.1.02 show the EORTC Quality of Life Questionnaire (QLQ)-C30 and 
CR29 results for constructed scales. The Global health status, all 5 functional scales 
and 5 of the 9 symptom scales/items are of most relevance to this study and have 
been included. The EORTC has published QLQ-C30 reference data from 1773 colorectal 
cancer patients (EORTC Quality of Life Group, 2010) and this is also shown in Table 
5.1.01 for comparison. The reference data is from patients with all stages of colorectal 
cancer and 29% had stage I to IV, 37% had recurrent disease and 34% had an unknown 
stage of disease. 
 
The EORTC Colorectal Cancer Module QLQ-CR29 consists of 5 functional scales and 18 
symptom scales. Four of the functional scales and 13 of the symptom scales are most 
relevant to this project and have been included in the analysis. High scores on the 
functional scales of QLQ-C30 and CR29 represent a high/healthy level of functioning. A 
high score on global health status also means a high quality of life. However a high 
score in the symptom scale indicates a high level of symptoms or problems. SA Pilkington    Results and Discussion 
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QL  73.4  20.3  60.7  23.4 
PF  88.5  14.5  79.2  21.1 
RF  82.4  28.5  70.4  32.8 
EF  79.1  19.7  68.9  24.5 
CF  84.9  20.6  85.2  20.4 
SF  86.6  21.2  76.0  28.6 
FA  23.3  22.6  34.7  28.4 
NV  3.6  9.9  7.3  17.2 
PA  16.4  24.5  24.0  29.6 
CO  16.7  26.6  15.8  27.9 
DI  20.8  28.0  16.6  27.6 SA Pilkington    Results and Discussion 
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88.3  19.6  118 
61.7  27.2  120 
31.9  30.7  68 
13.9  20.4 
48 
35.0  23.8  120 
25.4  23.1  119 
8.9  18.7  120 
1.1  6.0  119 
16.7  25.2  120 
13.1  23.0  120 
24.7  31.6  120 
27.5  27.3  119 
12.2  21.1  120 
13.3  21.8  120 
16.7  27.5 
118 
38.5  39.3  52 
3.9  13.6  34 
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Table 5.1.03 shows the single item results for QLQ-C30 global health scale. 
Preoperative data from this study and the EORTC reference data from colorectal cancer 
patients (all stages) (EORTC Quality of Life Group, 2010) are shown. 
 
 
0  4  5  13  23  34  20 
3  4  12  26  27  18  10 
0  2  5  14  26  31  22 
4  5  12  23  26  20  11 
 
Using an independent samples T-test to compare mean Global Health/Quality of Life 
(QL) status, participants with severe anal incontinence had a worse QL status with a 
mean difference of -10.6 (95% CI: -19.9 to -1.2) compared to those with a CCI of less 
than 9 (P=0.027) (see Table 5.1.04). 
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22  64.8  19.1 
98  75.3  20.2 
 
Simple linear regression indicated that baseline CCI was a predictor of QL (b=-0.789, 
p=0.034, 95%CI -1.410 to -0.057). Using multiple linear regression to control for 
tumour height, cancer diagnosis and female gender there was a significant relationship 
between baseline CCI and QL as shown in Table 5.1.05. 
 
 
-0.880  -1.609  -0.152  0.018 
-0.266  -0.828  0.296  0.350 
-5.894  -16.98  5.195  0.295 
-2.815  -10.71  5.081  0.482 
 
 
Tables 5.1.06 and 5.1.07 show the mean and standard deviation for relevant scales 
from QLQ C-30 and CR29 when the group is split for severe anal incontinence (CCI >= 
9). The QLQ-C30 questionnaire recorded diarrhoea (DI) as a symptom in 52 
participants (43%). Participants with no severe incontinence (CCI less than 9), reported 
significantly less diarrhoea symptoms (mean difference 13.4, p= 0.041, 95% CI: 0.53 to 
26.4) than those with CCI of 9 or greater. Tables 5.1.06 and 5.1.07 also summarise the 
results from independent T-test comparison of means when divided into groups 
depending on severity of anal incontinence. The Mean CCI of participants with no SA Pilkington    Results and Discussion 
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severe incontinence is subtracted from mean CCI of participants with severe 
incontinence to give the mean difference. The following functional and symptom scales 
have been omitted as the mean differences were not significant: emotional and 
cognitive functioning, nausea/vomiting, pain, constipation, body image, anxiety, 
sexual function in men and women, urinary frequency, dysuria, abdominal pain, 
bloated feeling, impotence and dyspareunia. 
 
  n  Mean  Std 
Deviation 
Mean 
difference 
95% CI 
Lower 
95% CI 
Upper 
p 
Global 
health  
22  64.8  19.1  -10.6  -19.9  -1.2  0.027 
status/qol  98  75.3  20.2         
Physical 
functioning 
22  80.6  17.7  -9.7  -16.3  -3.1  0.004 
  98  90.3  13.2         
Role 
functioning 
22  70.5  34.1  -14.6  -27.7  -1.5  0.029 
  97  85.1  26.5         
Social 
functioning 
22  76.5  23.4  -12.3  -22.0  -2.6  0.013 
  97  88.9  20.1         SA Pilkington    Results and Discussion 
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Mean difference = mean severe incontinence – mean CCI < 9 
  n  Mean  Std 
Deviation 
Mean 
Difference 
95% CI 
Lower 
95% CI 
Upper 
p 
Fatigue  22  32.3  25.4  11.0  0.6  21.4  0.039 
  97  21.3  21.6         
DI  22  31.8  34.9  13.5  0.5  26.4  0.041 
  98  18.4  25.8         
Urinary   22  21.2  30.1  15.1  6.8  23.4  0.000 
incontinence  98  6.1  13.8         
Buttock pain  22  33.3  30.9  24.8  15.0  34.5  0.000 
  98  8.5  18.1         
Flatulence  22  45.5  26.3  22.1  9.9  34.3  0.000 
  97  23.4  26.0         
Faecal   22  36.4  28.9  29.6  21.2  37.9  0.000 
incontinence  98  6.8  14.3         
Sore skin  22  27.3  33.5  17.1  7.3  26.8  0.001 
  98  10.2  16.9         
Stool   22  39.4  26.0  17.2  6.9  27.6  0.001 
frequency  98  21.9  21.2         
Embarrassed   22  37.9  40.2  26.1  14.1  38.1  0.000 
by bowel 
movement 
96  11.8  21.1         SA Pilkington    Results and Discussion 
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Table 5.1.8 compares the frequency of faecal incontinence measured on the CR-29 
questionnaire with the CCI severity groupings. There are some interesting differences 
with 4 patients in the severe incontinence group who report no faecal incontinence on 
the CR-29 questionnaire. The CR-29 questionnaire only detected 7 patients with faecal 
incontinence symptom scores of “quite a bit” or “very much”.
 
 
    CCI = 0  CCI = 1 to 
8 
CCI = 9 to 
20 
Total 
Not at all  50  29  4  83 
A little  3  15  12  30 
Quite a bit  1  0  3  4 
  Very much  0  0  3  3 
  Total  54  44  22  120 SA Pilkington    Results and Discussion 
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  5.1.2
 
Tables 5.1.09 and 5.1.10 display the preoperative anorectal manometry results. All 
participants contributed to the results (n = 120) 
 
Height above anal 
verge (cm) 
Mean (mmHg)  Standard Deviation 
4  33  22 
3  46  23 
2  49  22 
1  38  23 
 
 
 
Height above anal 
verge (cm) 
Mean (mmHg)  Standard Deviation 
4  67  48 
3  85  58 
2  91  62 
1  91  58 
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Table 5.1.11 shows the preoperative mean and maximal values for MRP and MSP, 
comparing participants with CCI less than 9 with participants with severe anal 
incontinence. Participants with severe anal incontinence had significantly lower 
squeeze pressures (mean difference in max MSP = 40mmHg, p = 0.002; 95%CI: 14.6 to 
65.8) but there was no difference in resting pressures. 
 
 
41.5  15.6 
41.8  12.7 
59.7  21.5 
62.4  18.3 
89.85  48.6 
55.2  43.2 
119.3  56.2 
79.1  47.2 
 
Using linear regression, there was a significant negative relationship between CCI and 
MSP before surgery as shown in Figure 5.1.02 (B = -0.032, p = 0.001, 95%CI: -0.051 to 
-0.013). There was no correlation between mean MRP and CCI. SA Pilkington    Results and Discussion 
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There were significant differences in MSP between men (n = 71) women (n = 49) over 
the first 4cm from the anal verge (mean difference = -58mmHg, p < 0.001; 95%CI:     -
73 to -43) as shown in Table 5.1.12. There were no clinically relevant and significant 
differences in MRP between men and women. 
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(Women - Men) 
 
Height (cm) 
Mean 
difference in 
MSP (mmHg) 
95% Confidence 
interval 
  P value 
    Lower  Upper   
4  -59  -73  -45  <0.001 
3  -73  -90  -57  <0.001 
2  -60  -80  -40  <0.001 
1  -38  -58  -17  <0.001 
Average over 
anal canal 
-58  -73  -43  <0.001 
Maximal  -61  -80  -42  <0.001 
 
Before surgery, proportionally more women than men had severe anal incontinence 
(Chi-squared test: p = 0.003) (see Table 5.1.13). 
 
 
 
65 (92%)  6 (8%)  71 (100%) 
33 (67%)  16 (33%)  49 (100%) 
98  22  120 
 
A highly significant relationship was found between preoperative CCI and mean MSP (B 
= 6.752, p = 0.001, 95%CI: -0.051 to -0.013). However when a general linear model 
was used to adjust for female gender, Global Health Status, diarrhoea symptom and 
stool frequency symptom this relationship was no longer significant (Table 5.1.14). SA Pilkington    Results and Discussion 
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-0.017  -0.039  0.004  0.115 
-2.688  -4.809  -0.567  0.013 
-0.021  -0.066  0.024  0.362 
-0.025  -0.010  0.060  0.167 
0.063  0.022  0.105  0.003 
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The preoperative EORTC QLQ-C30 data from this study is similar to published EORTC 
reference data, suggesting that quality of life in the study group is likely to be typical 
and representative for colorectal cancer patients. In general the study group tended to 
score more highly in the Global health status and function scales, and had less severe 
scores on the symptom scales than the reference group. There are some important 
differences between the two groups which may account for this. Most of the patients in 
the reference group were post-operative whereas the study data in this chapter is from 
preoperative patients. The reference group included metastatic or recurrent cancer in 
37% and these patients are likely to have a worse score. In addition the reference data 
is taken from patients with cancers distributed throughout the colon and rectum 
whereas the present study is limited to left sided cancers. The reference data includes 
patients with stomas and some of these were permanent stomas after APR. In the 
preoperative group there were no participants with permanent stomas, although 4 
participants did go on to have APR. The CR-29 module reported high symptoms scores 
in urinary frequency, flatulence and stool frequency.  
 
Rothbarth et al (Rothbarth, et al., 2001) investigated patients with varying degrees of 
incontinence as measured by CCI and demonstrated that patients with a CCI of 9 or 
greater, had a significantly lower quality of life which was comparable to house-bound 
individuals. Using this information, the research participants were grouped into a 
severe group which included all participants with a CCI of 9 or greater and a non-
severe group (CCI < 9). There were 22 (18%) participants in the severe incontinence 
group. The non-severe group had 54 participants with perfect anal continence (CCI = 0) 
and 44 participants with mild to moderate incontinence (CCI between 1 and 8). Severe 
anal incontinence was associated with a significantly lower mean EORTC global health 
status (GL) of 65 compared to 75 (maximum score equating to excellent GL is 100). 
Although the mean difference was 10, the 95% confidence interval was between 20 and 
-1. Although there was a significant difference between GL in those with severe 
incontinence and those with no severe incontinence, the clinical relevance of this 
difference cannot be determined by the present study. From the 95% confidence 
intervals, we can estimate that the magnitude of the difference in GL is between 20 and 
-1. A difference of 10 or above would be clinically relevant but if it is smaller than this 
it would not be clinically relevant (Osoba, Rodrigues, Myles, Zee, & Pater, 1998). A 
larger sample size is needed to demonstrate more precisely what the difference in the 
groups is likely to be. 
 
Using “severe incontinence” as defined by CCI of 9 or greater, the prevalence of anal 
incontinence in this study before surgery was 18%. This is a fairly high level of SA Pilkington    Results and Discussion 
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incontinence and has not been extensively investigated with prospective studies. In a 
group of patients with colorectal cancer a higher level of incontinence than in the 
general community might be expected because these patients often have a change in 
bowel habit to looser stool. This symptom can present with faecal incontinence as the 
patient‟s continence mechanisms have more difficulty controlling the looser stool and 
are therefore more likely to leak. 
 
Attempts to quantify the community prevalence of faecal incontinence have been 
limited by poor response rates and inappropriate data-collection methods. Faecal 
incontinence is an embarrassing condition and there is no universally accepted 
definition. A systematic literature review to estimate the prevalence of faecal 
incontinence was carried out by Macmillan et al (Macmillan, et al., 2004) and 16 
studies were identified. However, only 3 of these adequately attempted to reduce 
sources of bias. These population studies (Johanson & Lafferty, 1996; Kalantar, et al., 
2002; Lam, et al., 1999) reported a faecal incontinence prevalence in the general 
community of 11-15%. Different definitions of anal incontinence were used including:  
 
1.  Any involuntary leakage of stool or soiling of undergarments 
2.  Unwanted release of liquid or solid faeces at an inappropriate time or place 
3.  At least two of: stool leakage, pad for faecal soiling, incontinence of flatus > 25% of 
the time.  
 
Although these definitions would include participants in the severe incontinence 
group, they would also include some participants in the non-severe group. If the 
definitions were applied to the present study, the estimation of faecal incontinence 
would be even higher.  
 
A study from Korea (Jang, et al., 2010) has analysed preoperative anorectal manometry 
data on 80 patients with rectal cancer and reported anal incontinence in only 4/80 
patients (5%). This was a retrospective study and therefore may have missed some 
cases of incontinence. Faecal incontinence was defined as daily leakage of gas or loose 
stool. These symptoms alone would give a minimum CCI score of 4. Anal incontinence 
is difficult to measure accurately in a retrospective study because patients often do not 
report this embarrassing symptom. Usually it is necessary to carefully ask about the 
symptom of anal incontinence and the use of a scoring system such as CCI is essential 
for maximising the uniformity of the data collected. 
 
The CR-29 module uses a single question to assess faecal incontinence: “Have you had 
leakage of stools from your back passage?” Like most symptoms, anal incontinence SA Pilkington    Results and Discussion 
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has many facets to it and the exact wording of the question will have slightly different 
meanings to different people. In addition, “a little” faecal leakage will have a different 
impact on different people. Some people may be able to ignore it altogether so that it 
has no effect on their quality of life or daily activities and other people may need to 
wear a pad in case of leakage and may feel very anxious about trying to continue with 
their daily activities with the risk of an embarrassing episode. The CCI scoring system 
tries to assess anal incontinence in more depth than a single question and may 
unmask the extent of anal incontinence more accurately. 
 
A low anal squeeze pressure is often associated with anal incontinence. Consistent 
with this, was the finding that participants with severe anal incontinence had a 
significantly lower squeeze pressure than those with no severe incontinence (CCI < 9). 
The squeeze pressure is thought to reflect activity of the external anal sphincter 
primarily whereas resting pressure is thought to be more dependent on internal anal 
sphincter activity. No difference was found in resting pressures between continent and 
incontinent participants prior to surgery.  
 
In clinical practice pelvic floor exercises and anal sphincter exercises are often 
recommended for patients with faecal incontinence. The aim of this treatment is to 
improve sphincter strength, endurance and speed of response. Biofeedback can be 
used to facilitate this process and monitor progress. A programme of exercises is 
started often in combination with other treatments such as diet, evacuation training 
and drugs that alter stool consistency. The evidence for exercise programmes is not 
strong, but recent NICE guidelines recommend their use in patients with faecal 
incontinence (NICE Clinical Guideline, 2007). In theory, the exercises would enable the 
patient to avoid faecal leakage by improved external anal sphincter and pelvic floor 
muscle function. Resting pressure might also be improved due to increased muscle 
tone, although the internal anal sphincter is thought to be primarily responsible for 
resting pressure. This is a smooth muscle and therefore not influenced by voluntary 
muscle exercises. Again, in theory, patients with low squeeze pressures may be most 
likely to benefit from biofeedback exercises. A significant improvement in squeeze 
pressures with exercises has not been demonstrated in previous research (Ho, et al., 
1996; Loening, 1990).  
 
Before surgery, women were 4 times more likely than men to have severe anal 
incontinence. Women are known to have lower squeeze pressures than men and in this 
study there was a significant mean difference of 58mmHg. Although simple linear 
regression confirmed a highly significant relationship between preoperative CCI and 
mean squeeze pressure, after adjustment for female gender, this relationship was no SA Pilkington    Results and Discussion 
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longer significant. It is possible that with a larger sample size a significant relationship 
would be demonstrated as the 95% confidence intervals were close to zero after 
adjustment. On the basis of the current results we can conclude that female gender 
alone was the most important factor in the relationship with preoperative CCI. 
 
In this study 18% of participants reported severe anal incontinence before surgery. The 
symptom of diarrhoea was reported in 43% of participants and 71% reported frequent 
bowel movements. Patients with a low squeeze pressure will be less able to control 
their diarrhoea and frequent bowel movement and may present with faecal 
incontinence as their primary symptom rather than a change in bowel habit. This is 
likely to be particularly true in women who have a lower MSP than men. It is important 
to exclude a diagnosis of colorectal cancer in patients who present with faecal 
incontinence. 
 
To investigate whether patients with colorectal cancer do have a higher level of 
incontinence than non-cancer patients, it would be interesting to record the CCI for all 
patients presenting to the colorectal clinics with suspected cancer (two-week wait 
patients). It would then be possible to compare the CCI results for patients who had 
been diagnosed with cancer and those who were not. SA Pilkington    Results and Discussion 
  93   
 
 
The functional outcome following anterior resection is often overlooked as the main 
focus is usually cancer cure. However loss of anal continence has a profound effect on 
the patient‟s quality of life. Identifying patients at high risk for anal incontinence would 
allow appropriate counselling and may influence treatment options. 
 
 
Study procedures were followed as described in Chapter 4.1. 
 
  5.2.1
 
Preoperatively 49% (40/81) of patients had perfect anal continence (CCI=0), 42% 
(34/81) of patients had mild incontinence and 9% (7/81) of patients had severe 
incontinence (Table 5.2.01).  
 
After surgery 22% (18/81) of patients maintained their preoperative level of 
continence. Anal continence improved in 27% (22/81) with a range in CCI of 1 to 16 
and a median 4, but deteriorated in 51% (41/81) patients (range 1 to 16 and a median 
of 5.5). 
 
 Seventeen percent (14/81) of patients with no preoperative severe incontinence (CCI 
<=9) reported postoperative incontinence (CCI>9), compared with 2.5% (2/81) of those 
who had preoperative incontinence and no incontinence postoperatively (See Table 
5.2.02). This difference in proportions was significant (difference=15%, 95% CI: 5% to 
25%, McNemar: P=0.004). In those patients who developed severe anal incontinence, 
quality of life (FIQL: Fecal Incontinence Quality of Life questionnaire) decreased in all 
domains postoperatively although this did not reach significance (Table 5.2.03: test 
statistic Wilcoxon Signed Ranks Test).  
 
Patients who had severe anal incontinence at baseline, were 10.7 times more likely to 
still have severe anal incontinence at 3 months follow-up than those who did not have 
severe incontinence preoperatively (95% CI: 1.88 to 61.0, p = 0.008). SA Pilkington    Results and Discussion 
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40 (49%)  34 (42%)  7 (9%) 
22 (27%)  40 (49%)  19 (24%) 
 
Figures are number (total percentage) 
 
5 (6%)  14 (17%)  19 
2 (3%)  60 (74%)  62 
7  74 
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  Change in 
lifestyle 
domain 
Change in 
coping / 
behaviour 
domain 
Change in 
depression self 
perception 
domain 
Change in 
embarrassment 
domain 
Z  -1.66  -1.64  -0.98  -1.50 
Significance 
(2-tailed) 
0.10  0.10  0.33  0.13 
 
 
Preoperative and postoperative EORTC quality of life domains were assessed for 
equality using a 2 sided Wilcoxon signed ranks test. A significant result was found for 
deterioration in emotional functioning (P=0.043), social functioning (P=0.043), 
constipation (P<0.01) and defaecatory problems (P<0.01) hence significant evidence 
against preoperative and 3 month EORTC QoL domains being equal 
 
  5.2.2
A Pearson Chi-squared test was used to investigate the strength of relationships 
between postoperative anal incontinence (CCI score greater than 9) at 3 months and 
the following variables: gender, age, height of pathology, anastomotic height, presence 
of rectal anastomosis, length resected and exposure to preoperative radiotherapy. 
 
 
After anterior resection, 31% (11/35) of women reported incontinence (CCI>9), 
compared with 17% (8/46) of men (Table 5.2.04). This difference was not significant 
(difference=14%, 95% CI: -5% to 33%, P=0.14).  
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Figures are number (percentage) 
 
TOTAL 
11 (31%)  8 (17%)  19 
24 (69%)  38 (83%)  62 
 
 
Using logistic regression to adjust for preoperative severe anal incontinence, women 
were 1.7 times more likely to have severe anal incontinence postoperatively than men, 
however this was not statistically significant (95% CI: 0.581 to 5.35, p = 0.317). 
 
 
There was no difference in continence levels between patients younger than 70 years 
and those 70 years and older. There was no linear relationship between postoperative 
anal continence and age (b = 0.060, 95% CI: -0,057 to 0.177, p = 0.309), even when 
the baseline preoperative CCI was taken into account. 
 
 
One of the inclusion criteria for participants was that their pathology must be within 
30cm of the anal verge. The mean height was 16cm (SD 6.6cm) from the anal 
verge(Figure 5.2.01).  
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After anterior resection, 15% (9/59) of patients who had pathology at greater than 10 
cm from the anal verge (upper third of rectum) reported incontinence (CCI>9), 
compared with 55% (12/22) of patients who had pathology at or below 10cm (Table 
5.2.05). This difference was significant (difference=40%, 95% CI: 16.4% to 59.1%, 
P=0.004). 
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(low: 10cm or less from anal verge; high: greater than 10cm) 
Figures are number (percentage) 
 
10 (45%)  9 (15%) 
12 (55%)  50 (85%) 
 
 
Controlling for baseline CCI, there was a significant linear relationship between anal 
continence at 3 months (CCI) and height of pathology (p = 0.001, 95% CI: -0.437 to -
0.114), which can be described by the following equation (Table 5.2.06): 
 
Postoperative (3 months) CCI = 9 - 0.3 (pathology height) + 0.2 (preoperative CCI) 
 
 
Constant  9  6.3  12.2  < 0.01 
Pathology 
height 
-0.3  -0.4  -0.1  0.001 
Preoperative 
CCI 
0.2  -0.08  0.4  0.17 
 
 
Anastomotic height is thought to be a determinant of functional outcome. In this study 
anastomotic height and 3 month outcome data was available in only 17 cases. Simple 
linear regression showed a negative linear relationship between anastomotic height 
and CCI at 3 months (Figure 5.2.02) but this was not statistically significant (b=9.928, 
P=0.462, 95% CI: -0.932 to 0.444). 
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In this study patients who had pathology within 30cm of the anal verge were included 
in an attempt to capture all patients who would have a rectal anastomosis. Pathology 
reporting recorded the presence or absence of the peritoneal reflection. Where the 
peritoneal reflection was included in the specimen, it was assumed that the patient had 
had a rectal anastomosis. The functional result between patients with a rectal 
anastomosis (n = 62) and no rectal anastomosis (n = 19) was compared.  
 
Using an independent samples t-test to compare means of these two groups, there was 
no difference in means preoperatively (difference 0.02, P = 0.5) but postoperatively 
there was a difference of 4.4 (95% CI 2.6 to 6.2; P < 0.01). At 3 months follow-up, 
patients who had undergone rectal anastomosis had a significantly worse CCI with a 
mean difference in CCI of 4 (Table 5.2.07). This is shown in the Box and Whisker Plots 
shown in Figure 5.2.03 and 5.2.04. 
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3.1  3.1 
6.4  2.0 
 
 
 
  Higher anastomosis          Rectal anastomosis SA Pilkington    Results and Discussion 
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After anterior resection, 31% (19/62) of patients with a rectal anastomosis complained 
of severe incontinence compared to none of those with a higher anastomosis. This 
difference was significant (difference=31%, 95% CI: 11% to 43%, P=0.006) (Table 
5.2.08). 
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19 (31%)  0 (0%) 
43 (69%)  19 (100%) 
 
 
After adjusting for preoperative anal incontinence, the presence of a rectal 
anastomosis increases the postoperative CCI by a constant of 4.4 (95% CI 1.9 to 6.9, P 
= 0.001) using multiple linear regression. 
 
 
The length of bowel resected may affect continence after anterior resection. In this 
study, patients with severe incontinence at 3 months had slightly longer lengths of 
bowel removed (mean 20.4cm) when compared to those with mild or no incontinence 
(mean 17.3cm) (Figure 5.2.05). This mean difference of 3.1cm was significant (95% CI: 
0.3 to 5.9; P=0.03). There was no relationship between length of bowel resected and 
height of anastomosis (Figure 5.2.06) 
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An independent samples T-Test was used to compare the mean CCI at baseline and 3 
months, with exposure to radiotherapy (Table 5.2.09).  
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(radiotherapy 
exposure)
16  4.3  6.4 
(no radiotherapy 
exposure) 
65  2.8  3.7 
(radiotherapy 
exposure)
16  8.2  6.4 
(no radiotherapy
exposure)
65  4.7  4.5 
 
 
When comparing radiotherapy (n = 16) versus no radiotherapy (n = 65), there was no 
mean difference in these two groups before surgery and exposure to radiotherapy 
(difference = 1.48, p = 0.225) (Figure 5.2.07). However there was a significant mean 
difference of 3.5 in CCI at 3 months after surgery (p = 0.013, 95%CI: 0.780 to 6.272) 
(Figure 5.2.08).  
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Using paired samples t-test to compare means of CCI baseline and 3 months split for 
radiotherapy exposure, the mean difference in CCI between 3 months and baseline was 
1.8 (worsening of CCI) (P = 0.014, 95%CI: 0.38 to 3.29) in the no radiotherapy group. 
In the radiotherapy group, the mean difference in CCI between 3 months and baseline 
was 3.9 (worsening of CCI) (P = 0.044, 95%CI: 0.11 to 7.64)  
 
After anterior resection, 17% (11/65) of patients who did not have radiotherapy 
reported incontinence (CCI>9), compared with 50% (8/16) who did have preoperative 
radiotherapy (Table 5.2.10). This difference was significant (difference=33%, 95% CI: 9% 
to 56%, P=0.007). 
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Figures are number (percentage) 
   
8 (50%)  11 (17%) 
8 (50%)  54 (83%) 
 
 
  5.2.3
Logistic regression indicates that height of pathology (2.8x) (OR=0.22, 95% CI: 0.07 to 
0.65, p=0.006) and exposure to radiotherapy (2.5x) (OR=0.20, 95% CI: 0.06 to 0.66, 
p=0.008) are significant predictors of incontinence at 3 months. However when the 
combined effect on postoperative incontinence was assessed, neither term was 
significant (pathology height p=0.14, radiotherapy exposure p=0.21). This result 
probably indicates that height of pathology and exposure to radiotherapy are not 
independent factors. Alternatively the sample size may be too small. 
 
There is a significant linear relationship between postoperative CCI (CCI2) and 
exposure to radiotherapy (p = 0.013) which is described by the following equation: 
 
CCI2 = 4.662 + 3.526 (radiotherapyYN) 
95% CI 0.780 to 6.272 
 
However when the combined effect of rectal anastomosis, radiotherapy exposure and 
preoperative anal continence (CCI1) were assessed with multiple linear regression, the 
only independent predictor of CCI2 was rectal anastomosis (b = 3.827, 95% CI: 1.276 
to 6.378, p = 0.004) (Table 5.2.11). Patients with a rectal anastomosis had an increase 
in CCI of 3.8. 
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Model  B  95% CI lower 
bound 
95% CI upper 
bound 
Significance 
(Constant)  1.468  -0.805  3.741  0.202 
CCI1  0.171  -0.071  0.414  0.163 
Radiotherapy  2.153  -0.122  4.894  0.122 
Rectal anastomosis  3.827  1.276  6.378  0.004 
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Anorectal function is difficult to assess and quantify. It is important to measure the 
effect of anterior resection on anorectal function and to try to predict which patients 
will be at risk of a poorer outcome. A robust measuring stick is needed in the form of a 
validated symptom questionnaire with ranges for the general population.  
 
Prospective studies assessing outcome after anterior resection often do not include 
preoperative quality of life and symptom assessment (Karanjia, et al., 1992). 
Interpretation of postoperative continence and quality of life therefore is more difficult 
because there is nothing to compare the postoperative scores with. In addition, normal 
ranges according to age for the Cleveland Clinic Incontinence Score are not available.  
 
This study shows that before anterior resection anorectal function is compromised with 
42% of patients reporting mild incontinence (CCI 1 to 9) and 9% of patients reporting 
severe incontinence (CCI>9). It is important to take this into account when interpreting 
postoperative anal continence. “Normal” anorectal function in a group of patients with 
rectal cancer is difficult to define as many of them will have altered bowel function due 
to their pathology. Using preoperative values as the baseline is likely to be better than 
asking the patient to retrospectively recall what their normal bowel function was but is 
certainly not ideal. This group of patients is likely to have worse baseline bowel 
function than an age-matched group who do not have bowel pathology. 
 
Although anal incontinence improved in 27% of patients after surgery, it worsened in 
51% by an average CCI score of 5.5 and 17% of patients developed new severe faecal 
incontinence when assessed 3 months after anterior resection. In those patients who 
developed severe anal incontinence after surgery, quality of life decreased in all 
domains although this did not reach significance. 
 
Patients who had severe anal incontinence at baseline were almost 11 times more 
likely to still have severe anal incontinence after surgery than those who did not have 
severe incontinence preoperatively. 
 
Women are at higher risk of anal incontinence than men due to injuries to the anal 
sphincter and pelvic floor during childbirth (Dudding, Vaizey, & Kamm, 2008). In this 
study 17% of men and 31% of women reported anal incontinence. Although a 
difference of 14% was observed between men and women, it was not significant. A 
larger study would be needed to confirm or refute this finding. 
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Age was not associated with anal incontinence, although population studies have 
shown that anal incontinence is commoner in elderly people (Perry et al., 2002).  
Preoperatively 40 patients had perfect anal continence (CCI=0), 34 patients had mild 
incontinence and 7 patients had severe incontinence. After surgery 18 (22%) patients 
maintained their preoperative level of continence. Anal continence improved in 22 
(27%) with a range in CCI of 1 to 16 and a median 4, but deteriorated in 41(51%) 
patients (range 1 to 16 and a median of 5.5). There were 14 (17%) patients who 
developed severe incontinence postoperatively (p<0.01). In these patients quality of life 
(FIQL: Fecal Incontinence Quality of Life questionnaire) decreased in all domains 
postoperatively. 
 
EORTC quality of life assessment demonstrated a deterioration in emotional 
functioning postoperatively (p<0.05) and a higher level of defaecatory problems 
(p<0.01).   
 
Anorectal physiology showed a decrease in maximal rectal volume from 139ml (SD 59) 
to 106ml (SD 55) at 3 months postoperatively (p<0.01). 
The functional outcome following anterior resection may be overlooked, as the main 
aim of surgery is usually cancer cure. Loss of anal continence has a negative effect on 
the patient‟s quality of life. Although the present study does include this information, 
the stress of imminent major surgery may depress preoperative scores and make 
interpretation of postoperative changes from baseline difficult to interpret. In this 
study, participants were assessed three months after anterior resection and 17% had 
developed a new symptom of severe anal incontinence which caused a negative impact 
on their quality of life. Participants who were exposed to radiotherapy had a 3-fold 
increased risk of severe anal incontinence, although it was not possible to determine 
whether this variable was independent of height of pathology. SA Pilkington    Results and Discussion 
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In this section, trends in the first postoperative year are assessed for the participants 
who completed one year of follow-up. Table 5.5.4 summarises the baseline 
characteristics of these patients (n = 89). Participants with a poor functional outcome 
at one year were defined as those participants with severe anal incontinence (CCI 9 or 
greater) at one year. A good functional outcome was defined as CCI < 9 at one year.  
These two outcome groups were investigated for predictive factors. 
 
 
Study procedures were carried out as described in Section 4.1. SA Pilkington    Results and Discussion 
  114   
  5.3.1
Figure 5.3.01 shows the count of CCI scores at one year in the analysed participants. 
Graphs showing individual trends in CCI at 3 monthly time intervals over the first year 
are included in Appendix XVa and b. 
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Although all of the 89 participants contribute to the preoperative and one year data, 
there is some loss of data at the 3, 6 and 9 month data collection times as shown in 
Table 5.3.01. Over the first postoperative year mean CCI rose to just over 5 and then 
returned to preoperative levels by one year. Before surgery 17% had severe anal 
incontinence. At 3 months 27% had severe anal incontinence and this fell to 15% at 12 
months.  
 
*Percentages given are “valid” percentages and therefore do not include missing data 
 
3.9  5.3  4.7  4.9  4.0 
5.2  4.9  4.2  3.8  3.9 
15 (17%*)  22 (27%)  16 (22%)  12 (17%)  13 (15%) 
74 (83%)  60 (73%)  57 (78%)  59 (83%)  76 (85%) 
0  7  16  18  0 
 
 
Table 5.3.02 shows the mean CCI scores over the first year for participants with a poor 
functional outcome at one year (n = 13). Table 5.3.03 shows the mean CCI score over 
the first year for participants who had a good functional outcome at 12 months.  
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4.8  6.6  0 
11.0  5.2  1 
9.9  3.6  5 
11.1  3.2  3 
11.5  2.5  0 
 
 
 
3.8  4.9  0 
4.2  4.2  6 
4.0  3.9  11 
3.9  2.8  15 
2.7  2.3  0 
 
 
There was no significant or clinically relevant difference between preoperative CCI in 
participants who had severe incontinence at one year and those who didn‟t. However, 
after surgery there was a sustained and significant mean difference between these two 
groups which increased over the first year as shown in Table 5.3.04. Although 
participants in the good functional outcome group showed a small improvement in 
postoperative CCI, in the poor functional outcome group there was no improvement. 
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Mean difference = (Good functional outcome group) – (Poor functional outcome group) 
 
    95% Confidence  Interval   
  Mean difference  Lower  Upper  P 
CCI 
preoperative 
-1.2  -5.3  2.9  0.543 
CCI 3 months  -6.7  -10.1  -3.3  0.001 
CCI 6 months  -5.8  -8.9  -2.8  0.002 
CCI 9 months  -7.2  -9.6  -4.8  <0.001 
CCI 12 months  -8.8  -10.3  -7.2  <0.01 
 
 
 
The CCI score is comprised of 5 domains each of which is scored from 0 to 4 to give a 
final score with a maximum value of 20. Figure 5.3.02 shows the contribution of the 
five components of CCI to the final score. None of the participants had leakage of solid 
stool on a daily basis and some of the participants with severe incontinence did not 
have any incontinence to solid stool. The relative numbers of participants in the severe 
anal incontinence group can be seen to increase in all of the CCI domains as the scores 
worsen. Gas incontinence was fairly common even in participants without severe anal 
incontinence. 
 
Figure 5.03.03 shows the components of CCI in the participants with severe anal 
incontinence. They all had some leakage of liquid stool. One participant did not wear 
pads at all and three participants did not think that their bowel symptoms affected 
their quality of life. SA Pilkington    Results and Discussion 
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  5.3.2
A Pearson Chi-squared test was used to investigate the strength of the relationship 
between severe CCI at baseline, 3 and 12 months. There were seven participants in the 
analysed group who did not have data collected at 3 months.  
 
At baseline, 15 participants had severe anal incontinence and 4 (27%) still had severe 
incontinence at one year. However at one year, 11 (73%) participants had resolution of 
their severe incontinence. Severe incontinence developed in 9 (12%) of the participants 
who did not have severe incontinence at baseline (see Table 5.3.05). These differences 
were not significant (p = 0.221). 
 
 Forty-one percent of participants with severe CCI at 3 months also had severe CCI at 
one year and 95% of participants without severe CCI at 3 months had a good functional 
outcome (no severe CCI) at one year (p < 0.01). The sensitivity of severe CCI at 3 
months for predicting a poor functional outcome (severe CCI) at one year is 75% and 
the specificity is 81% (Table 5.3.06). Logistic regression was used to adjust for the 
following factors: preoperative CCI, female gender, stoma presence and exposure to 
radiotherapy (Table 5.3.07). A highly significant relationship was found between severe 
CCI at 3 months and severe CCI at one year (B = -2.577, 95% CI: 0.015 to 0.391, P = 
0.02). This relationship remained significant when adjusting for the other factors. 
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(Missing data n = 0) 
 
4 (27%)  11 (73%)  15 (100%) 
9 (12%)  65 (88%)  74 (100%) 
13 (15%)  76 (85%)  89 (100%) 
 
 
(Missing data at 3 months n = 7) 
 
 
9 (41%) 
 
13 (59%) 
 
22 (100%) 
 
3 (5%) 
 
57 (95%) 
 
60 (100%) 
12 (15%)  70 (85%)  82 (100%) SA Pilkington    Results and Discussion 
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-0.902  0.059  2.775  0.358 
-2.577  0.015  0.391  0.002 
0.914  0.440  14.142  0.302 
0.664  0.306  12.324  0.481 
-1.211  0.051  1.730  0.177 
-0.621  0.117  2.466  0.425 
 
  5.3.3
This project was carried out when laparoscopic surgery was being introduced to 
Southampton General Hospital. In this series, 47 (53%) operations were carried out 
laparoscopically and of these 8 (17%) were converted to open. Open surgery was 
performed on 42 (47%) participants. There appeared to be a small advantage in favour 
of laparoscopic surgery in avoiding severe anal incontinence at 1 year but this was not 
significant (B = 0.213,  95% CI: 0.044 to 1.027, p = 0.054). 
 
The configuration of the anastomosis was recorded in the operation note in 82 
participants. It was end to end in 37 and side to end in 45. Although the odds ratio 
was in favour of a side to end anastomosis, this was not significant (B = 0.354, 95%CI 
0.097 to 1.286, p = 0.115). 
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A proportion of patients are known to have a poor functional outcome after anterior 
resection. In this study follow up data over the first postoperative year was available in 
89 (74%) of participants recruited to a randomised trial.  
 
Before surgery 15 (17%) participants reported severe anal incontinence. However the 
mean CCI for the whole group was four. Patients with rectal cancer might have a higher 
incontinence score due to the presence of the cancer which may alter stool consistency 
and rectal filling sensation. The mean CCI was worst at 3 months after surgery when it 
rose to 5, before returning to near baseline at 12 months. The number of participants 
with severe anal incontinence also peaked at 3 months (27%) before decreasing to 
baseline levels. 
 
In this study, 27% of participants with severe anal incontinence at baseline still had 
severe incontinence at one year, but at 3 months, 41% of participants with severe anal 
incontinence had severe incontinence at one year. 
 
The participants who had a poor functional outcome at one year were studied. Their 
preoperative incontinence scores were similar to those of participants with a good 
functional outcome. However the mean CCI scores at 3 months were much worse in 
the poor functional outcome group (CCI = 11) than in the good functional outcome 
group (CCI = 4). The mean difference between the two groups worsened over the first 
postoperative year suggesting that there is some improvement in the good function 
group but not in the poor function group. Severe CCI score at 3 months was the 
strongest predictor of a poor functional outcome after adjusting for severe CCI at 
baseline, female gender, stoma reversal and BFB treatment. 
 
None of the participants reported daily leakage of solid stool after anterior resection. 
Uncontrolled passage of flatus was common in the groups with and without severe 
incontinence. A few patients scored highly in the pad usage and lifestyle restriction 
sections of the CCI score but did not have a total score of 9 or greater. This may 
represent particularly fastidious participants who wore a pad in case of a rare episode 
of leakage or who had relatively minor symptoms which impacted on their lifestyle 
excessively. In contrast three participants in the severe group did not feel that their 
symptoms restricted their lifestyle. It is likely that these participants were particularly 
well adjusted to their symptoms and were able to cope with really quite severe 
symptoms. 
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It is interesting to note that participants undergoing laparoscopic surgery had a 
tendency to less severe incontinence than those undergoing open surgery. A larger 
sample size is needed to demonstrate whether this is a significant result or not. Long-
term advantages in quality of life associated with laparoscopic surgery have been 
difficult to demonstrate (Jayne et al., 2007), although in theory the improved view and 
precision of laparoscopic surgery may reduce injury to surrounding structures in the 
pelvis and preserve anal continence. 
 
Anterior resection causes an acute worsening of anal incontinence. In the 3 monthly 
time intervals studied, this was maximal at 3 months but returned to baseline levels by 
one year. Although 17% reported severe anal incontinence before surgery, this rose to 
27% at 3 months. One year after surgery 15% had severe anal continence. 
 SA Pilkington    Results and Discussion 
  125   
 
 
This project has focussed mainly on anal incontinence, but difficulties with rectal 
evacuation are also described by patients after anterior resection. In this section, 
changes in stool frequency, symptom severity scores and anorectal manometry over 
the first postoperative year are explored. Only participants who completed the study 
are included (n=89). In particular, groups of participants with and without severe anal 
incontinence (CCI >=9) and with and without constipation (EORTC-C30 Q16) are 
investigated.  
 
 
Study procedures were carried out as described in Section 4.1. 
 
There were 13 participants with severe anal incontinence (CCI >= 9) and 76 with no 
severe anal incontinence (CCI < 9). There were 10 participants who complained of 
constipation “quite a bit” or “very much” (EORTC-C30 q16). 
 
  5.4.1
The number of stools in 24 hours was recorded on question 1 of the MSKCC bowel 
function questionnaire as shown in Table 5.4.01. Preoperatively the mean stool 
frequency in 24 hours was 3.5 (SD 2.6) and this was similar in participants with and 
without severe anal incontinence. However significant differences were observed 
during the first year after surgery. There was a significant and clinically relevant 
difference in stool frequency between the two groups at both 3 months and 12 
months. Participants with severe anal incontinence had a mean stool frequency of 5 
compared to 3 in the group without severe anal incontinence (p < 0.001). 
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71  3.4  2.1  -0.89  -2.5  0.7  0.271 
12  4.3  4.6         
68  3.4  2.0  -3.5  -5.0  -1.9  <0.001 
11  6.8  4.1         
58  3.2  2.2  -2.6  -4.6  -0.6  0.012 
8  5.8  5.1         
61  2.8  1.9  -1.8  -3.3  -0.2  0.025 
9  4.5  3.4         
74  2.8  1.9  -2.4  -3.7  -1.1  <0.001 
12  5.2  2.9         
 
 
The EORTC-C30 questionnaire includes one question about constipation (question 16: 
“Have you been constipated?”) which is scored from 0 to 100 where zero means “not at 
all” and 100 means “very much”. There were 10 participants who reported “quite a bit” 
or “very much” in response to question 16 before surgery. Only one of these 
participants reported similar levels of constipation at one year after surgery. There 
were 10 (11%) participants who reported constipation at 12 months after surgery and 
77 (89%) who did not. The mean constipation score was 15 (SD 25) before surgery and 
20 (SD 29) at one year after surgery. This small difference is unlikely to be clinically 
relevant and was not significant (p = 0.138). 
 
The group of participants with “quite a bit” or “very much” constipation (EORTC-C30 
Q16) at 1 year was looked at in more detail. Before surgery the scores in these two 
groups were low (“not at all” or “a little”). After surgery there was a widening difference 
in constipation scores between these two groups with a mean difference of 50 and 75 
at 6 and 12 months respectively (Table 5.4.02). This is a clinically relevant and SA Pilkington    Results and Discussion 
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significant difference. There appears to be a group of participants who develop 
significant symptoms of constipation after anterior resection. Two of these participants 
also had severe anal incontinence at 1 year. There was no difference in 24 hour stool 
frequency between the group with high symptom levels of constipation at 1 year and 
those with low constipation scores at 1 year, using an independent T-test (mean 
difference 0.8, 95% CI: -0.7 to 2.3, p = 0.293). 
 
 
10  30  33  17  -0.06  33  0.051 
77  13  24         
10  40  38  27  10  43  0.002 
71  13  22         
8  63  38  50  32  68  <0.001 
63  13  22         
8  50  25  37  19  54  <0.001 
63  13  23         
10  87  17  75  5  65  <0.001 
77  11  16         
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The MSKCC bowel function questionnaire includes 2 questions on bowel function 
(question 4: “Do you feel like you have totally emptied your bowels after a bowel 
movement?” and question 6: “Do you have another bowel movement within 15 minutes 
of the last bowel movement?”). The replies are scored from 0 to 100 where zero means 
“always” and 100 means “never”. Because of the way these questions are phrased a 
high score for question 4 implies a poor outcome whereas a high score for question 6 
implies a good outcome. 
 
  5.4.2
Small changes in bowel emptying were recorded with a mean value of 64 (SD 33) 
before surgery and 73 (SD 26) at 1 year after surgery. An independent T-test was used 
to compare mean scores of participants with high and low levels of constipation 
symptoms (EORTC C-30 Question 16). Data was missing from the 6 and 9 month data 
collection points making interpretation of the results difficult. But at 3 and 12 months 
significant differences were found with a mean difference in scores of 25 (Table 
5.4.03).  
 
At 12 months after surgery, the average score for bowel emptying suggests that 
participants in the constipation group “rarely” or “sometimes” felt as though they 
totally emptied their bowels after a bowel movement. Participants who did not report 
high levels of constipation as though like they had emptied their bowels after a bowel 
movement “most of the time”. However the 95% confidence intervals (8 to 42) are quite 
wide. 
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8  50  23  7  -17  32  0.565 
74  43  34         
8  63  30  24  3  45  0.024 
72  38  28         
7  54  30  12  -11  35  0.290 
63  41  29         
8  50  19  13  -6  34  0.171 
61  36  28         
10  60  24  25  8  42  0.004 
75  35  26         
 
 
Participants with severe anal incontinence at 12 months, also had worse bowel 
emptying (MSKCC question 4 score = 58) than those with no severe anal incontinence 
(MSKCC question 4 score = 35) and this difference was significant (95% CI: 8 to 38; p = 
0.004).  
 
  5.4.3
The scores for question 6 were 36 (SD 28) before surgery and 27 (SD 24) at 1 year 
after surgery. Overall there appears to be very little difference in these scores before 
and after surgery. Participants in the constipation group had similar scores to those 
not in the constipation group with a mean difference of 2 (95% CI: -17 to 22; p = 
0.785). 
 
However differences were found when the severe incontinence group was compared to 
the group with no severe incontinence. Using an independent T-test to compare means 
there was a significant difference in the scores to Question 6 at 1 year after surgery SA Pilkington    Results and Discussion 
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Table 5.4.04). Participants in the severe incontinence group reported bowel movement 
within 15 minutes of the last bowel movement “always” or “most of the time”. Whereas, 
in the group with no severe anal incontinence, this symptom was reported “rarely”.  
 
 
71  70  29  14  -4  32  0.124 
12  56  32         
69  63  30  21  4  38  0.017 
13  42  19         
62  68  26  15  6  35  0.155 
7  54  17         
60  69  24  22  5  40  0.014 
8  47  21         
74  74  26  30  15  45  <0.001 
13  44  18         
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  5.4.4
Maximum tolerable rectal volume was compared at baseline to values at 3 months and 
12 months after anterior resection. A mean difference of 37ml and 19ml was found at 
3 and 12 months respectively (p = 0.013) (Table 5.4.05). Maximum tolerable rectal 
volume falls after anterior resection and this may result in a more hypersensitive 
rectum with a smaller capacity. Although the values for maximum tolerable rectal 
volume are reduced after anterior resection, they do not fall into an abnormal range. 
 
 
66  138  60  37  23  51  <0.001 
66  101  55         
72  135  61  19  4  33  0.013 
72  116  66         
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Maximal tolerable rectal volume was compared in participants with and without severe 
anal incontinence at one year. Those with severe anal incontinence had a tendency to 
lower maximal tolerable rectal volumes but this did not reach statistical significance 
(Table 5.4.06). 
 
 
13  108  31  -31  -67  5  0.093 
76  139  64         
10  73  42  -33  -70  3  0.074 
56  106  55         
12  83  38  -40  -81  0.3  0.052 
60  123  68         
 
 
Participants with constipation (EORTC-C30 Q16) at one year were assessed for 
differences in maximum tolerable rectal volume over the first postoperative year. 
Before surgery, the volumes were similar. The mean difference was greatest at 3 
months (39ml, 95%CI: -0.77 to 80, p = 0.054). 
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There were 76 participants with an intact RAIR before surgery and 11 with no RAIR. 
Amongst the participants with preoperative RAIR, 17 (22%) had preserved RAIR at both 
3 and 12 months after surgery, 10 (13%) had an absent RAIR at 3 and 12 months, 16 
(21%) had return of RAIR at 12 months and 13 (17%) were equivocal. The relationship 
between severe incontinence (CCI>=9) and constipation (EORTC-C30 Q16) at 12 
months after surgery and the presence of RAIR at 3 and 12 months after surgery was 
explored using logistic regression. No significant relationships were found as 
summarised in Tables 5.4.07 and 5.4.08. 
 
 
25  33  0.504 (0.125 to 2.029)  0.335 
6  4     
26  33  0.506 (0.100 to 2.550)  0.409 
5  4     
 
 
 
25  34  1.781 (0.408 to 7.777)  0.443 
5  7     
26  38  0.474 (0.094 to 2.389)  0.366 
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The relationship between severe anal incontinence and the location of the anastomosis 
relative to the peritoneal reflection was explored. Logistic regression indicates that an 
anastomosis below the peritoneal reflection (p = 0.048) is a strong predictor of severe 
anal incontinence (OR=  8.2, 95% CI: 1.0 to 66.9). The odds of severe anal incontinence 
in participants with a rectal anastomosis is 8 times as great as participants with a 
higher anastomosis. The position of the anastomosis relative to the peritoneal 
reflection was not a predictor of constipation (EORTC-C30 Q16). Table 5.4.9 shows the 
relationships between presence or absence of a rectal anastomosis and severe anal 
incontinence and constipation. 
 
 
31  45  8.267 (1.022 to 66.880)  0.048 
1  12     
26  53  0.327 (0.085 to 1.261)  0.105 
6  4     
 
 
There were significant differences in anal manometry before and after surgery. Mean 
resting pressure was lower after surgery (p < 0.001) (Table 5.4.10) but mean squeeze 
pressure was not altered. 
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    n  Mean  SD  Mean 
difference 
95% CI 
Lower 
 
Upper 
p 
Max 
MRP 
Preop  68  60  20  13  8.7  17.8  <0.001 
  3 
months 
  47  17         
Max 
MRP 
Preop  72  60  21  16  12.1  20.9  <0.001 
  12 
months 
  43  17         
Mean 
MRP 
Preop  68  40  15  10  7.1  13.9  <0.001 
  3 
months 
  30  12         
Mean 
MRP 
Preop  72  40  14  12  8.6  15.0  <0.001 
  12 
months 
  28  11         
 
 
Mean resting pressure profiles along the first 4cm of the anal sphincter are different in 
men and women (Figure 5.4.01). In women the peak in anal pressures is at 2cm 
whereas in men it is at 3cm. After surgery the male profile looks more like the female 
one with the peak in mean resting pressures at 2cm. 
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Mean resting pressure before surgery 
 
Mean squeeze pressure before surgery 
 
Mean resting pressure at 3 months 
 
Mean squeeze pressure at 3 months 
 
Mean resting pressure at 12 months 
 
Mean squeeze pressure at 12 months 
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The present study has focussed mainly on faecal incontinence after anterior resection, 
however the evidence in this chapter is that a significant group of participants also 
complained of difficulty with “constipation”. There were 10 (11%) participants who 
complained of constipation (“quite a bit” or “very much”) on EORTC-C30 Q16 at one 
year. This group of participants had a similar constipation score before surgery to 
those who did not complain of constipation at one year. This suggests that these 
participants developed constipation after their surgery rather than it being a pre-
existing condition. 
 
The definition of severe anal incontinence as CCI>=9 has been previously validated 
(Rothbarth, et al., 2001). Although extensively validated, the EORTC-C30 Q16 is rather 
ambiguous. It asks “Have you been constipated?” The term “constipation” is often used 
to describe a wide spectrum of symptoms including infrequent stools, hard stools, 
difficulty with rectal evacuation and sensation of incomplete emptying. Further 
information on symptoms relating to constipation could have been gathered by the 
addition of constipation specific questionnaires such as PAC-SYM (Frank, Kleinman, 
Farup, Taylor, & Miner, 1999) and PAC-QOL (Marquis, De La Loge, Dubois, McDermott, 
& Chassany, 2005). In the present study, data on rectal evacuation was collected in the 
MSKCC bowel function questionnaire. This is quite a difficult questionnaire for people 
to use as the questions are not phrased consistently. For example a high score on Q4 
implies a poor outcome whereas a high score for Q6 implies a good outcome. This was 
observed to lead to confusion for some participants completing the questionnaire and 
may result in inconsistent results. 
 
Participants with severe anal incontinence had a higher stool frequency than those 
without severe anal incontinence but there was no difference in stool frequency 
between those with and without constipation at one year. Bowel emptying was 
assessed by the MSKCC Q4 but only small changes were recorded after surgery and a 
larger sample size would be needed to determine if there was clinically relevant 
difference.  
 
At 12 months after surgery, the average score for bowel emptying suggests that 
participants in the constipation group “rarely” or “sometimes” felt as though they 
totally emptied their bowels after a bowel movement. Participants who did not report 
high levels of constipation felt as though like they had emptied their bowels after a 
bowel movement “most of the time”. Participants in the constipation group did not 
have lower stool frequency but did report incomplete evacuation to a greater degree. SA Pilkington    Results and Discussion 
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However the 95% confidence intervals (8 to 42) are quite wide and more data are 
needed to determine whether the mean difference really is large enough to be clinically 
relevant. 
 
There was a significant and clinically relevant difference in MSKCC Q6 scores (Do you 
have another bowel movement within 15 minutes of your last bowel movement?) 
between participants with and without severe anal incontinence Participants with 
severe anal incontinence reported return trips to the toilet within 15 minutes of a 
bowel movement “always” or “most of the time”. In contrast, participants without 
severe anal incontinence reported this symptom rarely. 
 
Maximum tolerable rectal volume was compared at baseline to values at 3 months and 
12 months after anterior resection. A mean difference of 37ml and 19ml was found at 
3 and 12 months respectively (p = 0.013).  
 
Maximum tolerable rectal volume falls after anterior resection (p = 0.013) and this may 
result in a more hypersensitive rectum with a smaller capacity. Although the values for 
maximum tolerable rectal volume are reduced after anterior resection, they do not fall 
into an abnormal range. However the confidence intervals are quite wide for the mean 
difference between preoperative and postoperative values. If the mean difference did 
fall at the upper limit of the 95% confidence intervals then it would be clinically 
relevant with values outside the normal range. 
 
Participants with severe anal continence had lower maximal tolerable rectal volumes 
after surgery but this did not reach statistical significance. In this study an intact RAIR 
was not essential for anal continence. Anastomosis below the peritoneal reflection was 
found to be associated with a worse outcome for severe incontinence but not for 
constipation. 
 
Surgery had a marked effect on lowering resting pressures but squeeze pressures were 
not affected. Serial pressure profiles of the anal canal showed a peak in resting 
pressures at 3cm in men but at 2 cm in women. After surgery the resting pressure 
profiles of the men looked more like the profile in women with the peak in pressures at 
2cm. The squeeze pressure in men was significantly higher than in women, but there 
was no obvious change with surgery. 
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After anterior resection a significant group of participants complained of a change in 
their bowel habit with severe anal incontinence in 15% and constipation in 11% at one 
year. These patients can be investigated further with anorectal manometry and 
proctography to identify why this may be occurring and to target further treatment. 
 SA Pilkington    Results and Discussion 
  140   
   SA Pilkington    Results and Discussion 
  141   
 
 
The height of the anastomosis from the anal verge may be an important predictor of 
functional outcome after anterior resection. Previous studies have shown that a low 
anastomosis is associated with a worse functional outcome (Lee & Park, 1998; Lewis et 
al., 1995). 
 
In Southampton, anastomotic height is not routinely measured during the surgical 
procedure, so limited data were available on measured anastomotic height (M height). 
As it may be an important predictor of functional outcome, a method for estimating 
anastomotic height was investigated. Length of bowel resected (R length), distal 
resection margin (R margin) and inclusion of peritoneal reflection are all recorded in 
the pathology report. Height of pathology (T height) was recorded preoperatively.  
 
It was hypothesised that subtracting the length of the distal resection margin from the 
tumour height, would give an estimate of anastomotic height. In addition to the length 
of bowel below the tumour (distal resection margin) some additional bowel is removed 
in the stapling device. There is also some shrinkage of the specimen during the 
fixative process prior to histopathological reporting.  
 
 
Study procedures were carried out as described in Section 4.1. 
 
Height of the tumour above the anal verge was recorded preoperatively in all 
participants. Length of bowel resected (R length) and distal resection margin (R 
margin) was extracted from the pathology report (Table 5.5.01). Anastomotic height 
measured at the time of surgery (M height) was recorded in 33 participants but only 29 
of these also had the distal resection margin recorded on pathology. These 29 
participants were studied further to estimate height of anastomosis (Table 5.5.02 and 
5.5.03). SA Pilkington    Results and Discussion 
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n Distance in cm Range
(T height)
120  15  4 - 30 
(R margin) 
103  2.8  0 - 10 
(M height) 
33  8.8  3 - 20 
(R length) 
117  19.5  8.5 - 62 SA Pilkington    Results and Discussion 
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ID 
Tumour 
height 
Distal resection 
margin on pathology 
report 
Measured height 
of anastomosis 
Resection 
length 
1  10  1.3  3  10 
120  8  0.6  3  19 
21  5  1  4  15 
67  12  2.5  4  17 
89  7  3  5  19 
117  7  0.8  5  12 
119  7  0.8  5  24 
124  10  1  5  15 
86  10  2  6  19 
115  4  0.5  6  20 
116  5  1.7  7  15.5 
87  8  4  8  19 
93  8  0.3  8  23 
94  8  6.5  8  29 
118  10  0.8  8  18 
61  15  2  9  18 
90  10  4.5  9  19 
108  10  2  9  32 
45  20  0.7  10  13 
75  12  1.5  10  19 
92  10  1  10  22 
110  10  1.7  10  19 
47  15  4  12  10 
54  15  3.5  12  12 
73  12  3.5  12  12 
91  12  4  12  21 
95  10  2  12  20 
126  15  1.5  12  22 
65  20  1.8  15  16 SA Pilkington    Results and Discussion 
  144   
 
 
Distance in cm SD  Range
(T height) 
11  4.0  4 - 20 
(R height) 
2.1  1.5  0.3 – 6.5 
(R length) 
19.5  1.7  8.5 - 62 
(M height) 
8.0  3.2  3 - 15 
(E height) 
8.2  4.1  5.3 – 12.8 SA Pilkington    Results and Discussion 
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The relationship between predicted anastomotic height (T height – R margin) and 
measured anastomotic height (M height) was explored (See Figure 5.5.01).  
 
  
 
Simple linear regression indicates that there is a positive linear relationship (b=0.421, 
P=0.003, 95% CI: 0.156 to 0.686) between estimated anastomotic height and M height, 
which is described by the following equation: 
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The mean difference is close to zero. The 95% limits of agreement are shown in Figure 
5.5.02. The estimated height is expected to be between 5.44cm above or below the 
measured height for 95% of patients, assuming the distribution of differences is 
approximately Normal.  
 
 
A test of significance using the correlation coefficient shows that there seems to be a 
relationship between the difference and mean (r = 0.53, P = 0.003). However this 
apparent negative trend is driven by a few key points and may be due to these 
influential observations rather than a true relationship. 
Mean difference SA Pilkington    Results and Discussion 
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The length of bowel resected is independent of the anastomosis height as shown in the 
scatter plot Figure 5.5.03. 
 
 SA Pilkington    Results and Discussion 
  148   
 
On the basis of these data, it cannot be concluded that estimated height is a reliable 
surrogate to replace measured height. The estimated height is expected to be between 
5.44cm above or below the measured height most patients. A method for estimating 
anastomotic height would need a greater accuracy than this as it is important to 
classify how much of the rectum remains after surgery. In particular the estimation of 
anastomotic height should be able to locate which third of the rectum it is sited in, that 
is lower third (first 5cm), mid third (5 to 10 cm) or upper third (10 to 15cm from anal 
verge).  
 
Measurement of height of pathology is noted for its inaccuracy. It is extremely difficult 
to measure the length of a stretchy tube of bowel within the bony pelvis in a reliable 
and accurate manner. Likewise measuring the anastomotic height is also difficult. 
Looking at the raw data in Table 5.5.02, these difficulties are well-illustrated with 
several examples of measured anastomotic height being the same as the measured 
tumour height. Looking at the distal resection margin it is clear that this was not the 
case. Either measured height of the tumour or height of the anastomosis is inaccurate, 
or there may be errors with both. 
 
The average length of bowel resected was 19.5cm (range 8.5 to 62cm). The amount of 
bowel removed is dependent on intraoperative factors. The main priority is to get 
below the tumour without having to remove the anal sphincter. The amount of distal 
bowel removed depends largely on the blood supply to the remaining bowel and trying 
to achieve sufficient length to form a tension-free anastomosis. The finding that the 
length of bowel resected is not related to height of anastomosis is expected.  
 
For this project, the position of the anastomotic height will be measured from the anal 
verge where available in the participants who completed follow up (n = 22). Where the 
resected specimen does not contain peritoneal reflection, the participant will be 
classified as having a high anastomosis (n = 32) and a correlation with length of 
resection will be carried out. In a further 57 patients the peritoneal reflection was 
included in the resection specimen and therefore they must have a rectal anastomosis. 
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After anterior resection a considerable number of patients have disordered defaecation 
as a result of their surgery. Imaging of these patients during simulated rectal 
evacuation may distinguish between structural and functional causes. However, all 
measures whether using radiological techniques or an expulsion test, only simulate 
rectal evacuation. The natural process of defaecation is more complicated and involves 
coordination of colonic propulsion waves with abdominal and diaphragmatic effort in 
addition to the final event of rectal emptying.  
 
A Japanese study carried out on 62 patients who had undergone rectal resection, found 
that barium proctography was useful in evaluating defaecatory disorders (Morihiro, et 
al., 2008). They studied 62 patients who had undergone anterior resection and found 
that participants who were able to evacuate over 55% of the rectal contrast had a 
significantly lower CCI score, less soiling and less urgency. 
 
Several imaging techniques are available for assessing rectal evacuation. This study 
aims to compare Barium (BaP) and MR proctography to identify whether there are any 
differences between the findings from these two techniques for assessing simulated 
defaecation. The most appropriate test will be recommended for investigating patients 
with abnormal defaecation after anterior resection. 
 
This study was carried out as described in the Methods Section 4.2. Summary data 
from the 42 study participants is presented in Appendix XVI. 
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Between 8 May 2008 and 11 December 2009, this study invited 216 patients (202 
female and 14 male) to participate (Figure 5.6.01). At the appointment for Barium 
proctography, 71 participants were recruited and 42 of these completed the study by 
attending for MR proctography. The remaining 29 patients withdrew from the study. 
Participant characteristics are shown in Table 5.6.01 
 
 
 
59 (37 – 76) 
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Rectoceles were extremely common and present in almost all participants on both BaP 
and MR proctography. The measure of agreement on presence of rectocele was 
substantial (Kappa 0.690) (Table 5.6.02). Rectocele length ranged up to 5.95cm on BaP 
and 6.20cm on MR proctography. The mean rectocele length was 3.10cm (SD 1.44) on 
BaP and 2.90cm (SD 1.60) on MR proctography.  
 
(MR proctogram)  MR proctogram)
(BaP)
4  0 
(BaP)
3  35 
 
 
The mean difference in rectocele length measured on BaP and MR proctography was 
0.20 (95% CI: -0.23, 0.63; p = 0.35). This difference is not clinically relevant. Figure 
5.6.02 is a scatter plot showing rectocele length on BaP and MR proctography with a 
line of equivalence. To show the mean difference in rectocele length (BaP - MR 
proctography) against their mean for 38 participants, a Bland-Altman Plot was 
constructed (Figure 5.6.03). The mean difference was 0.2cm with standard deviation 
1.3cm. The Bland-Altman plot shows that 95% of the differences in rectocele length 
measured on BaP and MP lie between 2.8 and -2.4cm (mean +/- 2 x standard 
deviation). The difference for an individual would be between -2.4 and 2.8cm. SA Pilkington    Results and Discussion 
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To assess intra-observer reliability for measuring the size of rectoceles, the last 20 
Barium proctograms were reported again by the same reporter (DT) 12 months after 
the last participant was recruited. This was a considerable time gap to ensure that the 
reporter was not remembering the previous measurement. The mean difference in 
measuring length of rectocele was 0.16cm with standard deviation 0.91cm. The Bland-
Altman plot in Figure 5.6.04, shows that 95% of the differences in rectocele length 
measured on BaP and MR proctography lie between 1.96 and -1.66cm (mean +/- 2 x 
standard deviation). The difference for an individual would be between -1.66 and 
1.96cm. 
 
 SA Pilkington    Results and Discussion 
  155   
Inter-observer variability was assessed by comparing the measurement of rectocele 
length on MR proctography by one reporter (CT) with a second measurement by the 
other reporter (DT). The mean difference between the two measurements was 0.04cm 
and the standard deviation was 0.78cm. Figure 5.6.05 show the Bland-Altman plot for 
this data. 
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 Agreement between findings on BaP and MR proctography are shown in Table 5.6.03. 
Complete rectal emptying was observed in 29% (12/42) on BaP and in 2% (1/42) on MR 
proctography. Anismus was reported in 18 (43%) cases on MP and in 12 (29%) cases on 
BaP. The measure of agreement between presence of anismus was moderate (Kappa = 
0.493). There was complete agreement in 10 of the participants but an additional 8 
cases were reported on MR proctography alone compared to an additional 2 cases on 
BaP. The measurement of agreement between BaP and MR proctography for rectal 
intussusception was fair (Kappa 0.209). However MR proctography missed 31% (11/35) 
cases detected on BaP compared with 8% (2/26) missed by BaP. The measure of 
agreement between Oxford Grade of Rectal Intussusception was fair (Kappa 0.260). MR 
proctography underestimated the grade of rectal intussusception in 21 cases and in 13 
of these the difference was at least 2 grades (Table 5.6.4). There was substantial 
agreement between the presence of an enterocele on BaP and MR proctography (Kappa 
= 0.690). However the number of cases was small (n = 7) and BaP found 3 (43%) cases 
that were missed by MR proctography. Cystoceles and uterovaginal prolapse were not 
seen on BaP. MR proctography identified 21 cystoceles and 2 cases of uterovaginal 
prolapse. 
 
Raw data can be found in Appendix XVI 
 
38  35  0.690 
11  6  0.120 
12  1  NA 
12  18  0.493 
35  26  0.209 
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        MR Proctography  
 
    0   1   2   3   4   Total  
Ba Proctography  0   5   1   0   0   1   7  
  1   2   0   1   0   0   3  
  2   6   1   6   0   0   13  
  3   3   1   4   4   2   14  
  4   0   1   2   1   1   5  
  Total   16   4   13   5   4   42  SA Pilkington    Results and Discussion 
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An example of the different appearances on BaP and MR proctography in the same 
participant is shown in Figure 5.6.06. Both proctograms showed Grade 3 rectal 
intussusception (Figure 5.6.06 A and C). During the BaP, oral contrast in the small 
bowel can be seen in 5.6.06A. As the participant strains to evacuate the rectum this 
can be seen as an enterocele in Figure 5.6.06B. However on MR proctography an empty 
peritoneocele is seen on attempting to evacuate (Figure 5.6.06D). Although 
representative images have been selected, the dynamic sequence of images is easier to 
interpret. 
 
Small bowel (SB), rectal intussusception (RI), enterocele (e), peritoneocele (p), sacrum 
(s), pubic bone (pb) and bladder (Bl) have been marked. 
 
 
 
A 
B  D 
C 
SB 
s 
RI 
e 
s 
RI 
s 
s 
Bl 
Bl 
p 
pb 
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The changes in ARA from resting to contracting and evacuating during both BaP and 
MR proctography are shown in Table 5.6.05. During contraction, mean ARA decreased 
by 8
o (95% CI:  4, 13) and 11
o (95% CI: 6, 16) on BaP and MR proctography respectively. 
During evacuation, mean ARA increased by 18
o (95% CI: 11, 25) and 22
o (95% CI: 13, 
29) respectively. These changes were highly significant (p<0.001) (Figure 5.6.07 and 
Table 5.6.06). Using a paired T-test, no significant difference between ARA measured 
on BaP and MR proctography was found.  
 
109  24 
105  16 
101  27 
94  17 
128  27 
127  22 
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8.4  4.1  13  <0.001 
-18  -25  -11  <0.001 
11  5.8  16  <0.001 
-22  -29  -14  <0.001 
 
Measurements of ARJ on BaP and MR proctography are not directly comparable (Table 
5.6.07). It was not possible to identify the pubic symphysis on BaP without increasing 
the radiation exposure to the participant. This did not have ethical approval. Therefore 
measurements were taken from the sacral prominence to the ARJ on BaP. MR 
proctography did identify the pubic symphysis so measurements were taken from the 
PCL to the ARJ.  
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14.7  2.1 
2.3  1.5 
13.9  2.1 
1.8  1.6 
16.9  2.6 
5.7  1.7 
 
The difference in ARJ measurements associated with contraction and evacuation are 
similar on BaP and MR proctography despite being measured differently (Table 5.6.08). 
 
 
0.74  0.55  0.92  0.000 
-2.2  -2.7  -1.6  0.000 
0.58  0.23  0.93  0.001 
-3.3  -3.8  -2.8  0.000 
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The patient questionnaire was administered to 42 participants and 25 participants 
completed it for both BaP and MR proctography. In the group of participants who 
answered questionnaires for both tests, 13 (52%) felt that they opened their bowels as 
usual during both tests, 4 (16%) felt that they opened their bowels as usual during BaP 
only, 3(12%) felt that they opened their bowels as usual during MR proctography only 
and 5 (20%) felt that they did not open their bowels as usual during either test (Table 
5.6.09). There were 8 participants who only answered the questionnaire after BaP and 
9 who only answered after MR proctography.  
 
: Do you feel that you opened your bowels 
as
          Q1 answer after  
MR proctography 
13  4  4 
3  5  4 
4  5  0 
 
 
Q1 answer 
after BaP SA Pilkington    Results and Discussion 
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All participants who completed the questionnaire for both tests agreed to have either 
test repeated if necessary except for one participant who did not want the MR 
proctogram repeated (Table 5.6.10). This participant felt that the BaP was performed in 
a more “respectful” manner than the MR proctography. 
 
 
              Q2 answer after  
              MR proctogram 
25  1  7 
0  0  0 
9  0  0 
 
Q2 answer 
after BaP SA Pilkington    Results and Discussion 
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Question 3 asked patients to give a preference for BaP or MR proctography. There were 
8 participants who did not answer this question and they have not been included in the 
results. The tests were reported as equal in 2(6%) participants. A preference was 
reported in 32(94%) participants. MR proctography was the preferred test for 21(62%) 
participants and BaP was the preferred test for 11(32%) participants (Table 5.6.11).  
 
 
MRP  21 
BaP  11 
No data  8 
No preference  2 SA Pilkington    Results and Discussion 
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The second part of question 3 referred to the reason why the participant preferred one 
test or the other (Table 5.6.12). The most frequently chosen reason for test preference 
was “less embarrassing” and this was given as a reason by 22 (69%) participants. In all 
participants who preferred MR proctography, it was thought to be less embarrassing 
than BaP. Participants who preferred BaP (n=11) reported that the position was better, 
n=10 (91%), and that it was easier to empty n=7 (64%) but only 1 (9%) participant 
reported that it was less embarrassing than MR proctography. 
 
Table 5.6.12 Participant questionnaire Q3 reason: Reasons given for test
1 (9%)  21 (100%)  22 
5 (45%)  8 (38%)  13 
10 (91%)  6 (29%)  16 
7 (64%)  5 (24%)  12 
0  2 (10%)  2 
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Studies investigating rectal evacuation are difficult to carry out not least due to the 
embarrassing nature of the tests and the reluctance of participants to volunteer. This is 
reflected in the current study. Although 216 patients were invited to participate, the 
number recruited was 71 (33% recruitment) and 29 withdrew (41% dropout rate). This 
still leaves 42 participants which is a meaningful group to study. 
 
All patients in the study group were being investigated for pelvic floor disorders. There 
is likely to be a higher degree of abnormality within the study group than the general 
population and measurements taken will not reflect normal ranges. However the aim of 
this study was to investigate whether there are measurable differences between the 
two techniques. All proctograms are at best simulated defaecation and the degree to 
which this reflects events occurring in the privacy of the patients own toilet is 
debatable.  
 
Rectoceles were extremely common in the study group and were diagnosed on both 
BaP and MR proctography in 83% of participants. There was substantial agreement 
between BaP and MR proctography on presence of rectocele. BaP did not miss any 
rectoceles that were evident on MR proctography, but MR proctography missed 3 cases 
of rectocele. Rectocele emptying occurred more frequently on BaP. There was poor 
agreement between BaP and MR proctography (Kappa 0.12). The mean rectocele size 
was 3.10cm (SD 1.44) on BaP and 2.90cm (SD 1.60) on MR proctography. The mean 
difference in rectocele length was 0.2cm. This is not a clinically relevant difference and 
was not significant (p = 0.345). However the 95% CI demonstrates that the actual 
difference is probably between -0.2 and 0.6cm. A difference of 0.5cm might be 
clinically significant. A larger sample size would be necessary to assess whether the 
difference really is this large on average.  
 
The Bland-Altman plot (Figure 5.6.03) shows that 95% of the differences in rectocele 
length measured on BaP and MR proctography lie between 2.8 and -2.4cm. The 
maximum likely difference between rectoceles measured on BaP and MR proctography 
for an individual is approximately 2.6cm (standard deviation x 2). A difference this 
large would be clinically significant, therefore it cannot be concluded from this data 
that the two methods are comparable for assessing rectocele size. 
 
Intra-observer reliability for rectocele length on BaP was good. Figure 5.6.04 shows 
that 95% of the difference in rectocele length measurement lies between -1.66 and 
1.96cm. This is considerably better than the difference in rectocele length between BaP 
and MR proctography. Inter-observer reliability for rectocele length on MR SA Pilkington    Results and Discussion 
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proctography was also good as shown in Figure 5.6.05. The observed differences in 
rectocele size between BaP and MR proctography are therefore unlikely to be due to 
observer reliability alone. 
 
Participants seemed to have difficulty emptying the rectum when lying in the MRI 
scanner. Complete rectal emptying only occurred in 2% MR proctograms compared to 
29% BaP. This is a problem because other pathology such as rectal intussusception will 
be missed if the patient is unable to evacuate. Another explanation is that the 
ultrasound gel coats the rectum and is more difficult to completely expel. However the 
increased presence of anismus (8 additional cases on MR proctography) is more in 
keeping with participants having difficulty evacuating. 
 
Rectal intussusception was found on both BaP and MR proctography in 57% of 
participants (83% BaP). Shorvon‟s study on normal subjects found rectal 
intussusception in 50% of men and women (Shorvon, et al., 1989). The higher rate of 
detection of rectal intussusception in the present study may be due to the case mix 
which was entirely pelvic floor patients. The confirmation of rectal intussusception on 
proctography is important for the management of patients with obstructive defaecation 
who may be candidates for the Stapled Transanal Rectal Resection (STARR) procedure 
(Boccasanta et al., 2004; Meurette, Wong, Frampas, Regenet, & Lehur, 2010; 
Pechlivanides et al., 2007; Vermeulen, Lange, Sikkenk, & van der Harst, 2005). The 
results of the current study suggest that BaP detects more cases of rectal 
intussusception with only 8% missed on BaP compared to 31% on MR proctography. 
Symptoms are also important in patient selection for the STARR procedure and the 
proctogram findings must not be used in isolation. If the cases of rectal 
intussusception that were missed on MR proctography were asymptomatic or those 
that had a poor outcome after STARR, then perhaps missing them would not make a 
clinically significant difference. Symptoms at presentation and surgical outcome were 
not assessed in this project so we can only assume that MR proctography may miss a 
significant amount of rectal intussusception that might be treatable.  In addition MR 
proctography underestimated the Oxford Grade of Intussusception in 50% of cases and 
in 31% of cases this underestimation was by at least 2 grades. A relative 
contraindication to STARR is the finding of an enterocele. Enteroceles were rare in this 
study with only 7 cases. Importantly MR proctography missed 3 of the cases. Larger 
numbers of participants are needed to determine whether MR proctograms do miss in 
the region of 40 to 50% of rectal intussusception or not. Mucosal prolapse tends to be 
a clinical diagnosis and was poorly appreciated on either BaP or MR proctography. 
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Participant 12 shown in Figure 5.6.06, is a good example of agreement between the 
proctograms on Grade of rectal intussusception. However towards the end of 
evacuation an enterocele is clearly demonstrated on BaP, whereas the MR proctogram 
shows an empty peritoneocele. This could simply be within the margins of 
reproducibility due to the effort exerted by the individual during the two tests. 
Alternatively, it may be due to the horizontal position of the participant during MR 
proctography and this study did find that the MR proctograms reported less rectal 
emptying which could also be positional. Although representative static images have 
been included in Figure 5.6.06, some information is lost and the dynamic sequence is 
easier to interpret. 
 
Structures in the anterior compartment such as cystoceles and uterovaginal prolapse 
are not seen on BaP. Use of vaginal contrast allows some assessment of the anterior 
compartment to be made. In contrast, MR proctography does visualize the anterior 
compartment.  During MR proctography, 21 cystoceles and 2 uterovaginal prolapses 
were seen. These conditions tend to be treated by gynaecologists rather than 
colorectal surgeons. In addition they can be diagnosed with a high degree of accuracy 
on physical examination. 
 
The dynamics of normal rectal evacuation are not clearly defined. Good proctographic 
studies in normal subjects are difficult to carry out. Even determining what comprises a 
“normal” subject is difficult. The present study has been performed on a group of 
patients who are undergoing investigation for pelvic floor disorders and is therefore 
unlikely to include a large proportion of normal subjects. Shorvon (Shorvon, et al., 
1989) performed a proctogram series in “normal” individuals in 1989. No significant 
differences were found between men and women. In agreement with the present study, 
ARA was found to decrease during squeeze and increase on evacuation (Table 5.6.13). 
The more acute angles recorded Shorvon‟s subjects may reflect the younger age group 
studied. The mean age was 21 years compared with 59 years in the current study. SA Pilkington    Results and Discussion 
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96 (17)  80 (16)  98 (19) 
95 (16)  71 (12)  103 (15) 
109 (24)  101 (27)  128 (27) 
105 (16)  94 (17)  127 (22) 
 
Mean pelvic floor descent during evacuation was estimated by subtracting ARJ length 
during evacuation from resting length. It was 2.2cm on BaP and 3.3cm on MR 
proctography. Different techniques were used to make these measurements and they 
are not directly comparable. However, Shorvon‟s study found a similar value for 
descent of 2cm in both sexes.  
 
Reproducibility with repeated proctograms on the same individual was not investigated 
in this study or previous studies. It is unlikely that ethical approval would be given for 
repeated BaP on the same individual but MR proctography could be performed more 
than once on the same individual to assess repeatability. Some of the changes 
observed may be within the normal variation of repeated testing. 
 
Proctograms aim to simulate events occurring during defaecation. This study supports 
the use of proctograms as most patients felt that they were able to open their bowels 
as usual during the test. Only 20% of patients felt that they could not open their bowels 
as usual during either BaP or MR proctography. Most patients (52%) reported that they 
opened their bowels as usual during both tests, although 16% felt that they opened 
their bowel as usual during BaP only, compared with 12% during MR proctography only.  
Reduced embarrassment associated with the test was the most frequently given reason 
for choice of test (69%) suggesting that for most participants this was their biggest 
concern. MR proctography was consistently found to be less embarrassing than BaP 
and consequently was reported as the preferred test. However patients who reported a 
preference for BaP seemed to be less concerned about embarrassment than how they 
performed during the test and reported that the position was better and that it was 
easier to empty. It is not clear from this study whether patients would chose the least 
embarrassing test instead of the test that gave the most helpful results. It is certainly SA Pilkington    Results and Discussion 
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possible that patients would chose the most useful test even if it was also the most 
embarrassing. However this question was not specifically addressed. 
 
If repeating this investigation, asking the patient to score each of the 5 main reasons 
for test preference at the time of the test as well as inviting free comments would give 
more useful comparative data. In an ideal experiment the participant would be 
randomly assigned to receive either the BaP or MR proctogram as the first test. In the 
present study participants underwent BaP first followed by MR proctography. Their 
expectations of the test may have been altered by their experience on the first 
occasion leading to a selection bias. 
 
This is an important study investigating two methods of dynamic pelvic floor imaging 
in pelvic floor patients. BaP reproduced rectal emptying and demonstrated structural 
abnormalities to a greater extent than MR proctography. If using proctography to 
investigate disorders of rectal evacuation after anterior resection, this study suggests 
that BaP would be the best test to use. SA Pilkington    Results and Discussion 
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Incorporation of routine biofeedback training into the management of patients with 
rectal cancer who are undergoing anterior resection may result in improved anal 
continence when compared with standard management. 
 
 
The following trial was performed as described in Section 4.1. A table of the raw data 
is included in Appendix XIV.
  5.7.1
Figure 5.7.01 shows the trial profile. Between 27 November 2006 and 18 August 2008 
(21 months), 61 participants were randomly assigned to biofeedback training and 60 
participants were assigned to the control group. Follow up was completed on 13 May 
2010 with complete follow-up data available for 89 (74%) of 121 participants. All 
participants received the intended treatment and 89 completed the follow-up to 1 year 
and were analysed for primary outcome (final CCI). One participant withdrew 
immediately after randomisation. Randomisation was stratified for preoperative 
radiotherapy exposure. No postoperative radiotherapy was given. One participant in 
the radiotherapy group was allocated a randomization number in the no radiotherapy 
group. During the analysis this participant was included in the radiotherapy exposure 
group. Table 5.7.01 summarises participant follow up for all participants recruited. 
 
 The overall dropout rate after randomisation was 26% (n=32). This includes a small 
number of participants who withdrew from the study (n=10) and 22 who were not 
followed up for other reasons (Table 5.7.02).  
 
Thirteen participants were scheduled to have an anterior resection but were either 
inoperable (n=2) or had a non-restorative resection (abdominoperineal excision n=4, 
Hartmann‟s Procedure n=7). Two of these participants initially had an anterior 
resection but this was followed by an anastomotic leak necessitating end colostomy 
formation during their index admission. The other Hartmann‟s Procedures (n=5) were 
performed for technical reasons encountered during the operation. The possibility of 
APE and inoperability was discussed at the MDT meeting in these cases, but the 
consensus opinion was that there was a chance of restorative surgery so the patients 
were recruited to the study. 
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One participant in the control group developed a large rectovaginal fistula at 6 months 
as a complication of her surgery. She had significant faecal leakage associated with the 
fistula and therefore was withdrawn from the study. It was impossible to determine if 
leakage was due to poor sphincter function or to the fistula. Three participants were 
lost to follow up because they were too medically unfit to undergo further general 
anaesthesia for reversal of ileostomy.  
 
There were 5 deaths in the study. Postoperative anastomotic leak and subsequent 
sepsis was the cause of death in 3 participants who died at 8, 16 and 73 days after 
surgery. One participant died from metastatic disease at 161 days after surgery and 
one participant had a myocardial infarction at home at 156 days after surgery. They 
were reported as serious adverse events but none of these deaths could be causally 
linked to the research project. More participants in the control group died (n=4) 
compared to the BFB group (n=1). The death in the biofeedback group was due to 
anastomotic leak.  
 
The main diagnosis based on postoperative histology, was cancer in 88% (n=106) of 
the study group. There were 14 diagnoses of benign disease including 7 large 
tubulovillous adenomas and 7 diverticular strictures. The two intervention groups were 
fairly similar in their baseline demographic and clinical characteristics, as shown in 
Table 5.7.03. There were 50 (41%) women and 71 (59%) men. Participants were aged 
60 years or greater in 78% of the randomised group and aged 70 years or greater in 
47% of the randomised group. There were proportionally more men (n=38, 62%) in the 
BFB group than in the control group (n=33, 55%). 
 
 A total of 89 participants completed the study with follow-up to 1 year and were 
included in the ITT analysis. There were 43 participants in the control group and 46 
participants in the BFB group. Baseline characteristics were similar again (Table 5.7.04). 
There were 29 (63%) men in the BFB group compared to 21 (49%) in the control group. 
 
There were 43 temporary ileostomies in the total study group. The mean number of 
days before ileostomy closure was 168 (range 24 to 722). Only 5 participants with 
temporary ileostomies did not complete the trial and 2 of these were in the 
biofeedback group. In the BFB arm of the analysed group, there were 22 (47%) 
participants with a temporary ileostomy compared to 16 (35%) in the control group. 
 
There were 17 participants who requested telephone follow up. They were equally 
distributed between the control (n=9) and biofeedback groups (n=8) and did not have 
anorectal physiology testing at one year. After the first session which all participants SA Pilkington    Results and Discussion 
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attended, 17 participants declined further ARP testing. Eight of these participants were 
in the biofeedback group and therefore did not have the rectal catheter inserted for 
subsequent BFB sessions. Subjectively the rest of the information given to the 
participants was the same whether the participant was having a telephone or clinic 
follow up. SA Pilkington    Results and Discussion 
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Assessed for eligibility (n=304) 
Excluded (n=183) 
   Not meeting inclusion 
criteria (n=137) 
   Declined to participate 
(n=42) 
   Other reasons (n=4) 
Analysed (n=43) 
 Excluded from analysis 
(n=0) 
Lost to follow-up (n=13) 
Discontinued intervention 
(Withdrew) (n=4) 
“No Biofeedback” (n=60) 
 Received allocated 
intervention (n=60) 
Lost to follow-up (n=9) 
Discontinued intervention 
(Withdrew) (n=6) 
“Biofeedback” (n=61) 
 Received allocated 
intervention (n=61) 
Analysed (n=46) 
 Excluded from analysis 
(n=0) 
 
 
Randomized (n=121) 
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43 (72%)  46 (75%)  89 (74%) 
13(22%)  9 (15%)  22 (18%) 
4 (7%)  6 (10%)  10 (8%) 
60  61  121 
 
(excluding 10 participants who withdrew from the study) 
 
 
 
4  3  7 
4  1  5 
2  2  4 
1  2  3 
1  1  2 
1  0  1 
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33 (55%)  38 (62%)  71 (59%) 
27 (45%)  23 (38%)  50 (41%) 
43 (72%)  42 (69%)  85 (70%) 
9 (15%)  10(16%)  19 (16%) 
8 (13%)  9 (15%)  17 (14%) 
41 (68%)  32 (52%)  73 (60%) 
19 (32%)  29 (48%)  48 (40%) 
52 (87%)  55 (90%)  107 (88%) 
6 (10%)  5 (8%)  11 (9%) 
2 (3%)  1 (2%)  3 (2%) 
8 (13%)  7 (11%)  15 (13%) 
52 (87%)  54 (89%)  105 (87%) 
66 (9)  69 (10)   
4 (5)  4 (5)   
5 (1) 
6 (1) 
5 (1) 
5 (1) 
 
43 (15) 
83 (49) 
61 (21) 
110 (54) 
41 (15) 
84 (50) 
59 (21) 
114 (60) 
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21 (49%)  29 (63%)  50 (56%) 
22 (51%)  17 (37%)  39 (44%) 
33 (77%)  36 (78%)  69 (78%) 
6 (14%)  4 (9%)  10 (11%) 
4 (9%)  6 (13%)  10 (11%) 
27 (63%)  25 (54%)  52 (58%) 
16 (37%)  21 (46%)  37 (42%) 
36 (84%)  42 (91%)  78 (88%) 
5 (12%)  3 (7%)  8 (9%) 
2 (4%)  1 (2%)  3 (3%) 
6 (14%)  7 (15%)  13 (15%) 
37 (86%)  39 (85%)  76 (85%) 
4 (5)  3 (4)   
66 (9)  69 (10)   
4 (5)  3 (5)   
6 (1) 
6 (1) 
5 (1) 
5 (1) 
 
40 (13) 
76 (44) 
60 (19) 
102 (49) 
40 (15) 
87 (49) 
58 (21) 
117 (61) 
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  5.7.2
 
The mean CCI score at 1 year was 4 in both groups (see Table 5.7.05). The adjusted 
CCI score at 1 year is calculated by subtracting baseline CCI from final CCI. A negative 
value for adjusted CCI reflects a better outcome for the participant because their anal 
continence has improved compared to baseline CCI. Although there was a slightly 
better outcome in the control group after adjusting for baseline CCI, this difference 
was not significant. 
 
3.7 (3.5)  4.2 (4.2)  -0.5  0.549 
-2.1 to 
1.1 
-0.7 (5.5)  1.2 (6.0)  -1.9  0.129 
-4.3 to 
0.6 
 
The effect of BFB, baseline CCI, female gender, temporary stoma and radiotherapy 
exposure on final CCI was investigated to determine whether baseline CCI, temporary 
stoma and radiotherapy exposure are confounders in the relationship between BFB and 
final CCI. 
 
Simple linear regression indicated that BFB is not a predictor of final CCI (b=0.496, 
p=0.549, 95%CI -2.1 to 1.1). Using multiple linear regression to control for baseline 
CCI, gender, temporary stoma, radiotherapy exposure and baseline anal canal 
pressures (mean and maximal MSP) there was no significant relationship between final 
CCI and BFB as shown in Table 5.7.06 SA Pilkington    Results and Discussion 
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-0.539  -2.209  1.132  0.523 
0.945  -1.275  3.164  0.400 
-1.727  -4.267  0.813  0.180 
-0.960  -3.086  1.165  0.371 
0.062  -0.124  0.248  0.509 
-0.012  -0.072  0.048  0.689 
-0.001  -0.050  0.047  0.952 
 
Final CCI was converted to a binary variable where CCI score greater than or equal to 9 
was coded as 1 and CCI score less than 9 was coded as 0. Univariate logistic regression 
indicated that BFB (p=0.401) is not a strong predictor of severe anal incontinence (OR = 
0.571, 95%CI: 0.155 to 2.110). Adjusted odds ratio shows that BFB is not a predictor of 
final CCI as shown in Table 5.7.07. Preoperative CCI greater than or equal to 9 was a 
predictor of final CCI at one year. SA Pilkington    Results and Discussion 
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0.392  0.083  1.862  0.239 
5.745  0.383  86.216  0.206 
0.990  0.897  1.093  0.843 
1.462  0.229  9.328  0.688 
0.316  0.049  2.047  0.227 
0.995  0.895  1.107  0.933 
1.039  0.965  1.118  0.313 
1.027  0.953  1.107  0.488 
0.960  0.903  1.020  0.187 
0.080  0.007  .961  0.046 
 
 
Although there was no difference in CCI between control and BFB groups or even a 
slightly improved outcome in the control group if baseline CCI is accounted for, the 
BFB group had more patients with temporary stomas. 
 
The CCI score at one year in participants who had a temporary stoma was on average 2 
units worse than those who did not have a temporary stoma and this difference was 
significant (P = 0.019; 95% CI: 0.3 to 4) (Table 5.7.08).  But there was a similar 
difference in baseline CCI and when this was adjusted for there was no relevant or 
significant difference between stoma and no stoma groups. SA Pilkington    Results and Discussion 
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3.17 
(3.45) 
5.11 
(4.20) 
-1.94  -3.55  -0.32  0.019 
3.27 
(4.44) 
5.25 
(6.42) 
-2.49  -3.93  -0.22  0.048 
0.38 
(4.39) 
0.36 
(7.43) 
-0.02  -2.49  2.53  0.985 
 
  5.7.3
 
Slightly more participants withdrew from the BFB group (n=6) than the control group 
(n=4). As shown in Table 5.7.01, more participants dropped out in the control group 
and this was due to more participants dying or undergoing Hartmann‟s Procedure than 
in the BFB group (Table 5.7.02). 
 
Figure 5.7.02 displays the mean baseline CCI for participants who were analysed 
(n=89) and lost to follow up (n=31). The mean baseline CCI was 3.7 (SD 4.9) in the 
analysed group and 5.1 (SD 6.6) in the lost to follow up group.  SA Pilkington    Results and Discussion 
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  5.7.4
Table 5.7.09 and Figure 5.7.03 show the postoperative changes in CCI during the first 
year after anterior resection. The mean CCI gets a little worse at 3 months and then 
improves. There are no large differences between the biofeedback and the control 
groups. SA Pilkington    Results and Discussion 
  185   
 
43  4.4 (5.2) 
46  3.0 (4.6) 
39  5.1 (5.1) 
43  5.4 (4.8) 
37  4.7 (4.0) 
37  4.5 (4.5) 
35  4.6 (3.4) 
36  5.2 (4.1) 
43  3.7 (3.5) 
46  4.2 (4.2) SA Pilkington    Results and Discussion 
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At one year after surgery, biofeedback treatment did not influence the scores for 
MSKCC Q1 (stool frequency in 24 hours), 4 (bowel emptying) and 6 (Need to pass stool 
within 15 minutes of last bowel movement) (Table 5.7.10). 
 
45  3.2  2.2  0.3  -0.7  1.5  0.538 
41  2.9  2.2         
46  35  25  -5.9  -17  5.6  0.309 
40  41  29         
46  72  27  4  -7.7  16  0.496 
41  68  28         
 
 
Biofeedback did not influence maximum tolerable rectal volume (mean difference at 
one year -16ml, 95%CI: -47 to 15ml; p = 0.306) 
 
 
  5.7.5
Although 304 patients were assessed for eligibility at 82 consecutive MDT meetings, 
137 (45%) did not meet the inclusion criteria. The reasons for this are given in Table 
5.7.11. Almost one third of these patients had metastatic disease and therefore were 
treated palliatively without surgery. One quarter of patients were undergoing 
abdominoperineal resection with formation of a permanent colostomy. It was not 
possible to include patients who were admitted acutely and had emergency surgery 
(n=19, 14%) because they were discussed at the MDT after surgical intervention. 
Patients with significant psychological problems or who were thought to be unable to 
cope with the study were excluded after advice from the colorectal nurse specialists. 
This resulted in only 8 (6%) exclusions and therefore is unlikely to have introduced 
significant bias in the selection process. Forty-two patients declined to participate 
although they were eligible and the reasons they gave for not taking part are given in 
Table 5.7.12. SA Pilkington    Results and Discussion 
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Palliative care due to metastatic disease  42 (31%) 
Abdominoperineal resection with permanent colostomy  36 (26%) 
Emergency surgery  19 (14%) 
Declined to have surgery or were too unfit  13 (9%) 
Surgery at a private hospital  10 (7%) 
Psychological problems  8 (6%) 
Other colorectal resection  5 (4%) 
Hartmann‟s Procedure with permanent colostomy  2 (1%) 
Died  2 (1%) 
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No reason given  14 (33%) 
Time constraints  8 (19%) 
Felt too anxious  6 (14%) 
Didn‟t want to travel  4 (10%) 
Felt too old  2 (5%) 
Carer for relative  2 (5%) 
Didn‟t want additional rectal examination  2 (5%) 
Felt too unwell  2 (5%) 
Embarrassed  1 (2%) 
Didn‟t like look of equipment  1 (2%) 
 
Participant recruitment to the trial was slower to accrue than had been predicted so 
recruitment was extended from 12 to 21 months. Recruitment was terminated when 
121 participants had been recruited.  SA Pilkington    Results and Discussion 
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Anal incontinence and excessive stool frequency after anterior resection can be 
troublesome for some patients and difficult to treat. Symptoms usually improve with 
time and anti-diarrhoeal agents are frequently used for symptomatic control. 
Biofeedback is useful for the treatment of these types of symptoms and is widely used 
in different clinical contexts. There is some evidence to suggest that biofeedback 
treatment may be effective after anterior resection (Ho, et al., 1996). However in this 
study, routine biofeedback did not result in any measureable difference in incontinence 
scores between patients who received biofeedback training and those who did not.  
 
The study participants were typical for patients with rectal cancer. Rectal cancer is 
more common in men than in women (3:2) and is predominantly a disease of the 
elderly with 71% of patients presenting with rectal cancer aged 60 years or older and 
53% aged 70 years or older. The results from this study are similar, with 58% men and 
42% women. Participants were aged 60 years or greater in 78% of the randomised 
group and aged 70 years or greater in 47% of the randomised group. The main 
diagnosis was cancer in 87% of the randomised group.  
 
The two treatment allocation groups were well matched in their baseline 
characteristics, although in the BFB group 29 (48%) participants had a temporary 
ileostomy compared with 19 (32%) in the control group. Participants with a temporary 
stoma have a period of about 3 months after their surgery before the stoma is reversed 
and intestinal continuity restored. Although a considerable amount of research 
demonstrates the negative effect of an ileostomy on quality of life, little has been done 
to investigate whether the functional outcome is worse after a stoma is reversed 
compared to patients who do not have a stoma. It is generally thought that function 
after stoma reversal is worse than in patients who never had a stoma. It is difficult to 
know whether this effect is due to the presence of a low anastomosis which usually 
accompanies the formation of a defunctioning ileostomy. The larger number of 
patients with an ileostomy in the BFB group might bias the results if indeed patients 
have a worse outcome after a temporary stoma. However in the analysed group, there 
was less of a difference with 21 (46%) participants in the BFB group having an 
ileostomy compared to 16 (37%) in the control group.  
 
In this study participants who had a temporary stoma did have a worse outcome than 
those who did not have a stoma. But this difference disappeared when the baseline CCI 
was taken into account. Biofeedback was not associated with improved final CCI in 
patients who had a stoma.  
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Stoma nurses routinely see all patients prior to anterior resection because the need for 
an ileostomy is unpredictable before surgery. Part of the advice given by the stoma 
nurses before surgery includes information about pelvic floor and anal sphincter 
muscle exercises to improve anal sphincter function after reversal of ileostomy. Forty 
percent of the participants had an ileostomy and are likely to have been encouraged by 
their stoma nurse to do exercises. Many patients in the control group would have 
received advice about exercises to improve anal continence. This effect was not 
controlled for and it would have been unethical to attempt to stop the stoma nurses 
from giving this information to the control group. However this may have resulted in 
dilution of the biofeedback effect. 
 
It was not possible to stratify randomisation for stoma formation as this was a largely 
unpredictable event decided by the surgeon at the time of surgery. Surgery took place 
after randomisation and after the first intervention. In addition the sample size was 
only large enough for stratification of one factor and radiotherapy exposure is thought 
to have a significant impact on functional outcome after anterior resection. 
 
Slightly more participants withdrew from the BFB group (n=6) than the control group 
(n=4). The numbers are very small but it is possible that the BFB participants withdrew 
because they didn‟t want to do the BFB exercises any more. Overall more participants 
dropped out in the control group and this was due to more participants dying or 
undergoing Hartmann‟s Procedure than in the BFB group. 
 
All participants were recruited through the colorectal MDT meetings. Other studies 
have included “biopsy-proven adenocarcinoma of the rectum” judged resectable for 
cure with an abdominal procedure (Holm, Singnomklao, Rutqvist, & Cedermark, 1996) 
as part of the eligibility criteria. In the current trial, all participants had biopsy-proven 
or suspicious radiological imaging for cancer. In addition they had been judged 
resectable by the colorectal MDT process.  
 
Three hundred and four patients with a colorectal cancer within 30cm of the anal verge 
presented and were discussed at the colorectal MDT during the 21 month study 
period. At the MDT meeting they were deemed suitable for primary resection with 
anastomosis (with or without a covering ileostomy) and curative intent. Despite this 
robust recruitment process, there was an overall dropout rate of 26% and the most 
frequent reason for this was that a different operation was performed.  
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There was an apparent failure of the MDT meeting to predict the suitability for primary 
resection in 11 cases, as shown in Table 5.7.02. The three reasons for this were APE, 
inoperable tumour and Hartmann‟s Procedure. 
 
No lower limit was set for height of tumour above the anal verge. Occasionally it 
becomes evident during surgery that the cancer is too low to preserve the sphincter 
and an abdominoperineal resection is performed. This occurred in 4 cases in this trial. 
The possibility of non-restorative surgery was discussed at the MDT meeting and with 
the patient prior to surgery. Perhaps these 4 patients should not have been recruited to 
the trial. However, there was a chance of restorative surgery so it was deemed 
reasonable to recruit them. The number of patients who had a possible similar 
outcome but had restorative surgery was not recorded. If a lower limit had been set for 
height of tumour above the anal verge, these participants would not have been 
recruited. But some participants with low tumours would have been excluded although 
they did undergo anterior resection. This wide inclusion policy allowed us to recruit 
patients with low cancers. Sphincter function is likely to be poorer in patients who have 
very low anastomoses so they were an important group to include in this trial.  
 
Most patients with inoperable cancer were excluded from the trial but inoperable 
disease was discovered at laparotomy in 2 participants despite full imaging workup 
and MDT discussion. There were 7 participants who underwent Hartmann‟s Procedure 
with end colostomy formation.  The reasons for this were technical difficulties 
encountered during the surgery or due to anastomotic leak postoperatively with return 
to theatre. These are unpredictable events and it would not be possible to identify and 
exclude these participants before randomization. 
 
It is very unlikely that a clinical trial will have no dropouts but any dropout is 
associated with introduction of potential bias into the results. One way of trying to 
account for missing data is to use imputation. However a dropout rate of 26% is 
acceptable for a clinical trial of this nature. The baseline CCI was slightly worse in the 
participants who were lost to follow up (CCI=5) compared with those in the analysed 
group (CCI=4).  
 
The study was powered to detect a difference in CCI of 30% with 80% power. A 
difference of this order of magnitude was not found. The difference in CCI between the 
two groups was very small and would not be clinically relevant. Before concluding that 
biofeedback is of no use in improving outcome after anterior resection and accepting 
the null hypothesis it is necessary to critically assess the trial design for any features 
that may lead to a Type II error. The trial was adequately powered (80%) and sufficient SA Pilkington    Results and Discussion 
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participants were recruited and contributed to the final analysis as demanded by the 
sample size calculation. Other possible explanations for this result include: primary 
outcome tool (CCI) was too blunt to detect changes, participant compliance with the 
biofeedback exercise was not consistent between the two groups and participants were 
not blinded to treatment group. 
 
The Cleveland Clinic Incontinence score (CCI) is a widely used score of anal 
incontinence. It is easy to understand and use but when compared with the 
reproducibility of other scoring systems it does not perform so well. CCI was used as 
the primary outcome measure but may not be sensitive enough to detect differences in 
anal continence between the two intervention groups. 
 
Outcome from biofeedback training is known to be highly dependent on participant 
motivation. Participants in the biofeedback group received a phone call every 3 months 
to remind them about doing the exercises, but compliance was low. The participant 
questionnaire suggests that participants did find doing the exercises helpful. Although 
in general participants had low levels of incontinence, biofeedback did not seem to 
improve anal continence. 
 
With a clinical trial such as this one, it is impossible to blind the participants to the 
intervention they are receiving. Although the information sheet clearly stated that BFB 
training after anterior resection was experimental and that it was not known whether 
BFB improved anal continence or not, some patients not randomised to BFB may have 
tried to do exercises in the hope of improving their outcome. A cohort study of 
patients not included in the trial time course could be studied for comparison to see if 
the information given to the participants altered their expectations and final 
continence scores as a direct result of taking part in the study. Pilates are a popular 
form of exercise in women and some of the women in the study continued to do 
pilates irrespective of which group they were randomised to. If repeating this study it 
would be useful to record information about exercises (pilates or as advised by the 
stoma nurses) already performed by the participants and whether they continued these 
for the duration of the study. 
 
The biofeedback sessions were carried out by an experienced GI nurse specialist. 
However there was no quality control of the information provided to the participants. 
Audio-taping of the consultation would have been a useful method for gaining further 
information about the uniformity and quality of the BFB sessions. 
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This study does not support a role for the routine use of focussed biofeedback in 
patients undergoing anterior resection to improve anal incontinence as measured by 
CCI. It is possible that the involvement of other nursing specialists including stoma 
nurses, who routinely recommend sphincter exercises, may have diluted the effect of 
biofeedback in the study group.  
 
There may be a place for selective biofeedback training in patients who have 
symptoms of anterior resection syndrome and further research would be useful in this 
area. Preliminary studies suggest that there may be a role for neuromodulation in 
these patients (Ratto et al., 2005) and again this would be a very interesting area for 
further research. 
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Although routine biofeedback for all patients undergoing anterior resection is an 
attractive option to reduce anal incontinence (Ho, et al., 1996), this randomised trial 
does not show any added advantage when compared with standard treatment. 
Participants in the control and treatment arms of the trial both received preoperative 
advice about exercises for the anal sphincter from the stoma nurses. The extent of this 
advice and how rigorously it was adhered to by the participants was not assessed but 
may have resulted in bias. A useful addition to this trial would have been to record 
whether participants were performing any kind of regular pelvic floor or sphincter 
exercises. 
 
In this project, 15% of participants had a poor functional outcome at one year after 
major rectal resectional surgery. This impacted on their quality of life and symptom 
severity scoring. These participants were characterised by having a CCI greater than or 
equal to 9. “Anterior resection syndrome” can be defined as CCI greater or equal to 9 
at one year after surgery. 
 
There may be a place for selective biofeedback training in patients who have 
symptoms of anterior resection syndrome and further research would be useful in this 
area. A significant proportion of participants with severe anal incontinence at 3 months 
had a poor functional outcome at one year and this would be a good group to target 
for biofeedback. Preliminary studies suggest that there may be a role for 
neuromodulation in patients with a poor functional outcome after anterior resection 
(Ratto, et al., 2005). Data from the current trial report that 41% (9/22) of the study 
group with severe incontinence at 3 months will still have severe incontinence at one 
year. A randomised trial to compare BFB versus neuromodulation for patients with 
severe anal incontinence at 3 months would demonstrate whether there was any 
advantage to BFB or neuromodulation in this group. The main outcome measure would 
be anal incontinence at one year as assessed with CCI. It would be interesting to 
include the Bristol Stool Form Chart (Heaton, et al., 1991; Heaton, et al., 1992; 
O'Donnell, et al., 1990) in the outcome measures. 
 
There is a significant increase in severe anal incontinence after anterior resection at 3 
months. This is accompanied by changes in anorectal physiology. Before surgery, 17% 
of participants reported severe anal incontinence. Although the prevalence of severe 
incontinence at one year was similar to that before surgery, the majority of affected 
individuals (69%) did not have severe incontinence before surgery. There appears to be 
a shift in anal incontinence after anterior resection with 73% of individuals with severe SA Pilkington    Summary 
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incontinence before surgery no longer reporting severe incontinence, and 12% of 
individuals developing new severe anal incontinence which had not resolved at one 
year. 
 
Anastomotic height is an important factor for rectal function after anterior resection. 
Tumour height and length of bowel resection cannot be used as a surrogate for 
measuring anastomotic height. Therefore it is important to assess anastomotic height 
with rigid sigmoidoscopy. This is best achieved immediately after surgery when the 
patient is still in a modified lithotomy position. The integrity of the anastomosis can be 
checked and the height measured under reproducible conditions. 
 
Barium proctography is superior to MR proctography for assessing anatomical 
abnormalities associated with rectal dysfunction. Further investigation is warranted to 
see if this is a useful investigation in patients with anterior resection syndrome. 
 
Quality of life and functional outcome are not major contributors to the MDT process 
at present (Emmertsen & Laurberg, 2008). Tailoring of surgery, radiotherapy and 
chemotherapy with a view to optimising survival whilst minimising poor functional 
outcome, is important and would be facilitated by the inclusion of routine health-
related quality of life and symptom assessment (Wilson, et al., 2006). 
 
This is an important trial which documents functional outcome and quality of life after 
anterior resection. No added advantage was found when routine biofeedback was 
added to standard management. A significant group of participants had a poor 
functional outcome that had not resolved 12 months after surgery. 
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1  0  1  63  1  1  0  0    1  10  1  1  completed  0  0 
2  1  0  62  1  1  0  1    0  12  1  1  APE  0  na 
3  1  1  82  0  1  0  1  231  0  18  1  1  completed  0  0 
4  0  0  84  0  1  0  0    0  5  1  0  leak died  0  na 
5  0  1  65  1  1  0  1  722  0  15  1  0  completed  13  10 
6  0  0  73  0  1  0  1    0  8  1  na  APE  5  na 
7  1  1  76  0  1  0  1  188  0  10  1  0  completed  0  10 
8  1  0  85  1  1  0  0    0  12  1  1  leak died  13  na 
9  1  1  75  0  1  0  1  269  0  15  0  0  completed  0  2 
10  0  1  74  1  1  0  0    0  18  1  0  completed  11  2 
11  1  1  74  0  1  0  0    0  18  1  0  completed  4  4 
12  0  0  66  0  1  0  0    0  35  0  1  died  0  na 
13  1  1  71  1  1  0  0    0  10  1  1  completed  4  4 
14  0  0  67  1  1  0  0    0  10  none  na  inoperable  20  na 
15  1  1  75  0  1 polyp 
cancer 
0  0    0  22  0  1  completed  0  0 
16  0  1  65  0  1  0  1  56  0  18  1  0  completed  8  0 
17  1  1  57  1  1  0  1  101  0  17  1  0  completed  16  3 
18  0  1  50  1  1  0  0    0  20  0  0  completed  0  5 
19  0  1  53  0  1  0  1  287  0  25  0  0  completed  3  0 
20  1  1  75  0  1  0  0    0  15  1  1  completed  0  0 
21  0  1  69  1  1  0  1  77  0  5  1  1  completed  0  2 
22  1  1  50  1  TVA  0  0    0  14  1  1  completed  0  2 
 SA Pilkington    Appendices 
  248   
Appendix XIV Participant Raw Data : BFB Project (continued) 
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23  1  1  81  0  1  0  1  119  0  18  1  0  completed  0  0 
24  0  1  74  1  1  0  0    0  16  1  1  completed  3  0 
25  1  1  69  0  1  0  0    0  20  0  0  completed  5  1 
26  0  1  73  0  1  0  0    0  30  0  0  completed  3  2 
27  0  1  56  1  1  0  0    0  30  0  1  completed  0  3 
28  1  1  69  0  1  0  1  164  0  12  1  0  completed  0  10 
29  0  0  54  1  Diverticular 
stricture 
0  0    0  25  1  0  died  4  na 
30  0  1  82  0  1  0  0    0  27  0  0  completed  5  3 
31  1  1  56  0  TVA  0  0    0  16  0  0  completed  5  4 
32  1  1  72  1  1  0  1  279  0  8  1  0  completed  0  5 
33  1  1  86  1  1  0  1  146  0  12  1  1  completed  5  0 
34  0  1  74  0  1  0  0    0  15  1  1  completed  0  8 
35  0  1  64  1  TVA  0  0    0  15  1  ?  completed  6  6 
36  0  1  58  1  1  0  0    0  18  0  0  completed  0  3 
37  1  1  82  1  1  0  0    0  15  0  1  completed  7  1 
38  1  1  71  1  TVA  0  0    0  18  1  1  completed  3  3 
39  1  0  74  0  1  0  0    0  14  1  na  hartmann  9  na 
40  0  0  51  1  1  0  1  58  0  13  1  0  xdeclined  0  na 
41  0  1  71  0  1  0  1  102  0  10  1  1  completed  8  4 
42  1  1  69  0  1  0  0    0  13  0  0  completed  3  0 
43  0  1  75  1  1  0  0    0  15  1  0  completed  3  3 
44  0  0  50  1  1  0  0    0    0  0  xdeclined  0  2 
45  1  1  59  0  1  0  0    0  20  0  1  completed  0  0 
46  1  1  60  1  TVA  0  0    0  16  1  1  completed  7  8 SA Pilkington    Appendices 
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Appendix XIV Participant Raw Data : BFB Project (continued) 
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47  1  1  55  1  1  0  0    0  15  0  1  completed  0  4 
48  1  1  62  0  Diverticular 
stricture 
0  0    0  20  0  1  completed  9  1 
49  0  1  69  1  1  0  0    0  25  0  1  completed  9  1 
50  0  1  78  1  Diverticular 
stricture 
0  0    0  30  0  0  completed  4  2 
51  1  1  70  0  1  2  1  64  0  10  1  0  completed  1  7 
52  0  1  46  0  Diverticular 
stricture 
0  0    0  20  0  0  completed  0  8 
53  1  1  68  0  1  0  0    0  15  1  0  completed  0  10 
54  0  1  64  1  1  0  0    0  15  1  1  completed  4  4 
55  0  1  78  0  1  0  0    0  25  0  0  completed  0  1 
56  1  0  91  1  1  0  0    0  17  none  na  inoperable  17  na 
57  0  0  52  0  Diverticular 
stricture 
0  0    0  20  0  0  died  0  na 
58  1  1  57  1  1  0  1  413  0  15  1  1  completed  0  4 
59  0  1  63  0  1  0  1  341  0  10  0  ?  completed  2  6 
60  1  1  57  0  Diverticular 
stricture 
0  0    0  25  0  1  completed  9  4 
61  1  1  63  1  1  0  0    0  15  1  1  completed  12  18 
62  0  1  79  0  1  0  0    0  15  1  1  completed  4  0 
63  0  1  64  0  1  0  0    0  25  1  ?  completed  2  1 
64  1  1  67  0  1  0  0    0  25  1  1  completed  1  4 
65  0  1  71  1  1  0  0    0  20  0  1  completed  7  4 
66  1  1  75  0  1  0  0    0  20  1  1  completed  0  0 SA Pilkington    Appendices 
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Appendix XIV Participant Raw Data : BFB Project (continued) 
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67  1  0  90  0  1  0  1    0  12  1  1  no reversal  8  na 
68  0  1  64  1  TVA  0  0    0  30  0  0  completed  0  4 
69  1  1  88  0  1  0  1  76  0  10  1  1  completed  6  2 
70  0  0  93  0  1  0  0    0  8  1  0  xdeclined  0  na 
71  1  1  81  1  1  0  0    0  30  1  1  completed  2  2 
72  0  1  61  0  Diverticular 
stricture 
0  0    0  20  0  1  completed  0  4 
73  0  1  81  0  1  0  0    0  12  1  1  completed  0  5 
74  1  1  78  0  1  0  0    0  22  0  1  completed  0  3 
75  1  0  79  0  1  0  1    0  12  1  1  no reversal  0  na 
76  1  1  86  0  1  0  0    0  20  0  1  completed  0  0 
77  0  0  70  0  1  0  0    0  25  1  0  xdeclined  2  na 
78  0  1  67  0  TVA  0  0    0  12  1  1  completed  0  6 
79  0  0  61  0  1  0  0    0  25  0  1  xdeclined  0  na 
80  1  1  67  1  1  0  0    0  17  0  0  completed  0  12 
81  0  1  65  1  1  0  0    0  20  0  1  completed  6  0 
82  1  1  72  1  1  0  0    0  15  1  0  completed  0  1 
83  1  1  71  0  1  0  1  24  0  10  1  0  completed  2  12 
84  0  1  69  0  1  0  0    0  27  0  0  completed  0  0 
85  0  1  78  1  1  0  0    0  25  0  0  completed  7  2 
86  1  1  70  0  1  0  1  195  0  10  1  1  completed  0  0 
87  0  0  75  1  1  2  1    0  8  1  0  no reversal ileostomy  16  na 
88  1  1  78  0  1  2  1  179  0  8  1  0  completed  4  9 
89  0  1  60  1  1  1  1  203  0  7  1  1  completed  13  14 
90  1  1  73  0  1  1  1  137  0  10  1  0  completed  1  7 SA Pilkington    Appendices 
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Appendix XIV Participant Raw Data : BFB Project (continued) 
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91  0  1  68  0  1  1  1  241  0  12  1  1  completed  6  2 
92  1  0  75  0  1  1  1    0  10  1  0  leak hartmann  11  na 
93  0  1  61  0  1  1  1  144  0  8  1  0  completed  0  10 
94  1  1  63  1  1  1  1  98  0  8  1  1  completed  20  0 
95  1  0  60  1  1  1  0    0  10  1  0  xdeclined  4  na 
101  1  1  70  1  1  2  1  158  0  15  1  0  completed  99  3 
102  0  0  73  0  1  2  1    0  5  1  na  hartmann  0  na 
103  1  1  77  1  1  1  0    0  10  1  1  completed  0  0 
104  0  0  48  0  1  2  1    0  8  1  na  hartmann  0  na 
105  1  1  56  0  1  2  1  150  0  6  1  0  completed  0  7 
106  0  1  73  0  1  2  1  239  0  7  1  1  completed  0  1 
107  0  0  71  1  1  1  1  175  0  8  1  1  early exit  0  na 
108  1  1  59  1  1  2  1  70  0  10  0  0  completed  10  4 
109  0  1  78  0  1  1  1  243  0  10  1  0  completed  18  13 
110  1  1  55  0  1  2  1  112  0  10  1  1  completed  0  4 
111  1  0  65  0  1  2  0    0  11  0  ?  xdeclined  2  na 
112  0  0  64  0  1  2  1    0  15  1  na  hartmann  0  na 
113  0  0  68  0  1  1  1    0  7  1  na  APE  0  na 
114  1  0  48  1  1  1  1    0  4  1  na  APE  14  na 
115  0  1  57  0  1  2  1  113  0  4  1  1  completed  0  9 
116  1  0  62  0  1  1  1  194  0  5  1  1  xdeclined  4  na 
117  0  1  55  1  1  2  1  89  0  7  1  1  completed  0  1 
118  1  0  55  0  1  2  1  203  0  10  1  1  xdeclined  5  na 
119  1  1  70  0  1  1  1  96  0  7  1  1  completed  0  12 
120  0  1  74  0  1  1  1  108  0  8  1  1  completed  15  4 SA Pilkington    Appendices 
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Appendix XIV Participant Raw Data : BFB Project (continued) 
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121  0  0  67  0  1  1  1    0  12  1  na  leak hartmann  0  na 
122  0  1  81  1  1  1  1  147  0  10  0  0  completed  15  2 
123  1  1  70  0  1  1  1  91  0  13  1  0  completed  4  7 
124  1  0  44  0  1  1  1  40  0  10  0  1  xdeclined  3  na 
125  1  0  52  0  1  2  1    0  6  1  na  hartmann  4  na 
126  0  1  52  1  1  2  1  72  0  15  1  1  completed  15  3 
 
 
BFB = 1    Participant was randomized to receive biofeedback training 
Analysed = 1  Participant completed follow up to 1 year after surgery and was included in the analysed sample (n = 89) 
Short DXT = 0  No radiotherapy 
Short DXT = 1  Short course preoperative radiotherapy 
Short DXT = 2  Long course preoperative chemoradiotherapy 
Stoma delay  Days following surgery before stoma reversal 
Anastomosis  0 = side to side anastomosis 
      1 = end to side anastomosis 
CCI baseline  Cleveland Clinic Incontinence score at baseline 
CCI final    Cleveland Clinic Incontinence score at 1 year after surgery SA Pilkington    Appendices 
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N = 89 
 
Appendix XVa  Participants with severe anal incontinence at one year (CCI >= 9) 
      N = 13 
 
Appendix XVb  Participants with no severe anal incontinence at one year (CCI <9) 
ordered from worst highest CCI score at one year (final) to lowest CCI score at one year 
      N = 76 
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Appendix XVb (continued) 
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Appendix XVb (continued) 
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Appendix XVb (continued) 
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Appendix XVb (continued) 
 
     
     
     
 
   
     
Participants 1, 3, 15, 45 and 76 reported CCI = 0 at all 5 time points over the first year 
after anterior resection 
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  Appendix XVIa Barium Proctography Raw Data 
 
  Appendix XVIb MR Proctography Raw Data SA Pilkington    Appendices 
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 (RI: rectal intussusception) (Rectocele size is corrected for radiological magnification) 
ID  Age 
years 
Female 
= 1 
Rectocele 
= 1 
Rectocele 
empties = 1 
Rectocele 
length (cm) 
Enterocele 
= 1 
Complete rectal 
emptying = 1 
Anismus 
= 1 
RI = 1  RI grade 
1  40  1  1  0  3.5  0  0  1  1  2 
3  66  1  1  1  1.1  0  0  1  0  0 
4  62  1  1  1  3.5  1  1  0  1  2 
5  72  1  1  1  2.1  1  1  0  1  4 
6  48  1  1  0  4.6  0  1  1  1  2 
7  65  1  1  1  3.5  0  1  0  1  3 
9  73  1  1  0  6.0  0  0  0  1  2 
10  64  1  1  0  4.2  1  0  0  1  4 
11  61  1  1  1  2.8  1  1  0  1  3 
12  76  1  1  1  2.8  1  1  0  1  3 
13  72  1  1  1  2.1  0  1  0  1  4 
14  50  1  1  0  4.2  0  0  0  1  2 
17  69  1  1  1  1.8  0  1  0  0  0 
20  50  1  1  0  1.4  0  0  1  1  1 
21  70  1  1  1  2.8  0  1  0  1  3 SA Pilkington    Appendices 
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Appendix XVIa Barium Proctography Raw Data (continued) 
 
ID  Age 
years 
Female 
= 1 
Rectocele 
= 1 
Rectocele 
empties = 1 
Rectocele 
length (cm) 
Enterocele 
= 1 
Complete rectal 
emptying = 1 
Anismus 
= 1 
RI = 1  RI grade 
23  47  1  1  0  3.5  0  0  0  1  2 
25  61  0  0  NA  0.0  0  0  0  1  3 
27  47  1  1  0  5.3  0  0  0  1  3 
29  49  1  1  0  4.2  0  0  0  1  1 
30  53  1  1  0  4.2  0  0  0  1  3 
31  44  1  1  0  2.1  0  0  0  1  3 
32  64  0  0  NA  0.0  0  0  1  0  0 
33  56  1  1  0  2.5  0  0  1  1  3 
34  57  1  1  0  5.6  0  0  0  1  4 
37  69  1  1  0  0.7  1  0  0  1  4 
38  50  1  1  0  3.9  0  0  0  1  2 
40  56  1  1  1  0.0  0  1  0  0  0 
42  72  1  1  0  0.0  0  0  0  1  2 
45  54  1  1  0  4.2  1  0  0  1  3 
46  58  0  0  0  0.0  0  0  1  1  2 
47  37  1  1  1  2.8  0  0  1  1  3 
51  69  1  1  1  4.2  0  0  0  1  3 SA Pilkington    Appendices 
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Appendix XVIa Barium Proctography Raw Data (continued) 
 
ID  Age 
years 
Female 
= 1 
Rectocele 
= 1 
Rectocele 
empties = 1 
Rectocele 
length (cm) 
Enterocele 
= 1 
Complete rectal 
emptying = 1 
Anismus 
= 1 
RI = 1  RI grade 
52  49  1  1  0  3.9  0  1  0  1  3 
55  64  1  1  0  3.5  0  0  0  1  2 
56  60  1  1  1  2.8  0  0  1  1  2 
57  42  1  1  0  3.2  0  0  1  0  0 
58  54  1  1  0  3.9  0  0  0  0  0 
59  58  1  1  0  4.9  0  0  1  1  1 
63  74  1  1  0  1.4  0  0  1  1  2 
65  76  0  0  NA  0.0  0  0  0  0  0 
68  64  1  1  0  1.8  0  1  0  1  2 
71  64  1  1  0  3.5  0  0  0  1  3 
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(RI: rectal intussusception) 
 
ID  Age 
years 
Female 
= 1 
Rectocele 
= 1 
Rectocele 
empties = 1 
Rectocele 
length (cm) 
Enterocele 
= 1 
Complete rectal 
emptying = 1 
Anismus 
= 1 
RI = 1  RI grade 
1  40  1  1  0  3  0  0  1  1  1 
3  66  1  1  0  2  0  0  1  0  0 
4  62  1  1  0  4.6  1  0  0  1  2 
5  72  1  1  1  4.3  1  0  0  1  4 
6  48  1  1  0  4  0  0  1  0  0 
7  65  1  1  0  2.8  0  0  0  1  2 
9  73  1  1  0  5.1  0  0  0  1  2 
10  64  1  1  0  6.2  0  0  0  1  2 
11  61  1  1  1  3  1  0  0  1  3 
12  76  1  1  0  2  0  0  0  1  3 
13  72  1  1  1  3  0  0  0  1  3 
14  50  1  1  0  4  0  0  1  1  2 
17  69  1  0  0  0  0  0  0  0  0 
20  50  1  1  0  2  0  0  1  0  0 SA Pilkington    Appendices 
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Appendix XVIb MR Proctography Raw Data (continued) 
 
ID  Age 
years 
Female 
= 1 
Rectocele 
= 1 
Rectocele 
empties = 1 
Rectocele 
length (cm) 
Enterocele 
= 1 
Complete rectal 
emptying = 1 
Anismus 
= 1 
RI = 1  RI grade 
21  70  1  1  0  3.5  0  0  0  1  3 
23  47  1  1  NA  2  0  0  1  0  0 
25  61  0  0  0  NA  0  0  0  0  0 
27  47  1  1  0  4.4  0  0  0  1  2 
29  49  1  1  0  1  0  0  1  0  0 
30  53  1  1  0  2.5  0  0  1  0  0 
31  44  1  1  NA  2.3  0  0  0  1  1 
32  64  0  0  0  0  0  0  1  0  0 
33  56  1  1  NA  1.5  0  0  0  1  2 
34  57  1  1  0  5  0  0  0  1  1 
37  69  1  1  1  3.5  1  0  0  1  2 
38  50  1  1  NA  2.5  0  0  1  0  0 
40  56  1  1  1  3  0  0  0  1  4 
42  72  1  1  0  4.3  0  0  0  1  2 
45  54  1  1  0  3.3  0  0  0  1  2 
46  58  0  0  NA  0  0  0  1  0  0 
47  37  1  1  0  3.8  0  0  1  0  0 SA Pilkington    Appendices 
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Appendix XVIb MR Proctography Raw Data (continued) 
 
ID  Age 
years 
Female 
= 1 
Rectocele 
= 1 
Rectocele 
empties = 1 
Rectocele 
length (cm) 
Enterocele 
= 1 
Complete rectal 
emptying = 1 
Anismus 
= 1 
RI = 1  RI grade 
51  69  1  1  1  3.8  0  1  0  1  3 
52  49  1  1  1  3.7  0  0  0  1  4 
55  64  1  1  0  4.3  0  0  1  1  2 
56  60  1  1  0  2.3  0  0  0  1  2 
57  42  1  0  NA  NA  0  0  1  0  0 
58  54  1  1  0  4  0  0  1  1  1 
59  58  1  1  0  3.8  0  0  1  1  2 
63  74  1  0  0  0  0  0  1  0  0 
65  76  0  0  NA  NA  0  0  0  0  0 
68  64  1  1  0  2  0  0  1  0  0 
71  64  1  1  0  5.1  0  0  0  1  4 
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